date generated: 2022-03-15
Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch
Here is the first few lines of the input profile.
## x
## 0610009B22Rik 0.02592933
## 0610009E02Rik 0.75195906
## 0610009L18Rik -1.06444668
## 0610010K14Rik 0.44760852
## 0610012G03Rik -0.16331991
## 0610030E20Rik -0.62496606
Here are some metrics about the input data profile:
Profile metrics | |
---|---|
num_genesets | 1604 |
num_genes_in_profile | 17595 |
duplicated_genes_present | 0 |
num_profile_genes_in_sets | 8418 |
num_profile_genes_not_in_sets | 9177 |
Here is a plot of the input profiles. Note the dynamic ranges.
Here is the contour plot of the profile including all detected genes.
Gene sets metrics | |
---|---|
num_genesets | 1604 |
num_genesets_excluded | 426 |
num_genesets_included | 1178 |
Significance is calculated by -log10(p-value). All points shown are FDR<0.05.
Significance is calculated by -log10(p-value). Top N sets shown irrespective of FDR.
set | setSize | pANOVA | s.dist | p.adjustANOVA |
---|---|---|---|---|
FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | 19 | 9.33e-08 | 0.707 | 5.50e-06 |
ALPHA LINOLENIC OMEGA3 AND LINOLEIC OMEGA6 ACID METABOLISM | 12 | 2.65e-04 | 0.608 | 4.00e-03 |
GOLGI CISTERNAE PERICENTRIOLAR STACK REORGANIZATION | 12 | 5.67e-04 | 0.575 | 7.04e-03 |
PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | 12 | 7.89e-04 | 0.560 | 9.11e-03 |
RHOBTB3 ATPASE CYCLE | 10 | 2.45e-03 | 0.553 | 2.10e-02 |
TRANSPORT OF CONNEXONS TO THE PLASMA MEMBRANE | 13 | 8.36e-04 | 0.535 | 9.38e-03 |
BBSOME MEDIATED CARGO TARGETING TO CILIUM | 23 | 9.28e-06 | 0.534 | 2.80e-04 |
CITRIC ACID CYCLE TCA CYCLE | 22 | 2.49e-05 | 0.519 | 6.36e-04 |
NUCLEOBASE BIOSYNTHESIS | 15 | 6.68e-04 | 0.507 | 8.03e-03 |
KERATAN SULFATE BIOSYNTHESIS | 24 | 2.54e-05 | 0.497 | 6.36e-04 |
COPI INDEPENDENT GOLGI TO ER RETROGRADE TRAFFIC | 44 | 1.48e-08 | 0.493 | 1.16e-06 |
COOPERATION OF PREFOLDIN AND TRIC CCT IN ACTIN AND TUBULIN FOLDING | 26 | 2.52e-05 | 0.477 | 6.36e-04 |
HSP90 CHAPERONE CYCLE FOR STEROID HORMONE RECEPTORS SHR | 48 | 2.46e-08 | 0.465 | 1.70e-06 |
KERATAN SULFATE KERATIN METABOLISM | 30 | 1.46e-05 | 0.457 | 4.09e-04 |
CALNEXIN CALRETICULIN CYCLE | 26 | 5.90e-05 | 0.455 | 1.20e-03 |
GLYCOGEN STORAGE DISEASES | 12 | 6.44e-03 | 0.454 | 4.24e-02 |
GAP JUNCTION ASSEMBLY | 21 | 3.14e-04 | 0.454 | 4.62e-03 |
ENDOSOMAL VACUOLAR PATHWAY | 10 | 1.31e-02 | -0.453 | 6.81e-02 |
RETROGRADE NEUROTROPHIN SIGNALLING | 13 | 4.77e-03 | 0.452 | 3.39e-02 |
GLYCOGEN SYNTHESIS | 14 | 3.63e-03 | 0.449 | 2.74e-02 |
SEALING OF THE NUCLEAR ENVELOPE NE BY ESCRT III | 23 | 2.65e-04 | 0.439 | 4.00e-03 |
LDL CLEARANCE | 16 | 2.46e-03 | 0.437 | 2.10e-02 |
CHK1 CHK2 CDS1 MEDIATED INACTIVATION OF CYCLIN B CDK1 COMPLEX | 10 | 1.69e-02 | 0.436 | 8.00e-02 |
OLFACTORY SIGNALING PATHWAY | 40 | 2.56e-06 | -0.430 | 1.12e-04 |
RHO GTPASES ACTIVATE IQGAPS | 23 | 3.81e-04 | 0.428 | 5.21e-03 |
RECEPTOR MEDIATED MITOPHAGY | 11 | 1.49e-02 | 0.424 | 7.49e-02 |
PURINE SALVAGE | 12 | 1.14e-02 | 0.422 | 6.22e-02 |
N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | 35 | 1.74e-05 | 0.420 | 4.75e-04 |
CD28 DEPENDENT VAV1 PATHWAY | 11 | 1.64e-02 | 0.418 | 7.89e-02 |
ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | 11 | 1.65e-02 | 0.417 | 7.89e-02 |
N GLYCAN ANTENNAE ELONGATION | 15 | 5.19e-03 | 0.417 | 3.56e-02 |
TRANSLATION OF REPLICASE AND ASSEMBLY OF THE REPLICATION TRANSCRIPTION COMPLEX | 12 | 1.24e-02 | 0.417 | 6.54e-02 |
WNT5A DEPENDENT INTERNALIZATION OF FZD2 FZD5 AND ROR2 | 13 | 9.63e-03 | 0.415 | 5.44e-02 |
SYNTHESIS OF PYROPHOSPHATES IN THE CYTOSOL | 10 | 2.35e-02 | 0.414 | 1.00e-01 |
GLYCOGEN METABOLISM | 25 | 3.53e-04 | 0.413 | 5.01e-03 |
REGULATION OF TP53 ACTIVITY THROUGH ASSOCIATION WITH CO FACTORS | 14 | 8.18e-03 | 0.408 | 4.92e-02 |
CYTOSOLIC TRNA AMINOACYLATION | 24 | 5.42e-04 | 0.408 | 6.94e-03 |
INSERTION OF TAIL ANCHORED PROTEINS INTO THE ENDOPLASMIC RETICULUM MEMBRANE | 22 | 9.58e-04 | 0.407 | 1.05e-02 |
GLYCOSPHINGOLIPID METABOLISM | 38 | 1.44e-05 | 0.407 | 4.09e-04 |
WNT LIGAND BIOGENESIS AND TRAFFICKING | 21 | 1.61e-03 | 0.398 | 1.57e-02 |
SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | 20 | 2.11e-03 | 0.397 | 1.91e-02 |
GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | 14 | 1.08e-02 | 0.394 | 5.96e-02 |
SUPPRESSION OF PHAGOSOMAL MATURATION | 12 | 1.83e-02 | 0.393 | 8.39e-02 |
CS DS DEGRADATION | 14 | 1.24e-02 | 0.386 | 6.53e-02 |
IRE1ALPHA ACTIVATES CHAPERONES | 50 | 2.69e-06 | 0.384 | 1.13e-04 |
KERATAN SULFATE DEGRADATION | 11 | 2.84e-02 | 0.382 | 1.14e-01 |
ACTIVATION OF AMPK DOWNSTREAM OF NMDARS | 20 | 3.36e-03 | 0.379 | 2.62e-02 |
RECYCLING PATHWAY OF L1 | 40 | 3.41e-05 | 0.379 | 8.20e-04 |
POST CHAPERONIN TUBULIN FOLDING PATHWAY | 17 | 7.01e-03 | 0.378 | 4.49e-02 |
COPI MEDIATED ANTEROGRADE TRANSPORT | 91 | 5.78e-10 | 0.376 | 5.23e-08 |
set | setSize | pANOVA | s.dist | p.adjustANOVA |
---|---|---|---|---|
FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | 19 | 9.33e-08 | 7.07e-01 | 5.50e-06 |
ALPHA LINOLENIC OMEGA3 AND LINOLEIC OMEGA6 ACID METABOLISM | 12 | 2.65e-04 | 6.08e-01 | 4.00e-03 |
GOLGI CISTERNAE PERICENTRIOLAR STACK REORGANIZATION | 12 | 5.67e-04 | 5.75e-01 | 7.04e-03 |
PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | 12 | 7.89e-04 | 5.60e-01 | 9.11e-03 |
RHOBTB3 ATPASE CYCLE | 10 | 2.45e-03 | 5.53e-01 | 2.10e-02 |
TRANSPORT OF CONNEXONS TO THE PLASMA MEMBRANE | 13 | 8.36e-04 | 5.35e-01 | 9.38e-03 |
BBSOME MEDIATED CARGO TARGETING TO CILIUM | 23 | 9.28e-06 | 5.34e-01 | 2.80e-04 |
CITRIC ACID CYCLE TCA CYCLE | 22 | 2.49e-05 | 5.19e-01 | 6.36e-04 |
NUCLEOBASE BIOSYNTHESIS | 15 | 6.68e-04 | 5.07e-01 | 8.03e-03 |
KERATAN SULFATE BIOSYNTHESIS | 24 | 2.54e-05 | 4.97e-01 | 6.36e-04 |
COPI INDEPENDENT GOLGI TO ER RETROGRADE TRAFFIC | 44 | 1.48e-08 | 4.93e-01 | 1.16e-06 |
COOPERATION OF PREFOLDIN AND TRIC CCT IN ACTIN AND TUBULIN FOLDING | 26 | 2.52e-05 | 4.77e-01 | 6.36e-04 |
HSP90 CHAPERONE CYCLE FOR STEROID HORMONE RECEPTORS SHR | 48 | 2.46e-08 | 4.65e-01 | 1.70e-06 |
KERATAN SULFATE KERATIN METABOLISM | 30 | 1.46e-05 | 4.57e-01 | 4.09e-04 |
CALNEXIN CALRETICULIN CYCLE | 26 | 5.90e-05 | 4.55e-01 | 1.20e-03 |
GLYCOGEN STORAGE DISEASES | 12 | 6.44e-03 | 4.54e-01 | 4.24e-02 |
GAP JUNCTION ASSEMBLY | 21 | 3.14e-04 | 4.54e-01 | 4.62e-03 |
ENDOSOMAL VACUOLAR PATHWAY | 10 | 1.31e-02 | -4.53e-01 | 6.81e-02 |
RETROGRADE NEUROTROPHIN SIGNALLING | 13 | 4.77e-03 | 4.52e-01 | 3.39e-02 |
GLYCOGEN SYNTHESIS | 14 | 3.63e-03 | 4.49e-01 | 2.74e-02 |
SEALING OF THE NUCLEAR ENVELOPE NE BY ESCRT III | 23 | 2.65e-04 | 4.39e-01 | 4.00e-03 |
LDL CLEARANCE | 16 | 2.46e-03 | 4.37e-01 | 2.10e-02 |
CHK1 CHK2 CDS1 MEDIATED INACTIVATION OF CYCLIN B CDK1 COMPLEX | 10 | 1.69e-02 | 4.36e-01 | 8.00e-02 |
OLFACTORY SIGNALING PATHWAY | 40 | 2.56e-06 | -4.30e-01 | 1.12e-04 |
RHO GTPASES ACTIVATE IQGAPS | 23 | 3.81e-04 | 4.28e-01 | 5.21e-03 |
RECEPTOR MEDIATED MITOPHAGY | 11 | 1.49e-02 | 4.24e-01 | 7.49e-02 |
PURINE SALVAGE | 12 | 1.14e-02 | 4.22e-01 | 6.22e-02 |
N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | 35 | 1.74e-05 | 4.20e-01 | 4.75e-04 |
CD28 DEPENDENT VAV1 PATHWAY | 11 | 1.64e-02 | 4.18e-01 | 7.89e-02 |
ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | 11 | 1.65e-02 | 4.17e-01 | 7.89e-02 |
N GLYCAN ANTENNAE ELONGATION | 15 | 5.19e-03 | 4.17e-01 | 3.56e-02 |
TRANSLATION OF REPLICASE AND ASSEMBLY OF THE REPLICATION TRANSCRIPTION COMPLEX | 12 | 1.24e-02 | 4.17e-01 | 6.54e-02 |
WNT5A DEPENDENT INTERNALIZATION OF FZD2 FZD5 AND ROR2 | 13 | 9.63e-03 | 4.15e-01 | 5.44e-02 |
SYNTHESIS OF PYROPHOSPHATES IN THE CYTOSOL | 10 | 2.35e-02 | 4.14e-01 | 1.00e-01 |
GLYCOGEN METABOLISM | 25 | 3.53e-04 | 4.13e-01 | 5.01e-03 |
REGULATION OF TP53 ACTIVITY THROUGH ASSOCIATION WITH CO FACTORS | 14 | 8.18e-03 | 4.08e-01 | 4.92e-02 |
CYTOSOLIC TRNA AMINOACYLATION | 24 | 5.42e-04 | 4.08e-01 | 6.94e-03 |
INSERTION OF TAIL ANCHORED PROTEINS INTO THE ENDOPLASMIC RETICULUM MEMBRANE | 22 | 9.58e-04 | 4.07e-01 | 1.05e-02 |
GLYCOSPHINGOLIPID METABOLISM | 38 | 1.44e-05 | 4.07e-01 | 4.09e-04 |
WNT LIGAND BIOGENESIS AND TRAFFICKING | 21 | 1.61e-03 | 3.98e-01 | 1.57e-02 |
SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | 20 | 2.11e-03 | 3.97e-01 | 1.91e-02 |
GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | 14 | 1.08e-02 | 3.94e-01 | 5.96e-02 |
SUPPRESSION OF PHAGOSOMAL MATURATION | 12 | 1.83e-02 | 3.93e-01 | 8.39e-02 |
CS DS DEGRADATION | 14 | 1.24e-02 | 3.86e-01 | 6.53e-02 |
IRE1ALPHA ACTIVATES CHAPERONES | 50 | 2.69e-06 | 3.84e-01 | 1.13e-04 |
KERATAN SULFATE DEGRADATION | 11 | 2.84e-02 | 3.82e-01 | 1.14e-01 |
ACTIVATION OF AMPK DOWNSTREAM OF NMDARS | 20 | 3.36e-03 | 3.79e-01 | 2.62e-02 |
RECYCLING PATHWAY OF L1 | 40 | 3.41e-05 | 3.79e-01 | 8.20e-04 |
POST CHAPERONIN TUBULIN FOLDING PATHWAY | 17 | 7.01e-03 | 3.78e-01 | 4.49e-02 |
COPI MEDIATED ANTEROGRADE TRANSPORT | 91 | 5.78e-10 | 3.76e-01 | 5.23e-08 |
BETA OXIDATION OF VERY LONG CHAIN FATTY ACIDS | 11 | 3.33e-02 | 3.71e-01 | 1.30e-01 |
RESPONSE OF MTB TO PHAGOCYTOSIS | 21 | 3.31e-03 | 3.70e-01 | 2.60e-02 |
CARGO TRAFFICKING TO THE PERICILIARY MEMBRANE | 49 | 7.34e-06 | 3.70e-01 | 2.34e-04 |
ACTIVATED NTRK2 SIGNALS THROUGH FRS2 AND FRS3 | 10 | 4.51e-02 | 3.66e-01 | 1.60e-01 |
INTERFERON ALPHA BETA SIGNALING | 53 | 4.94e-06 | -3.63e-01 | 1.71e-04 |
BRANCHED CHAIN AMINO ACID CATABOLISM | 21 | 4.42e-03 | 3.59e-01 | 3.19e-02 |
N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | 24 | 2.43e-03 | 3.57e-01 | 2.10e-02 |
ATF6 ATF6 ALPHA ACTIVATES CHAPERONE GENES | 10 | 5.15e-02 | 3.56e-01 | 1.75e-01 |
KILLING MECHANISMS | 11 | 4.23e-02 | -3.54e-01 | 1.53e-01 |
VLDLR INTERNALISATION AND DEGRADATION | 12 | 3.50e-02 | 3.52e-01 | 1.33e-01 |
GAP JUNCTION TRAFFICKING AND REGULATION | 33 | 4.84e-04 | 3.51e-01 | 6.34e-03 |
ER QUALITY CONTROL COMPARTMENT ERQC | 21 | 5.66e-03 | 3.49e-01 | 3.83e-02 |
ACTIVATION OF BAD AND TRANSLOCATION TO MITOCHONDRIA | 15 | 1.99e-02 | 3.47e-01 | 8.86e-02 |
GOLGI TO ER RETROGRADE TRANSPORT | 119 | 6.02e-11 | 3.47e-01 | 1.01e-08 |
INSULIN PROCESSING | 24 | 3.26e-03 | 3.47e-01 | 2.59e-02 |
SYNTHESIS OF ACTIVE UBIQUITIN ROLES OF E1 AND E2 ENZYMES | 29 | 1.26e-03 | 3.46e-01 | 1.31e-02 |
ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | 38 | 2.34e-04 | 3.45e-01 | 3.67e-03 |
FATTY ACYL COA BIOSYNTHESIS | 32 | 7.84e-04 | 3.43e-01 | 9.11e-03 |
SULFUR AMINO ACID METABOLISM | 23 | 4.78e-03 | 3.40e-01 | 3.39e-02 |
AGGREPHAGY | 35 | 5.23e-04 | 3.39e-01 | 6.77e-03 |
GLUCONEOGENESIS | 27 | 2.37e-03 | 3.38e-01 | 2.08e-02 |
HYALURONAN UPTAKE AND DEGRADATION | 11 | 5.33e-02 | 3.36e-01 | 1.78e-01 |
NUCLEAR ENVELOPE NE REASSEMBLY | 64 | 3.79e-06 | 3.34e-01 | 1.39e-04 |
MATURATION OF SARS COV 2 SPIKE PROTEIN | 29 | 1.90e-03 | 3.33e-01 | 1.77e-02 |
DERMATAN SULFATE BIOSYNTHESIS | 11 | 5.65e-02 | 3.32e-01 | 1.87e-01 |
INTRAFLAGELLAR TRANSPORT | 52 | 3.49e-05 | 3.32e-01 | 8.21e-04 |
INFECTION WITH MYCOBACTERIUM TUBERCULOSIS | 24 | 4.93e-03 | 3.32e-01 | 3.43e-02 |
PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | 51 | 5.11e-05 | 3.28e-01 | 1.08e-03 |
THE ROLE OF NEF IN HIV 1 REPLICATION AND DISEASE PATHOGENESIS | 27 | 3.27e-03 | 3.27e-01 | 2.59e-02 |
INSULIN RECEPTOR RECYCLING | 20 | 1.19e-02 | 3.25e-01 | 6.41e-02 |
HSF1 ACTIVATION | 25 | 5.38e-03 | 3.22e-01 | 3.66e-02 |
SPRY REGULATION OF FGF SIGNALING | 16 | 2.60e-02 | 3.22e-01 | 1.07e-01 |
GLUTAMATE AND GLUTAMINE METABOLISM | 13 | 4.53e-02 | 3.21e-01 | 1.61e-01 |
TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | 171 | 5.69e-13 | 3.20e-01 | 1.34e-10 |
DISEASES ASSOCIATED WITH GLYCOSAMINOGLYCAN METABOLISM | 39 | 5.54e-04 | 3.20e-01 | 7.02e-03 |
LYSOSOME VESICLE BIOGENESIS | 33 | 1.53e-03 | 3.19e-01 | 1.52e-02 |
MATURATION OF NUCLEOPROTEIN | 10 | 8.30e-02 | -3.17e-01 | 2.42e-01 |
INITIATION OF NUCLEAR ENVELOPE NE REFORMATION | 17 | 2.42e-02 | 3.16e-01 | 1.02e-01 |
MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | 15 | 3.47e-02 | -3.15e-01 | 1.32e-01 |
ER TO GOLGI ANTEROGRADE TRANSPORT | 142 | 1.22e-10 | 3.13e-01 | 1.44e-08 |
PEROXISOMAL LIPID METABOLISM | 27 | 4.92e-03 | 3.13e-01 | 3.43e-02 |
PROTEIN METHYLATION | 17 | 2.56e-02 | 3.13e-01 | 1.06e-01 |
COPI DEPENDENT GOLGI TO ER RETROGRADE TRAFFIC | 86 | 5.85e-07 | 3.12e-01 | 3.00e-05 |
MHC CLASS II ANTIGEN PRESENTATION | 102 | 5.62e-08 | 3.11e-01 | 3.48e-06 |
RAF ACTIVATION | 34 | 1.69e-03 | 3.11e-01 | 1.63e-02 |
CTLA4 INHIBITORY SIGNALING | 20 | 1.65e-02 | 3.10e-01 | 7.89e-02 |
RAP1 SIGNALLING | 15 | 3.79e-02 | 3.10e-01 | 1.41e-01 |
TRNA AMINOACYLATION | 42 | 5.63e-04 | 3.08e-01 | 7.04e-03 |
HSF1 DEPENDENT TRANSACTIVATION | 33 | 2.39e-03 | 3.06e-01 | 2.08e-02 |
APOPTOSIS INDUCED DNA FRAGMENTATION | 10 | 9.44e-02 | -3.05e-01 | 2.67e-01 |
KSRP KHSRP BINDS AND DESTABILIZES MRNA | 16 | 3.46e-02 | -3.05e-01 | 1.32e-01 |
ASPARTATE AND ASPARAGINE METABOLISM | 10 | 9.79e-02 | 3.02e-01 | 2.72e-01 |
GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | 30 | 4.24e-03 | 3.02e-01 | 3.08e-02 |
SPHINGOLIPID METABOLISM | 80 | 3.33e-06 | 3.01e-01 | 1.27e-04 |
ADENYLATE CYCLASE INHIBITORY PATHWAY | 13 | 6.12e-02 | 3.00e-01 | 1.96e-01 |
SELECTIVE AUTOPHAGY | 72 | 1.10e-05 | 3.00e-01 | 3.24e-04 |
EPHRIN SIGNALING | 19 | 2.41e-02 | 2.99e-01 | 1.02e-01 |
DARPP 32 EVENTS | 23 | 1.32e-02 | 2.99e-01 | 6.82e-02 |
PRESYNAPTIC DEPOLARIZATION AND CALCIUM CHANNEL OPENING | 11 | 8.66e-02 | -2.98e-01 | 2.49e-01 |
CARGO CONCENTRATION IN THE ER | 31 | 4.21e-03 | 2.97e-01 | 3.08e-02 |
NUCLEOTIDE LIKE PURINERGIC RECEPTORS | 13 | 6.65e-02 | 2.94e-01 | 2.08e-01 |
CREB1 PHOSPHORYLATION THROUGH THE ACTIVATION OF ADENYLATE CYCLASE | 11 | 9.15e-02 | 2.94e-01 | 2.60e-01 |
VEGFR2 MEDIATED VASCULAR PERMEABILITY | 27 | 8.69e-03 | 2.92e-01 | 5.11e-02 |
ASPARAGINE N LINKED GLYCOSYLATION | 285 | 2.66e-17 | 2.91e-01 | 1.57e-14 |
PTK6 REGULATES RHO GTPASES RAS GTPASE AND MAP KINASES | 13 | 6.91e-02 | 2.91e-01 | 2.14e-01 |
PEROXISOMAL PROTEIN IMPORT | 59 | 1.12e-04 | 2.91e-01 | 2.07e-03 |
RESOLUTION OF D LOOP STRUCTURES THROUGH SYNTHESIS DEPENDENT STRAND ANNEALING SDSA | 25 | 1.21e-02 | -2.90e-01 | 6.47e-02 |
ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 12 | 20 | 2.52e-02 | 2.89e-01 | 1.05e-01 |
HDMS DEMETHYLATE HISTONES | 30 | 6.22e-03 | -2.89e-01 | 4.17e-02 |
CARBOXYTERMINAL POST TRANSLATIONAL MODIFICATIONS OF TUBULIN | 36 | 2.75e-03 | 2.88e-01 | 2.28e-02 |
REGULATION OF MECP2 EXPRESSION AND ACTIVITY | 29 | 7.83e-03 | -2.85e-01 | 4.81e-02 |
NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | 14 | 6.46e-02 | 2.85e-01 | 2.02e-01 |
PKA MEDIATED PHOSPHORYLATION OF CREB | 19 | 3.14e-02 | 2.85e-01 | 1.24e-01 |
IRON UPTAKE AND TRANSPORT | 51 | 4.52e-04 | 2.84e-01 | 5.99e-03 |
TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN G2 CELL CYCLE ARREST | 15 | 5.73e-02 | 2.84e-01 | 1.88e-01 |
DEFECTIVE CFTR CAUSES CYSTIC FIBROSIS | 59 | 1.71e-04 | 2.83e-01 | 2.93e-03 |
AUTOPHAGY | 139 | 9.74e-09 | 2.82e-01 | 8.20e-07 |
COOPERATION OF PDCL PHLP1 AND TRIC CCT IN G PROTEIN BETA FOLDING | 36 | 3.56e-03 | 2.81e-01 | 2.73e-02 |
ACYL CHAIN REMODELLING OF PE | 17 | 4.78e-02 | 2.77e-01 | 1.66e-01 |
SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | 16 | 5.49e-02 | 2.77e-01 | 1.83e-01 |
INTERFERON GAMMA SIGNALING | 74 | 3.78e-05 | -2.77e-01 | 8.73e-04 |
RAB GERANYLGERANYLATION | 57 | 3.61e-04 | 2.73e-01 | 5.07e-03 |
PKMTS METHYLATE HISTONE LYSINES | 51 | 7.53e-04 | -2.73e-01 | 8.87e-03 |
LYSINE CATABOLISM | 11 | 1.18e-01 | 2.72e-01 | 3.08e-01 |
SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | 13 | 8.98e-02 | 2.72e-01 | 2.57e-01 |
RESOLUTION OF D LOOP STRUCTURES | 31 | 9.15e-03 | -2.71e-01 | 5.23e-02 |
CHOLESTEROL BIOSYNTHESIS | 24 | 2.20e-02 | 2.70e-01 | 9.61e-02 |
RUNX1 REGULATES GENES INVOLVED IN MEGAKARYOCYTE DIFFERENTIATION AND PLATELET FUNCTION | 54 | 5.98e-04 | -2.70e-01 | 7.26e-03 |
GAP JUNCTION DEGRADATION | 11 | 1.21e-01 | 2.70e-01 | 3.12e-01 |
COPII MEDIATED VESICLE TRANSPORT | 66 | 1.70e-04 | 2.68e-01 | 2.93e-03 |
THE ROLE OF GTSE1 IN G2 M PROGRESSION AFTER G2 CHECKPOINT | 66 | 1.73e-04 | 2.67e-01 | 2.93e-03 |
SIGNAL AMPLIFICATION | 31 | 1.00e-02 | 2.67e-01 | 5.58e-02 |
GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | 16 | 6.42e-02 | 2.67e-01 | 2.02e-01 |
DEGRADATION OF CYSTEINE AND HOMOCYSTEINE | 13 | 9.58e-02 | 2.67e-01 | 2.70e-01 |
INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | 13 | 9.61e-02 | 2.67e-01 | 2.70e-01 |
INTRA GOLGI AND RETROGRADE GOLGI TO ER TRAFFIC | 185 | 4.87e-10 | 2.65e-01 | 4.78e-08 |
BUDDING AND MATURATION OF HIV VIRION | 27 | 1.71e-02 | 2.65e-01 | 8.01e-02 |
SIGNALING BY HEDGEHOG | 141 | 5.58e-08 | 2.65e-01 | 3.48e-06 |
DEPOLYMERISATION OF THE NUCLEAR LAMINA | 13 | 9.80e-02 | 2.65e-01 | 2.72e-01 |
ROS AND RNS PRODUCTION IN PHAGOCYTES | 28 | 1.53e-02 | 2.65e-01 | 7.60e-02 |
G ALPHA Z SIGNALLING EVENTS | 45 | 2.20e-03 | 2.64e-01 | 1.98e-02 |
G1 S SPECIFIC TRANSCRIPTION | 26 | 2.08e-02 | 2.62e-01 | 9.25e-02 |
NUCLEOTIDE SALVAGE | 21 | 3.78e-02 | 2.62e-01 | 1.40e-01 |
TRANSCRIPTION OF E2F TARGETS UNDER NEGATIVE CONTROL BY P107 RBL1 AND P130 RBL2 IN COMPLEX WITH HDAC1 | 15 | 7.92e-02 | 2.62e-01 | 2.34e-01 |
FORMATION OF APOPTOSOME | 10 | 1.52e-01 | 2.62e-01 | 3.69e-01 |
TRANSLOCATION OF SLC2A4 GLUT4 TO THE PLASMA MEMBRANE | 63 | 3.32e-04 | 2.61e-01 | 4.77e-03 |
PENTOSE PHOSPHATE PATHWAY | 13 | 1.03e-01 | 2.61e-01 | 2.84e-01 |
NEUROTOXICITY OF CLOSTRIDIUM TOXINS | 10 | 1.53e-01 | 2.61e-01 | 3.70e-01 |
SEROTONIN RECEPTORS | 10 | 1.55e-01 | 2.60e-01 | 3.71e-01 |
PKA ACTIVATION IN GLUCAGON SIGNALLING | 16 | 7.18e-02 | 2.60e-01 | 2.19e-01 |
LAMININ INTERACTIONS | 29 | 1.56e-02 | -2.59e-01 | 7.69e-02 |
HEDGEHOG OFF STATE | 106 | 3.98e-06 | 2.59e-01 | 1.42e-04 |
ERKS ARE INACTIVATED | 13 | 1.06e-01 | 2.59e-01 | 2.86e-01 |
UPTAKE AND ACTIONS OF BACTERIAL TOXINS | 28 | 1.81e-02 | 2.58e-01 | 8.35e-02 |
DEFECTIVE B4GALT7 CAUSES EDS PROGEROID TYPE | 20 | 4.62e-02 | 2.57e-01 | 1.63e-01 |
TRANSCRIPTION OF E2F TARGETS UNDER NEGATIVE CONTROL BY DREAM COMPLEX | 18 | 5.97e-02 | 2.56e-01 | 1.93e-01 |
ACTIVATION OF RAC1 | 13 | 1.10e-01 | 2.56e-01 | 2.93e-01 |
TRANSFERRIN ENDOCYTOSIS AND RECYCLING | 26 | 2.39e-02 | 2.56e-01 | 1.01e-01 |
FGFR2 LIGAND BINDING AND ACTIVATION | 12 | 1.25e-01 | -2.56e-01 | 3.20e-01 |
GLYCOSAMINOGLYCAN METABOLISM | 113 | 2.78e-06 | 2.55e-01 | 1.13e-04 |
UPTAKE AND FUNCTION OF ANTHRAX TOXINS | 11 | 1.45e-01 | 2.54e-01 | 3.59e-01 |
GLUCAGON SIGNALING IN METABOLIC REGULATION | 30 | 1.64e-02 | 2.53e-01 | 7.89e-02 |
PROCESSING AND ACTIVATION OF SUMO | 10 | 1.66e-01 | 2.53e-01 | 3.88e-01 |
RHO GTPASES ACTIVATE WASPS AND WAVES | 36 | 8.71e-03 | 2.53e-01 | 5.11e-02 |
LOSS OF FUNCTION OF MECP2 IN RETT SYNDROME | 13 | 1.15e-01 | -2.53e-01 | 3.01e-01 |
CHONDROITIN SULFATE BIOSYNTHESIS | 18 | 6.42e-02 | 2.52e-01 | 2.02e-01 |
WNT5A DEPENDENT INTERNALIZATION OF FZD4 | 15 | 9.13e-02 | 2.52e-01 | 2.60e-01 |
MITOPHAGY | 29 | 1.94e-02 | 2.51e-01 | 8.74e-02 |
REGULATION OF FOXO TRANSCRIPTIONAL ACTIVITY BY ACETYLATION | 10 | 1.70e-01 | -2.51e-01 | 3.93e-01 |
PROTEIN FOLDING | 90 | 4.10e-05 | 2.50e-01 | 9.11e-04 |
O LINKED GLYCOSYLATION OF MUCINS | 40 | 6.63e-03 | 2.48e-01 | 4.30e-02 |
TELOMERE C STRAND SYNTHESIS INITIATION | 13 | 1.24e-01 | 2.46e-01 | 3.18e-01 |
METABOLISM OF POLYAMINES | 57 | 1.34e-03 | 2.46e-01 | 1.39e-02 |
CREB1 PHOSPHORYLATION THROUGH NMDA RECEPTOR MEDIATED ACTIVATION OF RAS SIGNALING | 28 | 2.51e-02 | 2.45e-01 | 1.05e-01 |
RHOBTB2 GTPASE CYCLE | 23 | 4.24e-02 | 2.45e-01 | 1.53e-01 |
REGULATION OF INSULIN LIKE GROWTH FACTOR IGF TRANSPORT AND UPTAKE BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | 92 | 5.23e-05 | 2.44e-01 | 1.08e-03 |
INTERACTION BETWEEN L1 AND ANKYRINS | 27 | 2.84e-02 | -2.44e-01 | 1.14e-01 |
HEDGEHOG LIGAND BIOGENESIS | 61 | 1.02e-03 | 2.43e-01 | 1.12e-02 |
PROLACTIN RECEPTOR SIGNALING | 11 | 1.63e-01 | 2.43e-01 | 3.83e-01 |
ATTENUATION PHASE | 23 | 4.41e-02 | 2.43e-01 | 1.58e-01 |
PROTEIN LOCALIZATION | 158 | 1.54e-07 | 2.42e-01 | 8.66e-06 |
ACTIVATION OF THE AP 1 FAMILY OF TRANSCRIPTION FACTORS | 10 | 1.87e-01 | 2.41e-01 | 4.19e-01 |
TP53 REGULATES TRANSCRIPTION OF SEVERAL ADDITIONAL CELL DEATH GENES WHOSE SPECIFIC ROLES IN P53 DEPENDENT APOPTOSIS REMAIN UNCERTAIN | 12 | 1.50e-01 | 2.40e-01 | 3.67e-01 |
REGULATION OF LOCALIZATION OF FOXO TRANSCRIPTION FACTORS | 12 | 1.51e-01 | 2.40e-01 | 3.69e-01 |
TP53 REGULATES TRANSCRIPTION OF CASPASE ACTIVATORS AND CASPASES | 11 | 1.69e-01 | -2.39e-01 | 3.93e-01 |
NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | 21 | 5.79e-02 | 2.39e-01 | 1.90e-01 |
METABOLISM OF CARBOHYDRATES | 260 | 3.79e-11 | 2.38e-01 | 7.43e-09 |
GABA RECEPTOR ACTIVATION | 55 | 2.25e-03 | 2.38e-01 | 1.99e-02 |
PLATELET ADHESION TO EXPOSED COLLAGEN | 13 | 1.37e-01 | -2.38e-01 | 3.43e-01 |
POSTMITOTIC NUCLEAR PORE COMPLEX NPC REFORMATION | 26 | 3.57e-02 | 2.38e-01 | 1.34e-01 |
SIGNALING BY NODAL | 15 | 1.11e-01 | -2.38e-01 | 2.93e-01 |
O GLYCOSYLATION OF TSR DOMAIN CONTAINING PROTEINS | 35 | 1.54e-02 | -2.37e-01 | 7.60e-02 |
G0 AND EARLY G1 | 25 | 4.06e-02 | 2.37e-01 | 1.48e-01 |
TP53 REGULATES TRANSCRIPTION OF ADDITIONAL CELL CYCLE GENES WHOSE EXACT ROLE IN THE P53 PATHWAY REMAIN UNCERTAIN | 20 | 6.88e-02 | 2.35e-01 | 2.13e-01 |
TRIGLYCERIDE CATABOLISM | 14 | 1.29e-01 | 2.34e-01 | 3.28e-01 |
REGULATION OF IFNG SIGNALING | 13 | 1.44e-01 | 2.34e-01 | 3.58e-01 |
ABC TRANSPORTER DISORDERS | 70 | 7.36e-04 | 2.33e-01 | 8.76e-03 |
CHEMOKINE RECEPTORS BIND CHEMOKINES | 17 | 9.62e-02 | -2.33e-01 | 2.70e-01 |
DEFECTS OF CONTACT ACTIVATION SYSTEM CAS AND KALLIKREIN KININ SYSTEM KKS | 11 | 1.81e-01 | -2.33e-01 | 4.09e-01 |
REGULATION OF HMOX1 EXPRESSION AND ACTIVITY | 63 | 1.43e-03 | 2.32e-01 | 1.44e-02 |
UNFOLDED PROTEIN RESPONSE UPR | 85 | 2.14e-04 | 2.32e-01 | 3.46e-03 |
PLASMA LIPOPROTEIN CLEARANCE | 28 | 3.40e-02 | 2.32e-01 | 1.31e-01 |
TRISTETRAPROLIN TTP ZFP36 BINDS AND DESTABILIZES MRNA | 16 | 1.11e-01 | -2.30e-01 | 2.93e-01 |
THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | 28 | 3.56e-02 | 2.29e-01 | 1.34e-01 |
GLUTATHIONE SYNTHESIS AND RECYCLING | 11 | 1.88e-01 | 2.29e-01 | 4.19e-01 |
SYNTHESIS OF PROSTAGLANDINS PG AND THROMBOXANES TX | 12 | 1.70e-01 | 2.29e-01 | 3.93e-01 |
CYCLIN A CDK2 ASSOCIATED EVENTS AT S PHASE ENTRY | 84 | 3.04e-04 | 2.28e-01 | 4.54e-03 |
CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | 48 | 6.48e-03 | 2.27e-01 | 4.24e-02 |
EXTRA NUCLEAR ESTROGEN SIGNALING | 68 | 1.20e-03 | 2.27e-01 | 1.28e-02 |
ATF6 ATF6 ALPHA ACTIVATES CHAPERONES | 12 | 1.73e-01 | 2.27e-01 | 3.97e-01 |
CLASS B 2 SECRETIN FAMILY RECEPTORS | 73 | 8.08e-04 | 2.27e-01 | 9.16e-03 |
ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | 30 | 3.22e-02 | 2.26e-01 | 1.27e-01 |
REGULATION OF TP53 EXPRESSION AND DEGRADATION | 34 | 2.27e-02 | 2.26e-01 | 9.78e-02 |
INTEGRATION OF ENERGY METABOLISM | 100 | 9.94e-05 | 2.25e-01 | 1.89e-03 |
METABOLISM OF NUCLEOTIDES | 92 | 1.97e-04 | 2.25e-01 | 3.23e-03 |
PLATELET SENSITIZATION BY LDL | 15 | 1.34e-01 | 2.23e-01 | 3.37e-01 |
NEGATIVE REGULATION OF FGFR3 SIGNALING | 24 | 5.84e-02 | 2.23e-01 | 1.90e-01 |
A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | 26 | 4.94e-02 | 2.23e-01 | 1.70e-01 |
REGULATION OF RUNX1 EXPRESSION AND ACTIVITY | 17 | 1.13e-01 | -2.22e-01 | 2.97e-01 |
SYNTHESIS OF PA | 29 | 3.93e-02 | 2.21e-01 | 1.44e-01 |
CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | 46 | 9.64e-03 | 2.21e-01 | 5.44e-02 |
SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | 18 | 1.05e-01 | 2.20e-01 | 2.85e-01 |
TRANSCRIPTIONAL REGULATION OF PLURIPOTENT STEM CELLS | 18 | 1.07e-01 | 2.20e-01 | 2.87e-01 |
HEPARAN SULFATE HEPARIN HS GAG METABOLISM | 52 | 6.27e-03 | 2.19e-01 | 4.18e-02 |
TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | 13 | 1.72e-01 | -2.19e-01 | 3.96e-01 |
ASSEMBLY AND CELL SURFACE PRESENTATION OF NMDA RECEPTORS | 36 | 2.33e-02 | 2.18e-01 | 1.00e-01 |
SCAVENGING OF HEME FROM PLASMA | 12 | 1.91e-01 | -2.18e-01 | 4.24e-01 |
SIGNAL TRANSDUCTION BY L1 | 21 | 8.47e-02 | 2.17e-01 | 2.46e-01 |
HOMOLOGOUS DNA PAIRING AND STRAND EXCHANGE | 41 | 1.61e-02 | -2.17e-01 | 7.85e-02 |
FOXO MEDIATED TRANSCRIPTION OF CELL DEATH GENES | 15 | 1.45e-01 | -2.17e-01 | 3.59e-01 |
RESPONSE OF EIF2AK1 HRI TO HEME DEFICIENCY | 15 | 1.48e-01 | 2.16e-01 | 3.64e-01 |
DISEASES ASSOCIATED WITH N GLYCOSYLATION OF PROTEINS | 17 | 1.23e-01 | 2.16e-01 | 3.17e-01 |
VEGFR2 MEDIATED CELL PROLIFERATION | 19 | 1.04e-01 | 2.15e-01 | 2.85e-01 |
PYRUVATE METABOLISM | 27 | 5.33e-02 | 2.15e-01 | 1.78e-01 |
INTERLEUKIN 10 SIGNALING | 19 | 1.05e-01 | -2.15e-01 | 2.85e-01 |
SARS COV 2 INFECTION | 65 | 2.78e-03 | 2.15e-01 | 2.29e-02 |
PROTEIN UBIQUITINATION | 70 | 1.93e-03 | 2.14e-01 | 1.78e-02 |
MITOCHONDRIAL TRNA AMINOACYLATION | 21 | 8.95e-02 | 2.14e-01 | 2.57e-01 |
SIALIC ACID METABOLISM | 32 | 3.64e-02 | 2.14e-01 | 1.36e-01 |
PI 3K CASCADE FGFR2 | 17 | 1.27e-01 | -2.14e-01 | 3.24e-01 |
STAT5 ACTIVATION DOWNSTREAM OF FLT3 ITD MUTANTS | 10 | 2.43e-01 | -2.13e-01 | 4.84e-01 |
NEGATIVE REGULATION OF FGFR4 SIGNALING | 24 | 7.15e-02 | 2.13e-01 | 2.19e-01 |
REGULATION OF PTEN STABILITY AND ACTIVITY | 66 | 2.88e-03 | 2.12e-01 | 2.36e-02 |
DISASSEMBLY OF THE DESTRUCTION COMPLEX AND RECRUITMENT OF AXIN TO THE MEMBRANE | 26 | 6.20e-02 | 2.11e-01 | 1.98e-01 |
GLUCAGON LIKE PEPTIDE 1 GLP1 REGULATES INSULIN SECRETION | 39 | 2.26e-02 | 2.11e-01 | 9.78e-02 |
HS GAG BIOSYNTHESIS | 30 | 4.57e-02 | 2.11e-01 | 1.62e-01 |
HDR THROUGH HOMOLOGOUS RECOMBINATION HRR | 64 | 3.75e-03 | -2.10e-01 | 2.82e-02 |
REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | 15 | 1.60e-01 | 2.09e-01 | 3.79e-01 |
MTORC1 MEDIATED SIGNALLING | 24 | 7.66e-02 | 2.09e-01 | 2.30e-01 |
HDACS DEACETYLATE HISTONES | 50 | 1.09e-02 | -2.08e-01 | 6.03e-02 |
CGMP EFFECTS | 15 | 1.65e-01 | -2.07e-01 | 3.85e-01 |
DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | 78 | 1.61e-03 | 2.07e-01 | 1.57e-02 |
REGULATION OF GENE EXPRESSION IN LATE STAGE BRANCHING MORPHOGENESIS PANCREATIC BUD PRECURSOR CELLS | 15 | 1.66e-01 | -2.07e-01 | 3.88e-01 |
ACYL CHAIN REMODELLING OF PG | 10 | 2.59e-01 | 2.06e-01 | 5.02e-01 |
FERTILIZATION | 13 | 1.98e-01 | -2.06e-01 | 4.32e-01 |
INTEGRIN CELL SURFACE INTERACTIONS | 75 | 2.02e-03 | -2.06e-01 | 1.85e-02 |
G BETA GAMMA SIGNALLING THROUGH CDC42 | 19 | 1.20e-01 | 2.06e-01 | 3.10e-01 |
FCERI MEDIATED NF KB ACTIVATION | 76 | 1.90e-03 | 2.06e-01 | 1.77e-02 |
SIGNALING BY CTNNB1 PHOSPHO SITE MUTANTS | 15 | 1.67e-01 | 2.06e-01 | 3.90e-01 |
INTRA GOLGI TRAFFIC | 43 | 1.96e-02 | 2.06e-01 | 8.81e-02 |
TRANS GOLGI NETWORK VESICLE BUDDING | 70 | 2.94e-03 | 2.06e-01 | 2.39e-02 |
PROCESSING OF SMDT1 | 16 | 1.55e-01 | 2.06e-01 | 3.71e-01 |
BETA CATENIN PHOSPHORYLATION CASCADE | 16 | 1.55e-01 | 2.05e-01 | 3.71e-01 |
SYNTHESIS OF PC | 26 | 7.09e-02 | 2.05e-01 | 2.19e-01 |
GLYCEROPHOSPHOLIPID BIOSYNTHESIS | 109 | 2.30e-04 | 2.04e-01 | 3.66e-03 |
AMINE LIGAND BINDING RECEPTORS | 29 | 5.70e-02 | 2.04e-01 | 1.88e-01 |
SPHINGOLIPID DE NOVO BIOSYNTHESIS | 42 | 2.24e-02 | 2.04e-01 | 9.75e-02 |
GABA B RECEPTOR ACTIVATION | 40 | 2.62e-02 | 2.03e-01 | 1.07e-01 |
NR1H3 NR1H2 REGULATE GENE EXPRESSION LINKED TO CHOLESTEROL TRANSPORT AND EFFLUX | 32 | 4.69e-02 | -2.03e-01 | 1.64e-01 |
REGULATION OF INSULIN SECRETION | 72 | 2.98e-03 | 2.02e-01 | 2.41e-02 |
MTOR SIGNALLING | 40 | 2.69e-02 | 2.02e-01 | 1.09e-01 |
VASOPRESSIN REGULATES RENAL WATER HOMEOSTASIS VIA AQUAPORINS | 37 | 3.35e-02 | 2.02e-01 | 1.30e-01 |
BUTYRATE RESPONSE FACTOR 1 BRF1 BINDS AND DESTABILIZES MRNA | 16 | 1.63e-01 | -2.01e-01 | 3.83e-01 |
LATE ENDOSOMAL MICROAUTOPHAGY | 32 | 4.89e-02 | 2.01e-01 | 1.69e-01 |
RETROGRADE TRANSPORT AT THE TRANS GOLGI NETWORK | 48 | 1.61e-02 | 2.01e-01 | 7.85e-02 |
KINESINS | 47 | 1.77e-02 | 2.00e-01 | 8.20e-02 |
ACTIVATION OF NMDA RECEPTORS AND POSTSYNAPTIC EVENTS | 84 | 1.55e-03 | 2.00e-01 | 1.53e-02 |
PROLONGED ERK ACTIVATION EVENTS | 13 | 2.13e-01 | 1.99e-01 | 4.51e-01 |
NCAM1 INTERACTIONS | 42 | 2.55e-02 | -1.99e-01 | 1.06e-01 |
DISEASES ASSOCIATED WITH GLYCOSYLATION PRECURSOR BIOSYNTHESIS | 18 | 1.44e-01 | 1.99e-01 | 3.58e-01 |
ERYTHROPOIETIN ACTIVATES RAS | 13 | 2.14e-01 | 1.99e-01 | 4.51e-01 |
MEMBRANE TRAFFICKING | 582 | 2.93e-16 | 1.99e-01 | 1.15e-13 |
PEPTIDE HORMONE METABOLISM | 60 | 7.82e-03 | 1.99e-01 | 4.81e-02 |
SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | 14 | 1.98e-01 | 1.99e-01 | 4.32e-01 |
CELLULAR RESPONSE TO HEAT STRESS | 94 | 9.54e-04 | 1.97e-01 | 1.05e-02 |
IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | 51 | 1.51e-02 | -1.97e-01 | 7.57e-02 |
ACTIVATION OF BH3 ONLY PROTEINS | 30 | 6.25e-02 | 1.97e-01 | 1.99e-01 |
DEGRADATION OF GLI1 BY THE PROTEASOME | 57 | 1.04e-02 | 1.96e-01 | 5.75e-02 |
HDR THROUGH SINGLE STRAND ANNEALING SSA | 37 | 3.92e-02 | -1.96e-01 | 1.44e-01 |
THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | 23 | 1.04e-01 | 1.96e-01 | 2.85e-01 |
DISEASES OF DNA REPAIR | 11 | 2.62e-01 | 1.95e-01 | 5.03e-01 |
NEGATIVE REGULATION OF NOTCH4 SIGNALING | 54 | 1.31e-02 | 1.95e-01 | 6.81e-02 |
REGULATION OF KIT SIGNALING | 16 | 1.77e-01 | 1.95e-01 | 4.04e-01 |
CLATHRIN MEDIATED ENDOCYTOSIS | 134 | 1.01e-04 | 1.95e-01 | 1.89e-03 |
NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | 20 | 1.32e-01 | -1.94e-01 | 3.34e-01 |
STABILIZATION OF P53 | 54 | 1.36e-02 | 1.94e-01 | 6.93e-02 |
CA DEPENDENT EVENTS | 36 | 4.38e-02 | 1.94e-01 | 1.57e-01 |
CLASS I PEROXISOMAL MEMBRANE PROTEIN IMPORT | 20 | 1.33e-01 | 1.94e-01 | 3.35e-01 |
CD28 CO STIMULATION | 31 | 6.21e-02 | 1.94e-01 | 1.98e-01 |
NEUROTRANSMITTER RECEPTORS AND POSTSYNAPTIC SIGNAL TRANSMISSION | 182 | 6.78e-06 | 1.94e-01 | 2.22e-04 |
RAB GEFS EXCHANGE GTP FOR GDP ON RABS | 88 | 1.72e-03 | 1.93e-01 | 1.65e-02 |
ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | 28 | 7.71e-02 | 1.93e-01 | 2.30e-01 |
MITOTIC METAPHASE AND ANAPHASE | 207 | 1.79e-06 | 1.93e-01 | 8.44e-05 |
FATTY ACID METABOLISM | 146 | 6.12e-05 | 1.92e-01 | 1.21e-03 |
B WICH COMPLEX POSITIVELY REGULATES RRNA EXPRESSION | 51 | 1.76e-02 | -1.92e-01 | 8.20e-02 |
NEUTROPHIL DEGRANULATION | 386 | 1.15e-10 | 1.91e-01 | 1.44e-08 |
REGULATION OF RAS BY GAPS | 66 | 7.18e-03 | 1.91e-01 | 4.57e-02 |
REGULATION OF HSF1 MEDIATED HEAT SHOCK RESPONSE | 75 | 4.23e-03 | 1.91e-01 | 3.08e-02 |
PINK1 PRKN MEDIATED MITOPHAGY | 22 | 1.21e-01 | 1.91e-01 | 3.12e-01 |
APC C MEDIATED DEGRADATION OF CELL CYCLE PROTEINS | 81 | 3.11e-03 | 1.90e-01 | 2.49e-02 |
E2F MEDIATED REGULATION OF DNA REPLICATION | 19 | 1.52e-01 | 1.90e-01 | 3.69e-01 |
ACTIVATION OF THE TFAP2 AP 2 FAMILY OF TRANSCRIPTION FACTORS | 10 | 2.99e-01 | -1.90e-01 | 5.46e-01 |
NEDDYLATION | 219 | 1.33e-06 | 1.90e-01 | 6.54e-05 |
METHYLATION | 11 | 2.77e-01 | 1.89e-01 | 5.19e-01 |
VXPX CARGO TARGETING TO CILIUM | 19 | 1.53e-01 | 1.89e-01 | 3.70e-01 |
HEME SIGNALING | 46 | 2.64e-02 | -1.89e-01 | 1.07e-01 |
ADENYLATE CYCLASE ACTIVATING PATHWAY | 10 | 3.03e-01 | 1.88e-01 | 5.50e-01 |
FC EPSILON RECEPTOR FCERI SIGNALING | 123 | 3.19e-04 | 1.88e-01 | 4.65e-03 |
DSCAM INTERACTIONS | 11 | 2.83e-01 | -1.87e-01 | 5.24e-01 |
DISEASES OF CARBOHYDRATE METABOLISM | 29 | 8.12e-02 | 1.87e-01 | 2.39e-01 |
SYNTHESIS OF PE | 13 | 2.44e-01 | 1.87e-01 | 4.84e-01 |
TBC RABGAPS | 43 | 3.43e-02 | 1.87e-01 | 1.31e-01 |
AMINO ACIDS REGULATE MTORC1 | 51 | 2.15e-02 | 1.86e-01 | 9.47e-02 |
CYCLIN A B1 B2 ASSOCIATED EVENTS DURING G2 M TRANSITION | 22 | 1.32e-01 | 1.86e-01 | 3.32e-01 |
VESICLE MEDIATED TRANSPORT | 615 | 4.82e-15 | 1.85e-01 | 1.42e-12 |
NUCLEOBASE CATABOLISM | 31 | 7.40e-02 | 1.85e-01 | 2.23e-01 |
SCF SKP2 MEDIATED DEGRADATION OF P27 P21 | 59 | 1.39e-02 | 1.85e-01 | 7.05e-02 |
NEGATIVE REGULATION OF MET ACTIVITY | 20 | 1.52e-01 | 1.85e-01 | 3.70e-01 |
RHOF GTPASE CYCLE | 41 | 4.11e-02 | 1.84e-01 | 1.49e-01 |
SYNTHESIS OF BILE ACIDS AND BILE SALTS | 23 | 1.27e-01 | 1.84e-01 | 3.24e-01 |
RESOLUTION OF SISTER CHROMATID COHESION | 102 | 1.37e-03 | 1.83e-01 | 1.40e-02 |
REGULATION OF RUNX3 EXPRESSION AND ACTIVITY | 53 | 2.09e-02 | 1.83e-01 | 9.27e-02 |
FCGR3A MEDIATED IL10 SYNTHESIS | 32 | 7.32e-02 | 1.83e-01 | 2.22e-01 |
PHOSPHOLIPASE C MEDIATED CASCADE FGFR2 | 12 | 2.74e-01 | -1.83e-01 | 5.15e-01 |
APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | 70 | 8.32e-03 | 1.82e-01 | 4.98e-02 |
GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | 18 | 1.81e-01 | 1.82e-01 | 4.09e-01 |
METAL ION SLC TRANSPORTERS | 25 | 1.16e-01 | 1.82e-01 | 3.03e-01 |
INTERFERON SIGNALING | 162 | 6.96e-05 | -1.81e-01 | 1.34e-03 |
DEFECTS IN COBALAMIN B12 METABOLISM | 13 | 2.59e-01 | 1.81e-01 | 5.02e-01 |
COBALAMIN CBL VITAMIN B12 TRANSPORT AND METABOLISM | 14 | 2.42e-01 | 1.81e-01 | 4.82e-01 |
RORA ACTIVATES GENE EXPRESSION | 18 | 1.85e-01 | -1.81e-01 | 4.15e-01 |
HEDGEHOG ON STATE | 82 | 4.83e-03 | 1.80e-01 | 3.40e-02 |
METABOLISM OF FAT SOLUBLE VITAMINS | 32 | 7.81e-02 | 1.80e-01 | 2.32e-01 |
CRMPS IN SEMA3A SIGNALING | 16 | 2.14e-01 | -1.80e-01 | 4.51e-01 |
PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | 17 | 2.00e-01 | 1.79e-01 | 4.36e-01 |
CILIUM ASSEMBLY | 192 | 1.94e-05 | 1.79e-01 | 5.19e-04 |
CLEC7A DECTIN 1 INDUCES NFAT ACTIVATION | 11 | 3.04e-01 | 1.79e-01 | 5.50e-01 |
MITOCHONDRIAL FATTY ACID BETA OXIDATION | 34 | 7.12e-02 | 1.79e-01 | 2.19e-01 |
RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | 107 | 1.40e-03 | 1.79e-01 | 1.42e-02 |
REDUCTION OF CYTOSOLIC CA LEVELS | 12 | 2.87e-01 | -1.77e-01 | 5.28e-01 |
GPCR LIGAND BINDING | 271 | 5.44e-07 | 1.77e-01 | 2.91e-05 |
ASSEMBLY OF THE HIV VIRION | 16 | 2.21e-01 | 1.77e-01 | 4.57e-01 |
LISTERIA MONOCYTOGENES ENTRY INTO HOST CELLS | 20 | 1.72e-01 | 1.76e-01 | 3.96e-01 |
BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN GENE EXPRESSION | 26 | 1.21e-01 | -1.76e-01 | 3.12e-01 |
EPHB MEDIATED FORWARD SIGNALING | 42 | 4.93e-02 | 1.75e-01 | 1.70e-01 |
COMPLEX I BIOGENESIS | 56 | 2.34e-02 | -1.75e-01 | 1.00e-01 |
COLLAGEN CHAIN TRIMERIZATION | 41 | 5.26e-02 | -1.75e-01 | 1.77e-01 |
FCERI MEDIATED MAPK ACTIVATION | 28 | 1.10e-01 | 1.74e-01 | 2.93e-01 |
G ALPHA Q SIGNALLING EVENTS | 155 | 1.82e-04 | 1.74e-01 | 3.02e-03 |
RAS ACTIVATION UPON CA2 INFLUX THROUGH NMDA RECEPTOR | 20 | 1.77e-01 | 1.74e-01 | 4.04e-01 |
CARGO RECOGNITION FOR CLATHRIN MEDIATED ENDOCYTOSIS | 94 | 3.56e-03 | 1.74e-01 | 2.73e-02 |
EGFR DOWNREGULATION | 28 | 1.11e-01 | 1.74e-01 | 2.94e-01 |
PI 3K CASCADE FGFR1 | 16 | 2.29e-01 | -1.74e-01 | 4.69e-01 |
TRANSMISSION ACROSS CHEMICAL SYNAPSES | 243 | 3.18e-06 | 1.74e-01 | 1.25e-04 |
STRIATED MUSCLE CONTRACTION | 27 | 1.19e-01 | -1.74e-01 | 3.08e-01 |
ABC FAMILY PROTEINS MEDIATED TRANSPORT | 95 | 3.56e-03 | 1.73e-01 | 2.73e-02 |
SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | 62 | 1.84e-02 | 1.73e-01 | 8.41e-02 |
SARS COV 1 INFECTION | 48 | 3.84e-02 | 1.73e-01 | 1.42e-01 |
PCP CE PATHWAY | 89 | 4.99e-03 | 1.72e-01 | 3.46e-02 |
SIGNALING BY FGFR3 | 34 | 8.24e-02 | 1.72e-01 | 2.41e-01 |
ACYL CHAIN REMODELLING OF PC | 17 | 2.21e-01 | 1.72e-01 | 4.57e-01 |
SEPARATION OF SISTER CHROMATIDS | 166 | 1.41e-04 | 1.71e-01 | 2.56e-03 |
PHOSPHOLIPID METABOLISM | 188 | 5.25e-05 | 1.71e-01 | 1.08e-03 |
MITOTIC G1 PHASE AND G1 S TRANSITION | 142 | 4.36e-04 | 1.71e-01 | 5.91e-03 |
AUF1 HNRNP D0 BINDS AND DESTABILIZES MRNA | 53 | 3.13e-02 | 1.71e-01 | 1.24e-01 |
BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | 76 | 9.98e-03 | 1.71e-01 | 5.58e-02 |
DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | 23 | 1.58e-01 | -1.70e-01 | 3.75e-01 |
G1 S DNA DAMAGE CHECKPOINTS | 65 | 1.78e-02 | 1.70e-01 | 8.21e-02 |
GLUCOSE METABOLISM | 81 | 8.68e-03 | 1.69e-01 | 5.11e-02 |
ADRENALINE NORADRENALINE INHIBITS INSULIN SECRETION | 27 | 1.30e-01 | 1.68e-01 | 3.29e-01 |
TERMINATION OF TRANSLESION DNA SYNTHESIS | 32 | 9.98e-02 | -1.68e-01 | 2.77e-01 |
TRANSCRIPTIONAL REGULATION BY MECP2 | 59 | 2.63e-02 | -1.67e-01 | 1.07e-01 |
TRANSPORT OF BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | 68 | 1.74e-02 | 1.67e-01 | 8.14e-02 |
ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 1 | 24 | 1.57e-01 | 1.67e-01 | 3.74e-01 |
ANCHORING FIBRIL FORMATION | 14 | 2.81e-01 | -1.67e-01 | 5.22e-01 |
TIGHT JUNCTION INTERACTIONS | 16 | 2.51e-01 | 1.66e-01 | 4.94e-01 |
NEGATIVE REGULATION OF MAPK PATHWAY | 42 | 6.36e-02 | 1.65e-01 | 2.01e-01 |
BLOOD GROUP SYSTEMS BIOSYNTHESIS | 15 | 2.68e-01 | 1.65e-01 | 5.08e-01 |
SIGNALING BY FLT3 FUSION PROTEINS | 19 | 2.13e-01 | -1.65e-01 | 4.51e-01 |
SIGNALING BY FGFR4 | 34 | 9.67e-02 | 1.65e-01 | 2.70e-01 |
METABOLISM OF NITRIC OXIDE NOS3 ACTIVATION AND REGULATION | 15 | 2.70e-01 | 1.65e-01 | 5.11e-01 |
POST TRANSLATIONAL PROTEIN MODIFICATION | 1230 | 4.88e-22 | 1.65e-01 | 5.75e-19 |
PRC2 METHYLATES HISTONES AND DNA | 33 | 1.02e-01 | -1.65e-01 | 2.81e-01 |
GENE AND PROTEIN EXPRESSION BY JAK STAT SIGNALING AFTER INTERLEUKIN 12 STIMULATION | 31 | 1.14e-01 | 1.64e-01 | 2.98e-01 |
CASPASE ACTIVATION VIA DEATH RECEPTORS IN THE PRESENCE OF LIGAND | 13 | 3.06e-01 | -1.64e-01 | 5.51e-01 |
INTERLEUKIN 12 FAMILY SIGNALING | 43 | 6.30e-02 | 1.64e-01 | 2.00e-01 |
GOLGI ASSOCIATED VESICLE BIOGENESIS | 55 | 3.56e-02 | 1.64e-01 | 1.34e-01 |
JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | 22 | 1.84e-01 | 1.64e-01 | 4.14e-01 |
PLATELET ACTIVATION SIGNALING AND AGGREGATION | 224 | 2.59e-05 | 1.63e-01 | 6.36e-04 |
INTERLEUKIN 12 SIGNALING | 37 | 8.60e-02 | 1.63e-01 | 2.48e-01 |
TERMINATION OF O GLYCAN BIOSYNTHESIS | 10 | 3.73e-01 | 1.63e-01 | 6.07e-01 |
OPIOID SIGNALLING | 87 | 8.99e-03 | 1.62e-01 | 5.21e-02 |
ACTIVATED PKN1 STIMULATES TRANSCRIPTION OF AR ANDROGEN RECEPTOR REGULATED GENES KLK2 AND KLK3 | 25 | 1.61e-01 | -1.62e-01 | 3.80e-01 |
ZINC INFLUX INTO CELLS BY THE SLC39 GENE FAMILY | 10 | 3.78e-01 | 1.61e-01 | 6.07e-01 |
COMMON PATHWAY OF FIBRIN CLOT FORMATION | 11 | 3.55e-01 | 1.61e-01 | 5.98e-01 |
CLASS A 1 RHODOPSIN LIKE RECEPTORS | 187 | 1.58e-04 | 1.60e-01 | 2.82e-03 |
DEGRADATION OF BETA CATENIN BY THE DESTRUCTION COMPLEX | 82 | 1.23e-02 | 1.60e-01 | 6.52e-02 |
ORC1 REMOVAL FROM CHROMATIN | 67 | 2.36e-02 | 1.60e-01 | 1.00e-01 |
REGULATION OF GLYCOLYSIS BY FRUCTOSE 2 6 BISPHOSPHATE METABOLISM | 11 | 3.60e-01 | 1.60e-01 | 6.01e-01 |
PRE NOTCH PROCESSING IN GOLGI | 18 | 2.42e-01 | 1.59e-01 | 4.82e-01 |
MET ACTIVATES RAP1 AND RAC1 | 10 | 3.83e-01 | 1.59e-01 | 6.09e-01 |
RHO GTPASES ACTIVATE FORMINS | 119 | 2.72e-03 | 1.59e-01 | 2.27e-02 |
FRS MEDIATED FGFR3 SIGNALING | 15 | 2.86e-01 | 1.59e-01 | 5.26e-01 |
PIWI INTERACTING RNA PIRNA BIOGENESIS | 19 | 2.30e-01 | -1.59e-01 | 4.71e-01 |
MITOCHONDRIAL PROTEIN IMPORT | 63 | 2.94e-02 | 1.59e-01 | 1.17e-01 |
MUCOPOLYSACCHARIDOSES | 11 | 3.63e-01 | 1.58e-01 | 6.02e-01 |
INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | 19 | 2.32e-01 | 1.58e-01 | 4.72e-01 |
HOST INTERACTIONS OF HIV FACTORS | 125 | 2.25e-03 | 1.58e-01 | 1.99e-02 |
EPH EPHRIN SIGNALING | 92 | 8.94e-03 | 1.58e-01 | 5.21e-02 |
DEFECTIVE EXT2 CAUSES EXOSTOSES 2 | 14 | 3.08e-01 | 1.57e-01 | 5.52e-01 |
E3 UBIQUITIN LIGASES UBIQUITINATE TARGET PROTEINS | 51 | 5.21e-02 | 1.57e-01 | 1.76e-01 |
SIGNALING BY HIPPO | 20 | 2.24e-01 | 1.57e-01 | 4.61e-01 |
SWITCHING OF ORIGINS TO A POST REPLICATIVE STATE | 86 | 1.20e-02 | 1.57e-01 | 6.43e-02 |
ENOS ACTIVATION | 11 | 3.68e-01 | 1.57e-01 | 6.06e-01 |
TRANSLATION OF SARS COV 2 STRUCTURAL PROTEINS | 44 | 7.25e-02 | 1.57e-01 | 2.21e-01 |
DNA METHYLATION | 24 | 1.85e-01 | -1.56e-01 | 4.15e-01 |
TRANSLESION SYNTHESIS BY Y FAMILY DNA POLYMERASES BYPASSES LESIONS ON DNA TEMPLATE | 39 | 9.16e-02 | -1.56e-01 | 2.60e-01 |
PARASITE INFECTION | 54 | 4.74e-02 | 1.56e-01 | 1.66e-01 |
SIGNALING BY THE B CELL RECEPTOR BCR | 103 | 6.35e-03 | 1.56e-01 | 4.20e-02 |
CHAPERONE MEDIATED AUTOPHAGY | 21 | 2.17e-01 | 1.56e-01 | 4.53e-01 |
DNA REPLICATION PRE INITIATION | 80 | 1.67e-02 | 1.55e-01 | 7.91e-02 |
DEGRADATION OF AXIN | 53 | 5.13e-02 | 1.55e-01 | 1.75e-01 |
FCGAMMA RECEPTOR FCGR DEPENDENT PHAGOCYTOSIS | 81 | 1.61e-02 | 1.55e-01 | 7.85e-02 |
SHC1 EVENTS IN EGFR SIGNALING | 11 | 3.74e-01 | 1.55e-01 | 6.07e-01 |
DEGRADATION OF DVL | 55 | 4.82e-02 | 1.54e-01 | 1.67e-01 |
PHASE 2 PLATEAU PHASE | 10 | 3.99e-01 | -1.54e-01 | 6.24e-01 |
CELL EXTRACELLULAR MATRIX INTERACTIONS | 18 | 2.59e-01 | 1.54e-01 | 5.02e-01 |
TCR SIGNALING | 101 | 7.61e-03 | 1.54e-01 | 4.78e-02 |
COHESIN LOADING ONTO CHROMATIN | 10 | 4.00e-01 | -1.54e-01 | 6.24e-01 |
INOSITOL PHOSPHATE METABOLISM | 46 | 7.16e-02 | 1.54e-01 | 2.19e-01 |
ROLE OF PHOSPHOLIPIDS IN PHAGOCYTOSIS | 22 | 2.13e-01 | 1.54e-01 | 4.51e-01 |
VITAMIN B5 PANTOTHENATE METABOLISM | 15 | 3.04e-01 | 1.53e-01 | 5.50e-01 |
EUKARYOTIC TRANSLATION ELONGATION | 88 | 1.30e-02 | -1.53e-01 | 6.80e-02 |
RAB REGULATION OF TRAFFICKING | 119 | 3.91e-03 | 1.53e-01 | 2.92e-02 |
TNF RECEPTOR SUPERFAMILY TNFSF MEMBERS MEDIATING NON CANONICAL NF KB PATHWAY | 12 | 3.59e-01 | -1.53e-01 | 6.01e-01 |
GROWTH HORMONE RECEPTOR SIGNALING | 20 | 2.37e-01 | 1.53e-01 | 4.78e-01 |
METABOLISM OF LIPIDS | 619 | 1.05e-10 | 1.53e-01 | 1.44e-08 |
THE NLRP3 INFLAMMASOME | 15 | 3.08e-01 | -1.52e-01 | 5.52e-01 |
G ALPHA I SIGNALLING EVENTS | 207 | 1.74e-04 | 1.52e-01 | 2.93e-03 |
G PROTEIN MEDIATED EVENTS | 52 | 5.97e-02 | 1.51e-01 | 1.93e-01 |
C TYPE LECTIN RECEPTORS CLRS | 112 | 5.80e-03 | 1.51e-01 | 3.90e-02 |
TRAF6 MEDIATED IRF7 ACTIVATION | 15 | 3.14e-01 | -1.50e-01 | 5.57e-01 |
SYNAPTIC ADHESION LIKE MOLECULES | 21 | 2.33e-01 | 1.50e-01 | 4.73e-01 |
NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | 17 | 2.84e-01 | 1.50e-01 | 5.25e-01 |
MET ACTIVATES PTK2 SIGNALING | 29 | 1.62e-01 | -1.50e-01 | 3.83e-01 |
GP1B IX V ACTIVATION SIGNALLING | 11 | 3.90e-01 | -1.50e-01 | 6.16e-01 |
AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | 25 | 1.97e-01 | 1.49e-01 | 4.30e-01 |
TP53 REGULATES TRANSCRIPTION OF CELL CYCLE GENES | 45 | 8.49e-02 | 1.48e-01 | 2.46e-01 |
HYALURONAN METABOLISM | 15 | 3.20e-01 | 1.48e-01 | 5.64e-01 |
INTERLEUKIN 15 SIGNALING | 12 | 3.74e-01 | -1.48e-01 | 6.07e-01 |
CLEC7A DECTIN 1 SIGNALING | 94 | 1.33e-02 | 1.48e-01 | 6.83e-02 |
DEADENYLATION OF MRNA | 25 | 2.02e-01 | 1.48e-01 | 4.36e-01 |
L1CAM INTERACTIONS | 108 | 8.17e-03 | 1.47e-01 | 4.92e-02 |
AQUAPORIN MEDIATED TRANSPORT | 41 | 1.04e-01 | 1.47e-01 | 2.84e-01 |
CELLULAR RESPONSE TO HYPOXIA | 72 | 3.17e-02 | 1.46e-01 | 1.25e-01 |
DAG AND IP3 SIGNALING | 40 | 1.13e-01 | 1.45e-01 | 2.97e-01 |
G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | 24 | 2.19e-01 | 1.45e-01 | 4.57e-01 |
FGFR1 LIGAND BINDING AND ACTIVATION | 10 | 4.28e-01 | -1.45e-01 | 6.46e-01 |
CYTOCHROME C MEDIATED APOPTOTIC RESPONSE | 12 | 3.87e-01 | 1.44e-01 | 6.13e-01 |
ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | 10 | 4.32e-01 | 1.44e-01 | 6.49e-01 |
HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | 10 | 4.32e-01 | 1.44e-01 | 6.49e-01 |
RHO GTPASES ACTIVATE NADPH OXIDASES | 20 | 2.67e-01 | 1.43e-01 | 5.08e-01 |
INTRINSIC PATHWAY FOR APOPTOSIS | 52 | 7.42e-02 | 1.43e-01 | 2.23e-01 |
SIGNALLING TO ERKS | 33 | 1.55e-01 | 1.43e-01 | 3.71e-01 |
TNF SIGNALING | 43 | 1.05e-01 | 1.43e-01 | 2.85e-01 |
POSITIVE EPIGENETIC REGULATION OF RRNA EXPRESSION | 66 | 4.47e-02 | -1.43e-01 | 1.60e-01 |
INTERLEUKIN 6 SIGNALING | 10 | 4.34e-01 | 1.43e-01 | 6.50e-01 |
METABOLISM OF STEROIDS | 117 | 7.75e-03 | 1.43e-01 | 4.81e-02 |
REGULATION OF INNATE IMMUNE RESPONSES TO CYTOSOLIC DNA | 13 | 3.74e-01 | 1.42e-01 | 6.07e-01 |
GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | 23 | 2.38e-01 | 1.42e-01 | 4.78e-01 |
FRS MEDIATED FGFR4 SIGNALING | 15 | 3.41e-01 | 1.42e-01 | 5.84e-01 |
CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | 19 | 2.85e-01 | 1.42e-01 | 5.25e-01 |
DECTIN 1 MEDIATED NONCANONICAL NF KB SIGNALING | 59 | 6.00e-02 | 1.42e-01 | 1.93e-01 |
ASSEMBLY OF THE PRE REPLICATIVE COMPLEX | 64 | 5.12e-02 | 1.41e-01 | 1.75e-01 |
CONSTITUTIVE SIGNALING BY AKT1 E17K IN CANCER | 26 | 2.14e-01 | 1.41e-01 | 4.51e-01 |
POLO LIKE KINASE MEDIATED EVENTS | 14 | 3.66e-01 | 1.40e-01 | 6.05e-01 |
ADORA2B MEDIATED ANTI INFLAMMATORY CYTOKINES PRODUCTION | 95 | 1.89e-02 | 1.39e-01 | 8.61e-02 |
TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | 17 | 3.20e-01 | 1.39e-01 | 5.64e-01 |
SIGNALING BY FLT3 ITD AND TKD MUTANTS | 16 | 3.36e-01 | -1.39e-01 | 5.79e-01 |
FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | 119 | 9.07e-03 | 1.39e-01 | 5.21e-02 |
GLUTATHIONE CONJUGATION | 30 | 1.89e-01 | 1.39e-01 | 4.20e-01 |
NF KB ACTIVATION THROUGH FADD RIP 1 PATHWAY MEDIATED BY CASPASE 8 AND 10 | 11 | 4.26e-01 | -1.39e-01 | 6.46e-01 |
DISEASES OF GLYCOSYLATION | 123 | 8.06e-03 | 1.38e-01 | 4.89e-02 |
EPIGENETIC REGULATION OF GENE EXPRESSION | 107 | 1.35e-02 | -1.38e-01 | 6.92e-02 |
PURINE CATABOLISM | 16 | 3.39e-01 | 1.38e-01 | 5.84e-01 |
PHASE II CONJUGATION OF COMPOUNDS | 64 | 5.64e-02 | 1.38e-01 | 1.87e-01 |
PEPTIDE LIGAND BINDING RECEPTORS | 112 | 1.19e-02 | 1.38e-01 | 6.42e-02 |
UNWINDING OF DNA | 12 | 4.09e-01 | 1.38e-01 | 6.28e-01 |
ACTIVATION OF ANTERIOR HOX GENES IN HINDBRAIN DEVELOPMENT DURING EARLY EMBRYOGENESIS | 69 | 4.85e-02 | -1.37e-01 | 1.68e-01 |
SARS COV INFECTIONS | 140 | 5.05e-03 | 1.37e-01 | 3.48e-02 |
SEMA3A PAK DEPENDENT AXON REPULSION | 16 | 3.42e-01 | 1.37e-01 | 5.85e-01 |
NEURONAL SYSTEM | 370 | 6.14e-06 | 1.37e-01 | 2.07e-04 |
INTERLEUKIN 20 FAMILY SIGNALING | 14 | 3.76e-01 | -1.37e-01 | 6.07e-01 |
SIGNALING BY NTRKS | 129 | 7.43e-03 | 1.37e-01 | 4.71e-02 |
ZINC TRANSPORTERS | 16 | 3.46e-01 | 1.36e-01 | 5.88e-01 |
RMTS METHYLATE HISTONE ARGININES | 47 | 1.08e-01 | -1.36e-01 | 2.88e-01 |
DISORDERS OF TRANSMEMBRANE TRANSPORTERS | 146 | 4.69e-03 | 1.36e-01 | 3.37e-02 |
SIGNALING BY NOTCH1 HD DOMAIN MUTANTS IN CANCER | 15 | 3.63e-01 | 1.36e-01 | 6.02e-01 |
PLASMA LIPOPROTEIN ASSEMBLY REMODELING AND CLEARANCE | 49 | 1.01e-01 | 1.36e-01 | 2.78e-01 |
RESPONSE OF EIF2AK4 GCN2 TO AMINO ACID DEFICIENCY | 96 | 2.22e-02 | -1.35e-01 | 9.67e-02 |
INNATE IMMUNE SYSTEM | 779 | 1.71e-10 | 1.35e-01 | 1.83e-08 |
SIGNALING BY RETINOIC ACID | 33 | 1.80e-01 | 1.35e-01 | 4.09e-01 |
METABOLISM OF AMINO ACIDS AND DERIVATIVES | 316 | 3.92e-05 | 1.35e-01 | 8.88e-04 |
BIOLOGICAL OXIDATIONS | 126 | 9.06e-03 | 1.35e-01 | 5.21e-02 |
SHC MEDIATED CASCADE FGFR3 | 13 | 4.01e-01 | 1.35e-01 | 6.24e-01 |
LYSOSPHINGOLIPID AND LPA RECEPTORS | 13 | 4.02e-01 | 1.34e-01 | 6.24e-01 |
NONSENSE MEDIATED DECAY NMD | 110 | 1.52e-02 | -1.34e-01 | 7.60e-02 |
INLB MEDIATED ENTRY OF LISTERIA MONOCYTOGENES INTO HOST CELL | 15 | 3.70e-01 | 1.34e-01 | 6.07e-01 |
RAS PROCESSING | 24 | 2.58e-01 | 1.33e-01 | 5.02e-01 |
SHC1 EVENTS IN ERBB4 SIGNALING | 13 | 4.05e-01 | 1.33e-01 | 6.24e-01 |
DNA REPLICATION | 122 | 1.10e-02 | 1.33e-01 | 6.05e-02 |
SUMOYLATION OF INTRACELLULAR RECEPTORS | 27 | 2.31e-01 | 1.33e-01 | 4.71e-01 |
IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | 10 | 4.66e-01 | 1.33e-01 | 6.77e-01 |
INTERLEUKIN 1 SIGNALING | 96 | 2.43e-02 | 1.33e-01 | 1.02e-01 |
ADAPTIVE IMMUNE SYSTEM | 611 | 2.37e-08 | 1.33e-01 | 1.70e-06 |
ABERRANT REGULATION OF MITOTIC EXIT IN CANCER DUE TO RB1 DEFECTS | 19 | 3.17e-01 | 1.33e-01 | 5.62e-01 |
SIGNALING BY EGFR | 47 | 1.16e-01 | 1.32e-01 | 3.03e-01 |
GPVI MEDIATED ACTIVATION CASCADE | 31 | 2.02e-01 | 1.32e-01 | 4.36e-01 |
ASYMMETRIC LOCALIZATION OF PCP PROTEINS | 62 | 7.34e-02 | 1.32e-01 | 2.22e-01 |
REGULATION OF CHOLESTEROL BIOSYNTHESIS BY SREBP SREBF | 56 | 8.88e-02 | 1.31e-01 | 2.55e-01 |
PHASE I FUNCTIONALIZATION OF COMPOUNDS | 59 | 8.08e-02 | 1.31e-01 | 2.39e-01 |
CD209 DC SIGN SIGNALING | 18 | 3.35e-01 | 1.31e-01 | 5.78e-01 |
CYTOSOLIC IRON SULFUR CLUSTER ASSEMBLY | 13 | 4.14e-01 | -1.31e-01 | 6.32e-01 |
OTHER SEMAPHORIN INTERACTIONS | 19 | 3.26e-01 | -1.30e-01 | 5.69e-01 |
CYTOSOLIC SULFONATION OF SMALL MOLECULES | 15 | 3.82e-01 | 1.30e-01 | 6.09e-01 |
HOMOLOGY DIRECTED REPAIR | 111 | 1.93e-02 | -1.29e-01 | 8.72e-02 |
TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | 11 | 4.61e-01 | 1.28e-01 | 6.74e-01 |
MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | 31 | 2.17e-01 | 1.28e-01 | 4.53e-01 |
ESTROGEN DEPENDENT GENE EXPRESSION | 108 | 2.15e-02 | -1.28e-01 | 9.47e-02 |
DAP12 INTERACTIONS | 30 | 2.25e-01 | -1.28e-01 | 4.63e-01 |
PI3K EVENTS IN ERBB2 SIGNALING | 15 | 3.91e-01 | -1.28e-01 | 6.16e-01 |
NR1H2 AND NR1H3 MEDIATED SIGNALING | 38 | 1.72e-01 | -1.28e-01 | 3.96e-01 |
HIV INFECTION | 221 | 1.07e-03 | 1.28e-01 | 1.14e-02 |
SIGNALING BY PDGFRA TRANSMEMBRANE JUXTAMEMBRANE AND KINASE DOMAIN MUTANTS | 12 | 4.44e-01 | 1.28e-01 | 6.57e-01 |
SIRT1 NEGATIVELY REGULATES RRNA EXPRESSION | 28 | 2.45e-01 | -1.27e-01 | 4.85e-01 |
GLYOXYLATE METABOLISM AND GLYCINE DEGRADATION | 26 | 2.63e-01 | 1.27e-01 | 5.03e-01 |
SIGNALING BY VEGF | 103 | 2.63e-02 | 1.27e-01 | 1.07e-01 |
S PHASE | 154 | 6.68e-03 | 1.27e-01 | 4.30e-02 |
ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | 29 | 2.38e-01 | 1.27e-01 | 4.78e-01 |
NUCLEAR SIGNALING BY ERBB4 | 31 | 2.23e-01 | 1.27e-01 | 4.60e-01 |
PI METABOLISM | 80 | 5.04e-02 | 1.27e-01 | 1.73e-01 |
NEGATIVE REGULATION OF FGFR1 SIGNALING | 27 | 2.56e-01 | 1.26e-01 | 5.01e-01 |
REGULATION OF TNFR1 SIGNALING | 34 | 2.03e-01 | 1.26e-01 | 4.36e-01 |
REGULATION OF BACH1 ACTIVITY | 11 | 4.69e-01 | 1.26e-01 | 6.78e-01 |
TICAM1 RIP1 MEDIATED IKK COMPLEX RECRUITMENT | 18 | 3.55e-01 | 1.26e-01 | 5.98e-01 |
PEXOPHAGY | 11 | 4.71e-01 | 1.26e-01 | 6.79e-01 |
SIGNALING BY GPCR | 487 | 2.25e-06 | 1.25e-01 | 1.02e-04 |
FORMATION OF INCISION COMPLEX IN GG NER | 43 | 1.56e-01 | 1.25e-01 | 3.71e-01 |
FGFR2 MUTANT RECEPTOR ACTIVATION | 27 | 2.61e-01 | -1.25e-01 | 5.02e-01 |
TIE2 SIGNALING | 17 | 3.73e-01 | 1.25e-01 | 6.07e-01 |
FORMATION OF THE CORNIFIED ENVELOPE | 32 | 2.23e-01 | 1.24e-01 | 4.60e-01 |
JOSEPHIN DOMAIN DUBS | 11 | 4.75e-01 | 1.24e-01 | 6.80e-01 |
CD28 DEPENDENT PI3K AKT SIGNALING | 21 | 3.24e-01 | 1.24e-01 | 5.69e-01 |
TRANSLESION SYNTHESIS BY POLK | 17 | 3.75e-01 | -1.24e-01 | 6.07e-01 |
SIGNALING BY ERBB4 | 57 | 1.05e-01 | 1.24e-01 | 2.85e-01 |
DISEASES OF IMMUNE SYSTEM | 25 | 2.83e-01 | -1.24e-01 | 5.25e-01 |
PROGRAMMED CELL DEATH | 186 | 3.60e-03 | 1.24e-01 | 2.73e-02 |
RHOBTB GTPASE CYCLE | 35 | 2.05e-01 | 1.24e-01 | 4.38e-01 |
RHOV GTPASE CYCLE | 33 | 2.20e-01 | 1.24e-01 | 4.57e-01 |
TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | 10 | 4.99e-01 | 1.23e-01 | 7.04e-01 |
POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | 62 | 9.34e-02 | 1.23e-01 | 2.64e-01 |
GLYCOLYSIS | 67 | 8.15e-02 | 1.23e-01 | 2.39e-01 |
REGULATION OF FZD BY UBIQUITINATION | 19 | 3.55e-01 | 1.22e-01 | 5.98e-01 |
HS GAG DEGRADATION | 20 | 3.43e-01 | 1.22e-01 | 5.86e-01 |
FOXO MEDIATED TRANSCRIPTION OF OXIDATIVE STRESS METABOLIC AND NEURONAL GENES | 24 | 3.00e-01 | -1.22e-01 | 5.47e-01 |
ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | 288 | 3.76e-04 | 1.22e-01 | 5.21e-03 |
RESPIRATORY ELECTRON TRANSPORT | 102 | 3.36e-02 | -1.22e-01 | 1.30e-01 |
CHROMATIN MODIFYING ENZYMES | 223 | 1.77e-03 | -1.22e-01 | 1.68e-02 |
REGULATION OF IFNA SIGNALING | 12 | 4.67e-01 | -1.21e-01 | 6.77e-01 |
MITOTIC SPINDLE CHECKPOINT | 97 | 3.96e-02 | 1.21e-01 | 1.45e-01 |
APOPTOSIS | 164 | 7.63e-03 | 1.21e-01 | 4.78e-02 |
REGULATION OF RUNX2 EXPRESSION AND ACTIVITY | 68 | 8.58e-02 | 1.21e-01 | 2.48e-01 |
PYRIMIDINE SALVAGE | 10 | 5.10e-01 | 1.20e-01 | 7.11e-01 |
CONDENSATION OF PROPHASE CHROMOSOMES | 31 | 2.47e-01 | -1.20e-01 | 4.88e-01 |
ACTIVATION OF SMO | 16 | 4.05e-01 | 1.20e-01 | 6.24e-01 |
RHO GTPASE EFFECTORS | 253 | 1.05e-03 | 1.20e-01 | 1.13e-02 |
NOTCH2 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 23 | 3.20e-01 | 1.20e-01 | 5.64e-01 |
MYD88 INDEPENDENT TLR4 CASCADE | 93 | 4.62e-02 | 1.20e-01 | 1.63e-01 |
OTHER INTERLEUKIN SIGNALING | 20 | 3.56e-01 | 1.19e-01 | 5.98e-01 |
CASPASE ACTIVATION VIA DEPENDENCE RECEPTORS IN THE ABSENCE OF LIGAND | 10 | 5.14e-01 | 1.19e-01 | 7.13e-01 |
DNA DAMAGE RECOGNITION IN GG NER | 38 | 2.03e-01 | 1.19e-01 | 4.36e-01 |
RNA POLYMERASE III TRANSCRIPTION TERMINATION | 23 | 3.24e-01 | -1.19e-01 | 5.69e-01 |
DISEASES OF METABOLISM | 197 | 4.19e-03 | 1.18e-01 | 3.08e-02 |
ESTROGEN DEPENDENT NUCLEAR EVENTS DOWNSTREAM OF ESR MEMBRANE SIGNALING | 21 | 3.48e-01 | 1.18e-01 | 5.90e-01 |
SIGNALING BY WNT IN CANCER | 31 | 2.55e-01 | 1.18e-01 | 4.99e-01 |
IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | 21 | 3.49e-01 | 1.18e-01 | 5.90e-01 |
APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | 34 | 2.35e-01 | 1.18e-01 | 4.75e-01 |
CONSTITUTIVE SIGNALING BY OVEREXPRESSED ERBB2 | 11 | 4.99e-01 | 1.18e-01 | 7.04e-01 |
FORMATION OF SENESCENCE ASSOCIATED HETEROCHROMATIN FOCI SAHF | 14 | 4.46e-01 | -1.18e-01 | 6.59e-01 |
SUMOYLATION OF IMMUNE RESPONSE PROTEINS | 11 | 5.00e-01 | 1.17e-01 | 7.04e-01 |
TELOMERE EXTENSION BY TELOMERASE | 22 | 3.46e-01 | 1.16e-01 | 5.88e-01 |
TNFR1 INDUCED NFKAPPAB SIGNALING PATHWAY | 29 | 2.80e-01 | 1.16e-01 | 5.22e-01 |
METABOLISM OF FOLATE AND PTERINES | 15 | 4.37e-01 | 1.16e-01 | 6.54e-01 |
TRIGLYCERIDE METABOLISM | 24 | 3.27e-01 | 1.16e-01 | 5.70e-01 |
INTRINSIC PATHWAY OF FIBRIN CLOT FORMATION | 15 | 4.39e-01 | -1.15e-01 | 6.55e-01 |
METABOLISM OF VITAMINS AND COFACTORS | 152 | 1.43e-02 | 1.15e-01 | 7.22e-02 |
ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | 32 | 2.59e-01 | 1.15e-01 | 5.02e-01 |
TNFR2 NON CANONICAL NF KB PATHWAY | 79 | 7.77e-02 | 1.15e-01 | 2.31e-01 |
SHC MEDIATED CASCADE FGFR4 | 13 | 4.73e-01 | 1.15e-01 | 6.80e-01 |
M PHASE | 344 | 2.63e-04 | 1.15e-01 | 4.00e-03 |
INFLUENZA INFECTION | 146 | 1.70e-02 | -1.15e-01 | 8.00e-02 |
DNA DOUBLE STRAND BREAK REPAIR | 140 | 1.98e-02 | -1.14e-01 | 8.85e-02 |
MITOCHONDRIAL CALCIUM ION TRANSPORT | 23 | 3.44e-01 | 1.14e-01 | 5.87e-01 |
MITOTIC G2 G2 M PHASES | 184 | 7.80e-03 | 1.14e-01 | 4.81e-02 |
GENE SILENCING BY RNA | 86 | 6.84e-02 | -1.14e-01 | 2.13e-01 |
NOTCH3 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 23 | 3.47e-01 | -1.13e-01 | 5.88e-01 |
MITOTIC TELOPHASE CYTOKINESIS | 13 | 4.81e-01 | -1.13e-01 | 6.84e-01 |
SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | 20 | 3.82e-01 | -1.13e-01 | 6.09e-01 |
MAPK6 MAPK4 SIGNALING | 83 | 7.69e-02 | 1.12e-01 | 2.30e-01 |
SIGNALING BY SCF KIT | 41 | 2.13e-01 | 1.12e-01 | 4.51e-01 |
SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | 53 | 1.59e-01 | 1.12e-01 | 3.77e-01 |
ORGANELLE BIOGENESIS AND MAINTENANCE | 284 | 1.22e-03 | 1.12e-01 | 1.29e-02 |
CYCLIN D ASSOCIATED EVENTS IN G1 | 45 | 1.96e-01 | 1.11e-01 | 4.30e-01 |
COSTIMULATION BY THE CD28 FAMILY | 51 | 1.71e-01 | 1.11e-01 | 3.94e-01 |
BILE ACID AND BILE SALT METABOLISM | 26 | 3.28e-01 | 1.11e-01 | 5.72e-01 |
INWARDLY RECTIFYING K CHANNELS | 32 | 2.78e-01 | 1.11e-01 | 5.21e-01 |
KERATINIZATION | 33 | 2.72e-01 | 1.11e-01 | 5.13e-01 |
SYNTHESIS OF LEUKOTRIENES LT AND EOXINS EX | 12 | 5.07e-01 | -1.11e-01 | 7.10e-01 |
SYNTHESIS OF IP3 AND IP4 IN THE CYTOSOL | 25 | 3.41e-01 | 1.10e-01 | 5.84e-01 |
TRAF6 MEDIATED NF KB ACTIVATION | 22 | 3.72e-01 | -1.10e-01 | 6.07e-01 |
INTERLEUKIN 1 FAMILY SIGNALING | 123 | 3.59e-02 | 1.10e-01 | 1.34e-01 |
EPHA MEDIATED GROWTH CONE COLLAPSE | 29 | 3.07e-01 | -1.10e-01 | 5.52e-01 |
EGR2 AND SOX10 MEDIATED INITIATION OF SCHWANN CELL MYELINATION | 27 | 3.25e-01 | 1.09e-01 | 5.69e-01 |
MAP3K8 TPL2 DEPENDENT MAPK1 3 ACTIVATION | 16 | 4.50e-01 | 1.09e-01 | 6.62e-01 |
SIGNALING BY FGFR2 IN DISEASE | 37 | 2.52e-01 | -1.09e-01 | 4.94e-01 |
HEMOSTASIS | 478 | 4.81e-05 | 1.09e-01 | 1.05e-03 |
TRANSPORT OF SMALL MOLECULES | 584 | 7.99e-06 | 1.08e-01 | 2.48e-04 |
METABOLISM OF WATER SOLUBLE VITAMINS AND COFACTORS | 102 | 5.92e-02 | 1.08e-01 | 1.92e-01 |
CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | 348 | 5.91e-04 | 1.07e-01 | 7.25e-03 |
CELL CYCLE MITOTIC | 479 | 6.17e-05 | 1.07e-01 | 1.21e-03 |
NOTCH4 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 20 | 4.08e-01 | -1.07e-01 | 6.27e-01 |
PTEN REGULATION | 133 | 3.35e-02 | 1.07e-01 | 1.30e-01 |
ASSEMBLY OF COLLAGEN FIBRILS AND OTHER MULTIMERIC STRUCTURES | 52 | 1.85e-01 | -1.06e-01 | 4.16e-01 |
RHOBTB1 GTPASE CYCLE | 23 | 3.78e-01 | 1.06e-01 | 6.07e-01 |
BETA CATENIN INDEPENDENT WNT SIGNALING | 140 | 3.07e-02 | 1.06e-01 | 1.22e-01 |
SIGNALING BY WNT | 274 | 2.66e-03 | 1.06e-01 | 2.24e-02 |
FLT3 SIGNALING IN DISEASE | 28 | 3.35e-01 | -1.05e-01 | 5.78e-01 |
DEACTIVATION OF THE BETA CATENIN TRANSACTIVATING COMPLEX | 41 | 2.45e-01 | 1.05e-01 | 4.85e-01 |
BIOTIN TRANSPORT AND METABOLISM | 11 | 5.47e-01 | -1.05e-01 | 7.40e-01 |
SIGNALING BY PTK6 | 50 | 2.03e-01 | 1.04e-01 | 4.36e-01 |
TRNA MODIFICATION IN THE NUCLEUS AND CYTOSOL | 43 | 2.40e-01 | -1.04e-01 | 4.80e-01 |
RNA POLYMERASE I TRANSCRIPTION TERMINATION | 31 | 3.19e-01 | -1.03e-01 | 5.64e-01 |
EPH EPHRIN MEDIATED REPULSION OF CELLS | 51 | 2.03e-01 | 1.03e-01 | 4.36e-01 |
MITOCHONDRIAL IRON SULFUR CLUSTER BIOGENESIS | 13 | 5.20e-01 | -1.03e-01 | 7.17e-01 |
RUNX3 REGULATES NOTCH SIGNALING | 13 | 5.21e-01 | -1.03e-01 | 7.17e-01 |
ACTIVATION OF MATRIX METALLOPROTEINASES | 15 | 4.90e-01 | 1.03e-01 | 6.94e-01 |
INITIAL TRIGGERING OF COMPLEMENT | 12 | 5.38e-01 | 1.03e-01 | 7.35e-01 |
ACTIVATION OF THE PRE REPLICATIVE COMPLEX | 30 | 3.32e-01 | 1.02e-01 | 5.75e-01 |
SENSORY PERCEPTION | 162 | 2.56e-02 | -1.02e-01 | 1.06e-01 |
RHOH GTPASE CYCLE | 37 | 2.86e-01 | 1.01e-01 | 5.26e-01 |
SIGNALING BY NOTCH4 | 83 | 1.11e-01 | 1.01e-01 | 2.93e-01 |
SIGNALING BY MODERATE KINASE ACTIVITY BRAF MUTANTS | 41 | 2.63e-01 | 1.01e-01 | 5.03e-01 |
ECM PROTEOGLYCANS | 68 | 1.51e-01 | -1.01e-01 | 3.69e-01 |
PHASE 0 RAPID DEPOLARISATION | 28 | 3.58e-01 | -1.00e-01 | 6.00e-01 |
SIGNALING BY TYPE 1 INSULIN LIKE GROWTH FACTOR 1 RECEPTOR IGF1R | 46 | 2.39e-01 | -1.00e-01 | 4.79e-01 |
INTERLEUKIN 7 SIGNALING | 19 | 4.49e-01 | -1.00e-01 | 6.62e-01 |
ANTI INFLAMMATORY RESPONSE FAVOURING LEISHMANIA PARASITE INFECTION | 119 | 5.91e-02 | 1.00e-01 | 1.92e-01 |
RAC2 GTPASE CYCLE | 87 | 1.07e-01 | 1.00e-01 | 2.87e-01 |
MEIOTIC RECOMBINATION | 42 | 2.64e-01 | -9.97e-02 | 5.03e-01 |
PHASE 4 RESTING MEMBRANE POTENTIAL | 14 | 5.19e-01 | -9.95e-02 | 7.17e-01 |
MISCELLANEOUS TRANSPORT AND BINDING EVENTS | 21 | 4.30e-01 | 9.94e-02 | 6.49e-01 |
RHOG GTPASE CYCLE | 74 | 1.40e-01 | 9.93e-02 | 3.49e-01 |
VIRAL MESSENGER RNA SYNTHESIS | 42 | 2.67e-01 | -9.91e-02 | 5.08e-01 |
FANCONI ANEMIA PATHWAY | 36 | 3.06e-01 | -9.86e-02 | 5.51e-01 |
CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | 11 | 5.72e-01 | 9.84e-02 | 7.61e-01 |
REGULATION OF PTEN GENE TRANSCRIPTION | 58 | 1.96e-01 | 9.83e-02 | 4.29e-01 |
NOTCH3 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 26 | 3.87e-01 | 9.80e-02 | 6.13e-01 |
SIGNALING BY CSF3 G CSF | 29 | 3.62e-01 | 9.79e-02 | 6.02e-01 |
INFLAMMASOMES | 19 | 4.63e-01 | -9.74e-02 | 6.76e-01 |
APC CDC20 MEDIATED DEGRADATION OF NEK2A | 24 | 4.11e-01 | 9.69e-02 | 6.28e-01 |
METABOLISM OF STEROID HORMONES | 22 | 4.32e-01 | 9.68e-02 | 6.49e-01 |
POLYMERASE SWITCHING ON THE C STRAND OF THE TELOMERE | 25 | 4.03e-01 | 9.66e-02 | 6.24e-01 |
ABC TRANSPORTERS IN LIPID HOMEOSTASIS | 14 | 5.33e-01 | 9.62e-02 | 7.31e-01 |
RUNX1 INTERACTS WITH CO FACTORS WHOSE PRECISE EFFECT ON RUNX1 TARGETS IS NOT KNOWN | 37 | 3.12e-01 | -9.61e-02 | 5.55e-01 |
TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | 16 | 5.07e-01 | 9.58e-02 | 7.10e-01 |
TNFR1 INDUCED PROAPOPTOTIC SIGNALING | 12 | 5.67e-01 | 9.55e-02 | 7.56e-01 |
UB SPECIFIC PROCESSING PROTEASES | 169 | 3.34e-02 | 9.50e-02 | 1.30e-01 |
HEME BIOSYNTHESIS | 13 | 5.55e-01 | 9.46e-02 | 7.49e-01 |
DNA DAMAGE BYPASS | 47 | 2.63e-01 | -9.44e-02 | 5.03e-01 |
RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | 125 | 6.86e-02 | -9.44e-02 | 2.13e-01 |
G PROTEIN BETA GAMMA SIGNALLING | 31 | 3.64e-01 | 9.42e-02 | 6.02e-01 |
NGF STIMULATED TRANSCRIPTION | 36 | 3.30e-01 | 9.39e-02 | 5.73e-01 |
ERYTHROPOIETIN ACTIVATES PHOSPHOINOSITIDE 3 KINASE PI3K | 11 | 5.90e-01 | -9.38e-02 | 7.77e-01 |
ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | 16 | 5.16e-01 | 9.38e-02 | 7.14e-01 |
ONCOGENIC MAPK SIGNALING | 77 | 1.55e-01 | 9.37e-02 | 3.71e-01 |
ORGANIC CATION ANION ZWITTERION TRANSPORT | 11 | 5.92e-01 | -9.32e-02 | 7.78e-01 |
TRANSLATION | 287 | 6.66e-03 | 9.32e-02 | 4.30e-02 |
REPRODUCTION | 81 | 1.49e-01 | -9.28e-02 | 3.66e-01 |
SCAVENGING BY CLASS A RECEPTORS | 14 | 5.48e-01 | 9.27e-02 | 7.40e-01 |
CELL CELL JUNCTION ORGANIZATION | 48 | 2.67e-01 | 9.27e-02 | 5.08e-01 |
REGULATED PROTEOLYSIS OF P75NTR | 12 | 5.79e-01 | 9.26e-02 | 7.67e-01 |
NEGATIVE REGULATION OF NMDA RECEPTOR MEDIATED NEURONAL TRANSMISSION | 21 | 4.66e-01 | 9.19e-02 | 6.77e-01 |
NON INTEGRIN MEMBRANE ECM INTERACTIONS | 57 | 2.31e-01 | -9.18e-02 | 4.71e-01 |
SHC1 EVENTS IN ERBB2 SIGNALING | 21 | 4.66e-01 | 9.18e-02 | 6.77e-01 |
NOTCH HLH TRANSCRIPTION PATHWAY | 28 | 4.01e-01 | -9.18e-02 | 6.24e-01 |
NEGATIVE REGULATION OF FGFR2 SIGNALING | 28 | 4.03e-01 | 9.14e-02 | 6.24e-01 |
SIGNALING BY INSULIN RECEPTOR | 65 | 2.03e-01 | 9.13e-02 | 4.36e-01 |
INTERLEUKIN 17 SIGNALING | 68 | 1.93e-01 | 9.12e-02 | 4.26e-01 |
TRANSCRIPTIONAL REGULATION BY SMALL RNAS | 65 | 2.04e-01 | -9.12e-02 | 4.37e-01 |
RNA POLYMERASE I PROMOTER ESCAPE | 51 | 2.61e-01 | -9.10e-02 | 5.02e-01 |
RHOJ GTPASE CYCLE | 54 | 2.48e-01 | 9.10e-02 | 4.89e-01 |
HIV ELONGATION ARREST AND RECOVERY | 32 | 3.73e-01 | -9.09e-02 | 6.07e-01 |
NEGATIVE EPIGENETIC REGULATION OF RRNA EXPRESSION | 69 | 1.92e-01 | -9.09e-02 | 4.24e-01 |
NICOTINAMIDE SALVAGING | 14 | 5.58e-01 | -9.05e-02 | 7.51e-01 |
SIGNALING BY NTRK2 TRKB | 24 | 4.43e-01 | 9.04e-02 | 6.57e-01 |
ACTIVATION OF GENE EXPRESSION BY SREBF SREBP | 43 | 3.07e-01 | 9.01e-02 | 5.51e-01 |
METABOLISM OF ANGIOTENSINOGEN TO ANGIOTENSINS | 10 | 6.23e-01 | 8.99e-02 | 7.98e-01 |
PRESYNAPTIC FUNCTION OF KAINATE RECEPTORS | 20 | 4.87e-01 | 8.98e-02 | 6.91e-01 |
INTRACELLULAR SIGNALING BY SECOND MESSENGERS | 284 | 9.58e-03 | 8.95e-02 | 5.44e-02 |
RAF INDEPENDENT MAPK1 3 ACTIVATION | 21 | 4.78e-01 | 8.95e-02 | 6.82e-01 |
SUMOYLATION OF DNA DAMAGE RESPONSE AND REPAIR PROTEINS | 73 | 1.87e-01 | -8.94e-02 | 4.18e-01 |
INTERLEUKIN 4 AND INTERLEUKIN 13 SIGNALING | 77 | 1.75e-01 | 8.94e-02 | 4.01e-01 |
SIGNALING BY BRAF AND RAF FUSIONS | 60 | 2.32e-01 | 8.93e-02 | 4.72e-01 |
CELL CYCLE CHECKPOINTS | 245 | 1.65e-02 | 8.90e-02 | 7.89e-02 |
SLC MEDIATED TRANSMEMBRANE TRANSPORT | 192 | 3.42e-02 | 8.87e-02 | 1.31e-01 |
NEUROTRANSMITTER RELEASE CYCLE | 48 | 2.89e-01 | 8.86e-02 | 5.29e-01 |
NEGATIVE REGULATION OF FLT3 | 14 | 5.66e-01 | -8.85e-02 | 7.56e-01 |
SIGNALING BY FGFR1 | 44 | 3.10e-01 | 8.85e-02 | 5.53e-01 |
BASE EXCISION REPAIR AP SITE FORMATION | 33 | 3.83e-01 | -8.78e-02 | 6.09e-01 |
GAP FILLING DNA REPAIR SYNTHESIS AND LIGATION IN GG NER | 25 | 4.48e-01 | -8.76e-02 | 6.62e-01 |
ALPHA PROTEIN KINASE 1 SIGNALING PATHWAY | 11 | 6.16e-01 | 8.74e-02 | 7.95e-01 |
MITOTIC PROPHASE | 98 | 1.36e-01 | 8.73e-02 | 3.40e-01 |
CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | 31 | 4.01e-01 | -8.72e-02 | 6.24e-01 |
TCF DEPENDENT SIGNALING IN RESPONSE TO WNT | 181 | 4.33e-02 | 8.72e-02 | 1.56e-01 |
TRAFFICKING OF AMPA RECEPTORS | 31 | 4.02e-01 | 8.70e-02 | 6.24e-01 |
FORMATION OF TC NER PRE INCISION COMPLEX | 53 | 2.74e-01 | 8.69e-02 | 5.15e-01 |
NOTCH2 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 11 | 6.19e-01 | -8.66e-02 | 7.96e-01 |
INTEGRIN SIGNALING | 24 | 4.63e-01 | 8.65e-02 | 6.76e-01 |
RESOLUTION OF ABASIC SITES AP SITES | 38 | 3.59e-01 | -8.60e-02 | 6.01e-01 |
G PROTEIN ACTIVATION | 23 | 4.76e-01 | 8.59e-02 | 6.80e-01 |
INTERLEUKIN 2 FAMILY SIGNALING | 32 | 4.01e-01 | -8.58e-02 | 6.24e-01 |
TRANSCRIPTIONAL REGULATION BY E2F6 | 34 | 3.91e-01 | 8.51e-02 | 6.16e-01 |
MUSCLE CONTRACTION | 161 | 6.33e-02 | -8.49e-02 | 2.00e-01 |
TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | 13 | 5.97e-01 | -8.47e-02 | 7.82e-01 |
MITOTIC PROMETAPHASE | 177 | 5.22e-02 | 8.47e-02 | 1.76e-01 |
SIGNALING BY RECEPTOR TYROSINE KINASES | 462 | 1.90e-03 | 8.45e-02 | 1.77e-02 |
NEGATIVE REGULATION OF TCF DEPENDENT SIGNALING BY WNT LIGAND ANTAGONISTS | 12 | 6.14e-01 | 8.42e-02 | 7.95e-01 |
INTERLEUKIN 6 FAMILY SIGNALING | 20 | 5.16e-01 | 8.39e-02 | 7.14e-01 |
PI 3K CASCADE FGFR4 | 13 | 6.01e-01 | -8.37e-02 | 7.83e-01 |
ADHERENS JUNCTIONS INTERACTIONS | 30 | 4.32e-01 | 8.29e-02 | 6.49e-01 |
AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | 14 | 5.92e-01 | 8.26e-02 | 7.78e-01 |
INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | 29 | 4.42e-01 | 8.26e-02 | 6.57e-01 |
SIGNALING BY INTERLEUKINS | 349 | 8.51e-03 | 8.21e-02 | 5.06e-02 |
GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR GG NER | 84 | 1.94e-01 | 8.21e-02 | 4.26e-01 |
RRNA PROCESSING IN THE MITOCHONDRION | 10 | 6.53e-01 | 8.20e-02 | 8.18e-01 |
RA BIOSYNTHESIS PATHWAY | 13 | 6.11e-01 | -8.14e-02 | 7.94e-01 |
NEPHRIN FAMILY INTERACTIONS | 23 | 5.00e-01 | 8.12e-02 | 7.04e-01 |
TOLL LIKE RECEPTOR CASCADES | 138 | 1.02e-01 | 8.07e-02 | 2.81e-01 |
DEREGULATED CDK5 TRIGGERS MULTIPLE NEURODEGENERATIVE PATHWAYS IN ALZHEIMER S DISEASE MODELS | 19 | 5.43e-01 | 8.06e-02 | 7.37e-01 |
TRNA PROCESSING IN THE NUCLEUS | 56 | 2.97e-01 | 8.06e-02 | 5.43e-01 |
HDR THROUGH MMEJ ALT NHEJ | 10 | 6.59e-01 | -8.05e-02 | 8.21e-01 |
CELL CYCLE | 598 | 8.01e-04 | 8.05e-02 | 9.16e-03 |
HCMV INFECTION | 107 | 1.52e-01 | 8.02e-02 | 3.69e-01 |
PLATELET CALCIUM HOMEOSTASIS | 26 | 4.80e-01 | -8.00e-02 | 6.84e-01 |
DOWNSTREAM SIGNAL TRANSDUCTION | 29 | 4.57e-01 | 7.99e-02 | 6.70e-01 |
RHOD GTPASE CYCLE | 51 | 3.24e-01 | 7.98e-02 | 5.69e-01 |
ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | 23 | 5.08e-01 | 7.97e-02 | 7.10e-01 |
ENDOGENOUS STEROLS | 20 | 5.37e-01 | -7.97e-02 | 7.35e-01 |
PROCESSING OF DNA DOUBLE STRAND BREAK ENDS | 74 | 2.40e-01 | -7.90e-02 | 4.80e-01 |
ATF4 ACTIVATES GENES IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 23 | 5.14e-01 | -7.87e-02 | 7.13e-01 |
NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | 58 | 3.01e-01 | 7.85e-02 | 5.49e-01 |
ERCC6 CSB AND EHMT2 G9A POSITIVELY REGULATE RRNA EXPRESSION | 36 | 4.17e-01 | -7.81e-02 | 6.35e-01 |
O LINKED GLYCOSYLATION | 85 | 2.15e-01 | 7.79e-02 | 4.51e-01 |
TRANSCRIPTIONAL REGULATION BY RUNX3 | 94 | 1.92e-01 | 7.79e-02 | 4.24e-01 |
MAP2K AND MAPK ACTIVATION | 36 | 4.19e-01 | 7.78e-02 | 6.37e-01 |
TRANSCRIPTIONAL REGULATION BY RUNX1 | 183 | 7.28e-02 | -7.70e-02 | 2.21e-01 |
IL 6 TYPE CYTOKINE RECEPTOR LIGAND INTERACTIONS | 14 | 6.18e-01 | 7.69e-02 | 7.96e-01 |
TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN G1 CELL CYCLE ARREST | 13 | 6.32e-01 | -7.66e-02 | 8.03e-01 |
DISEASES OF SIGNAL TRANSDUCTION BY GROWTH FACTOR RECEPTORS AND SECOND MESSENGERS | 369 | 1.17e-02 | 7.66e-02 | 6.34e-02 |
METABOLISM OF COFACTORS | 19 | 5.64e-01 | 7.65e-02 | 7.56e-01 |
NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | 44 | 3.81e-01 | 7.64e-02 | 6.09e-01 |
IRS MEDIATED SIGNALLING | 41 | 3.98e-01 | -7.64e-02 | 6.24e-01 |
INFECTIOUS DISEASE | 739 | 4.47e-04 | 7.62e-02 | 5.98e-03 |
MYOGENESIS | 25 | 5.11e-01 | -7.59e-02 | 7.11e-01 |
APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | 21 | 5.48e-01 | 7.58e-02 | 7.40e-01 |
RAC3 GTPASE CYCLE | 90 | 2.20e-01 | 7.49e-02 | 4.57e-01 |
IRAK4 DEFICIENCY TLR2 4 | 14 | 6.29e-01 | -7.45e-02 | 8.02e-01 |
RND3 GTPASE CYCLE | 38 | 4.27e-01 | 7.44e-02 | 6.46e-01 |
PRE NOTCH EXPRESSION AND PROCESSING | 68 | 2.90e-01 | -7.42e-02 | 5.32e-01 |
FOXO MEDIATED TRANSCRIPTION | 57 | 3.34e-01 | -7.41e-02 | 5.78e-01 |
RHO GTPASES ACTIVATE CIT | 18 | 5.88e-01 | -7.38e-02 | 7.76e-01 |
SUMOYLATION OF DNA REPLICATION PROTEINS | 43 | 4.04e-01 | 7.35e-02 | 6.24e-01 |
P38MAPK EVENTS | 13 | 6.48e-01 | 7.31e-02 | 8.15e-01 |
G ALPHA S SIGNALLING EVENTS | 108 | 1.90e-01 | 7.30e-02 | 4.22e-01 |
FOXO MEDIATED TRANSCRIPTION OF CELL CYCLE GENES | 15 | 6.27e-01 | 7.24e-02 | 8.01e-01 |
TRP CHANNELS | 20 | 5.75e-01 | -7.23e-02 | 7.64e-01 |
MICRORNA MIRNA BIOGENESIS | 24 | 5.40e-01 | -7.22e-02 | 7.36e-01 |
NS1 MEDIATED EFFECTS ON HOST PATHWAYS | 37 | 4.50e-01 | -7.17e-02 | 6.62e-01 |
FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | 18 | 5.99e-01 | -7.17e-02 | 7.82e-01 |
RHOU GTPASE CYCLE | 34 | 4.72e-01 | 7.14e-02 | 6.79e-01 |
BINDING AND UPTAKE OF LIGANDS BY SCAVENGER RECEPTORS | 35 | 4.66e-01 | -7.12e-02 | 6.77e-01 |
DEUBIQUITINATION | 243 | 5.68e-02 | 7.10e-02 | 1.87e-01 |
MEIOSIS | 68 | 3.12e-01 | -7.10e-02 | 5.55e-01 |
ONCOGENE INDUCED SENESCENCE | 32 | 4.88e-01 | 7.09e-02 | 6.91e-01 |
SUMOYLATION OF DNA METHYLATION PROTEINS | 16 | 6.24e-01 | -7.09e-02 | 7.98e-01 |
RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | 85 | 2.60e-01 | 7.07e-02 | 5.02e-01 |
RNA POLYMERASE I TRANSCRIPTION | 71 | 3.04e-01 | -7.06e-02 | 5.50e-01 |
SIGNALING BY RHO GTPASES MIRO GTPASES AND RHOBTB3 | 630 | 2.58e-03 | 7.06e-02 | 2.19e-02 |
NEGATIVE REGULATION OF THE PI3K AKT NETWORK | 97 | 2.33e-01 | 7.01e-02 | 4.73e-01 |
TRANSCRIPTIONAL REGULATION BY THE AP 2 TFAP2 FAMILY OF TRANSCRIPTION FACTORS | 33 | 4.87e-01 | 7.00e-02 | 6.91e-01 |
SUMOYLATION OF CHROMATIN ORGANIZATION PROTEINS | 60 | 3.49e-01 | -6.99e-02 | 5.90e-01 |
REGULATION OF GENE EXPRESSION IN BETA CELLS | 12 | 6.76e-01 | 6.98e-02 | 8.33e-01 |
HATS ACETYLATE HISTONES | 97 | 2.36e-01 | -6.97e-02 | 4.77e-01 |
TRANSCRIPTIONAL ACTIVATION OF MITOCHONDRIAL BIOGENESIS | 54 | 3.78e-01 | -6.94e-02 | 6.07e-01 |
GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTEGRINS | 12 | 6.78e-01 | -6.92e-02 | 8.33e-01 |
SUMOYLATION OF TRANSCRIPTION COFACTORS | 42 | 4.41e-01 | -6.87e-02 | 6.57e-01 |
LEISHMANIA INFECTION | 199 | 9.66e-02 | 6.84e-02 | 2.70e-01 |
NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | 16 | 6.37e-01 | 6.82e-02 | 8.06e-01 |
SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | 11 | 6.97e-01 | 6.79e-02 | 8.48e-01 |
DOWNSTREAM SIGNALING OF ACTIVATED FGFR2 | 24 | 5.66e-01 | -6.76e-02 | 7.56e-01 |
GAB1 SIGNALOSOME | 14 | 6.61e-01 | -6.76e-02 | 8.23e-01 |
TICAM1 DEPENDENT ACTIVATION OF IRF3 IRF7 | 12 | 6.85e-01 | 6.76e-02 | 8.40e-01 |
DEFECTS IN VITAMIN AND COFACTOR METABOLISM | 21 | 5.98e-01 | 6.65e-02 | 7.82e-01 |
ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | 59 | 3.78e-01 | 6.63e-02 | 6.07e-01 |
SIGNALING BY NOTCH2 | 33 | 5.10e-01 | 6.62e-02 | 7.11e-01 |
MAPK FAMILY SIGNALING CASCADES | 290 | 5.28e-02 | 6.62e-02 | 1.77e-01 |
POTASSIUM CHANNELS | 90 | 2.79e-01 | 6.60e-02 | 5.22e-01 |
NOTCH4 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 12 | 6.93e-01 | 6.58e-02 | 8.45e-01 |
INTERLEUKIN 37 SIGNALING | 18 | 6.30e-01 | 6.57e-02 | 8.02e-01 |
THE PHOTOTRANSDUCTION CASCADE | 22 | 5.94e-01 | -6.56e-02 | 7.79e-01 |
TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | 33 | 5.15e-01 | 6.55e-02 | 7.14e-01 |
RNA POLYMERASE III TRANSCRIPTION | 41 | 4.70e-01 | -6.52e-02 | 6.79e-01 |
SEROTONIN NEUROTRANSMITTER RELEASE CYCLE | 18 | 6.33e-01 | 6.50e-02 | 8.03e-01 |
MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | 15 | 6.66e-01 | -6.45e-02 | 8.24e-01 |
RHOA GTPASE CYCLE | 141 | 1.88e-01 | 6.42e-02 | 4.19e-01 |
PI 3K CASCADE FGFR3 | 13 | 6.89e-01 | -6.40e-02 | 8.43e-01 |
PLATELET AGGREGATION PLUG FORMATION | 32 | 5.33e-01 | 6.38e-02 | 7.31e-01 |
POTENTIAL THERAPEUTICS FOR SARS | 77 | 3.34e-01 | 6.37e-02 | 5.78e-01 |
METABOLISM OF PORPHYRINS | 19 | 6.31e-01 | 6.36e-02 | 8.02e-01 |
CRISTAE FORMATION | 31 | 5.40e-01 | 6.36e-02 | 7.36e-01 |
DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | 42 | 4.76e-01 | -6.36e-02 | 6.80e-01 |
DUAL INCISION IN TC NER | 65 | 3.76e-01 | -6.35e-02 | 6.07e-01 |
SIGNALING BY BMP | 25 | 5.84e-01 | 6.33e-02 | 7.73e-01 |
PURINERGIC SIGNALING IN LEISHMANIASIS INFECTION | 23 | 5.99e-01 | -6.33e-02 | 7.82e-01 |
MEIOTIC SYNAPSIS | 44 | 4.68e-01 | -6.33e-02 | 6.77e-01 |
LONG TERM POTENTIATION | 23 | 6.00e-01 | 6.32e-02 | 7.82e-01 |
CELLULAR RESPONSES TO EXTERNAL STIMULI | 607 | 8.06e-03 | 6.32e-02 | 4.89e-02 |
CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | 12 | 7.06e-01 | 6.29e-02 | 8.56e-01 |
PROTEIN PROTEIN INTERACTIONS AT SYNAPSES | 85 | 3.17e-01 | 6.28e-02 | 5.62e-01 |
TP53 REGULATES TRANSCRIPTION OF DNA REPAIR GENES | 61 | 4.05e-01 | -6.16e-02 | 6.24e-01 |
CARDIAC CONDUCTION | 107 | 2.71e-01 | -6.16e-02 | 5.13e-01 |
CELL JUNCTION ORGANIZATION | 73 | 3.64e-01 | 6.15e-02 | 6.02e-01 |
HIV LIFE CYCLE | 142 | 2.07e-01 | 6.15e-02 | 4.41e-01 |
G2 M CHECKPOINTS | 136 | 2.16e-01 | 6.14e-02 | 4.53e-01 |
TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | 43 | 4.88e-01 | -6.12e-02 | 6.91e-01 |
BASE EXCISION REPAIR | 61 | 4.09e-01 | -6.11e-02 | 6.28e-01 |
SEMAPHORIN INTERACTIONS | 64 | 3.99e-01 | -6.10e-02 | 6.24e-01 |
SELENOAMINO ACID METABOLISM | 109 | 2.74e-01 | -6.07e-02 | 5.15e-01 |
REGULATION OF COMMISSURAL AXON PATHFINDING BY SLIT AND ROBO | 10 | 7.41e-01 | 6.03e-02 | 8.70e-01 |
FGFRL1 MODULATION OF FGFR1 SIGNALING | 10 | 7.42e-01 | -6.01e-02 | 8.70e-01 |
TRANSCRIPTIONAL REGULATION BY RUNX2 | 108 | 2.81e-01 | 6.01e-02 | 5.22e-01 |
SIGNALING BY FGFR | 74 | 3.74e-01 | 5.98e-02 | 6.07e-01 |
P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | 12 | 7.22e-01 | -5.93e-02 | 8.67e-01 |
DNA REPAIR | 296 | 8.12e-02 | -5.90e-02 | 2.39e-01 |
PLASMA LIPOPROTEIN ASSEMBLY | 12 | 7.24e-01 | 5.88e-02 | 8.67e-01 |
DOWNSTREAM SIGNALING OF ACTIVATED FGFR3 | 20 | 6.49e-01 | 5.88e-02 | 8.15e-01 |
SODIUM CALCIUM EXCHANGERS | 10 | 7.48e-01 | -5.87e-02 | 8.72e-01 |
SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | 11 | 7.37e-01 | 5.85e-02 | 8.68e-01 |
PHOSPHORYLATION OF THE APC C | 17 | 6.79e-01 | 5.81e-02 | 8.33e-01 |
REGULATION OF SIGNALING BY CBL | 22 | 6.38e-01 | 5.80e-02 | 8.06e-01 |
DISEASES OF MITOTIC CELL CYCLE | 37 | 5.43e-01 | 5.78e-02 | 7.37e-01 |
ANTIGEN PROCESSING CROSS PRESENTATION | 96 | 3.29e-01 | 5.77e-02 | 5.72e-01 |
COLLAGEN DEGRADATION | 52 | 4.74e-01 | -5.74e-02 | 6.80e-01 |
CELL CELL COMMUNICATION | 106 | 3.09e-01 | 5.72e-02 | 5.53e-01 |
INHIBITION OF DNA RECOMBINATION AT TELOMERE | 39 | 5.37e-01 | -5.71e-02 | 7.35e-01 |
OVARIAN TUMOR DOMAIN PROTEASES | 36 | 5.56e-01 | 5.68e-02 | 7.49e-01 |
NF KB IS ACTIVATED AND SIGNALS SURVIVAL | 12 | 7.37e-01 | -5.61e-02 | 8.68e-01 |
RHO GTPASES ACTIVATE KTN1 | 11 | 7.48e-01 | 5.60e-02 | 8.72e-01 |
RRNA PROCESSING | 195 | 1.79e-01 | -5.58e-02 | 4.08e-01 |
SUMOYLATION | 168 | 2.13e-01 | -5.57e-02 | 4.51e-01 |
RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | 28 | 6.15e-01 | -5.50e-02 | 7.95e-01 |
DUAL INCISION IN GG NER | 41 | 5.43e-01 | -5.49e-02 | 7.37e-01 |
TRANSLATION OF SARS COV 1 STRUCTURAL PROTEINS | 28 | 6.17e-01 | 5.47e-02 | 7.96e-01 |
COLLAGEN FORMATION | 79 | 4.02e-01 | -5.45e-02 | 6.24e-01 |
DEATH RECEPTOR SIGNALLING | 132 | 2.82e-01 | 5.43e-02 | 5.24e-01 |
SIGNALING BY TGFB FAMILY MEMBERS | 96 | 3.63e-01 | 5.37e-02 | 6.02e-01 |
RET SIGNALING | 38 | 5.69e-01 | 5.34e-02 | 7.58e-01 |
COLLAGEN BIOSYNTHESIS AND MODIFYING ENZYMES | 63 | 4.64e-01 | -5.34e-02 | 6.76e-01 |
TOLL LIKE RECEPTOR TLR1 TLR2 CASCADE | 94 | 3.73e-01 | 5.32e-02 | 6.07e-01 |
APOPTOTIC EXECUTION PHASE | 45 | 5.37e-01 | 5.31e-02 | 7.35e-01 |
MITOCHONDRIAL TRANSLATION | 93 | 3.77e-01 | 5.31e-02 | 6.07e-01 |
PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | 15 | 7.23e-01 | 5.29e-02 | 8.67e-01 |
UCH PROTEINASES | 90 | 3.87e-01 | 5.28e-02 | 6.13e-01 |
PCNA DEPENDENT LONG PATCH BASE EXCISION REPAIR | 21 | 6.76e-01 | -5.28e-02 | 8.33e-01 |
SIGNALING BY FGFR2 | 63 | 4.73e-01 | 5.23e-02 | 6.80e-01 |
NUCLEAR ENVELOPE BREAKDOWN | 49 | 5.28e-01 | 5.21e-02 | 7.26e-01 |
G2 M DNA DAMAGE CHECKPOINT | 69 | 4.56e-01 | -5.19e-02 | 6.70e-01 |
FREE FATTY ACIDS REGULATE INSULIN SECRETION | 10 | 7.77e-01 | 5.18e-02 | 8.94e-01 |
THE CANONICAL RETINOID CYCLE IN RODS TWILIGHT VISION | 14 | 7.39e-01 | 5.13e-02 | 8.68e-01 |
INACTIVATION OF CSF3 G CSF SIGNALING | 24 | 6.65e-01 | 5.11e-02 | 8.24e-01 |
TFAP2 AP 2 FAMILY REGULATES TRANSCRIPTION OF GROWTH FACTORS AND THEIR RECEPTORS | 11 | 7.70e-01 | 5.10e-02 | 8.89e-01 |
CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | 92 | 3.98e-01 | 5.10e-02 | 6.24e-01 |
REGULATION OF TP53 ACTIVITY THROUGH METHYLATION | 18 | 7.09e-01 | -5.09e-02 | 8.58e-01 |
REGULATION OF TP53 ACTIVITY THROUGH PHOSPHORYLATION | 88 | 4.11e-01 | -5.07e-02 | 6.28e-01 |
TRANSPORT OF THE SLBP DEPENDANT MATURE MRNA | 34 | 6.09e-01 | 5.07e-02 | 7.92e-01 |
TRIGLYCERIDE BIOSYNTHESIS | 10 | 7.82e-01 | -5.05e-02 | 8.98e-01 |
MET PROMOTES CELL MOTILITY | 39 | 5.87e-01 | -5.03e-02 | 7.75e-01 |
COMPLEMENT CASCADE | 26 | 6.62e-01 | 4.95e-02 | 8.23e-01 |
TOLL LIKE RECEPTOR 9 TLR9 CASCADE | 91 | 4.17e-01 | 4.93e-02 | 6.35e-01 |
TRANSPORT OF MATURE MRNAS DERIVED FROM INTRONLESS TRANSCRIPTS | 41 | 5.86e-01 | 4.92e-02 | 7.75e-01 |
EFFECTS OF PIP2 HYDROLYSIS | 27 | 6.59e-01 | -4.91e-02 | 8.21e-01 |
MRNA SPLICING | 188 | 2.49e-01 | 4.88e-02 | 4.90e-01 |
REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | 83 | 4.42e-01 | 4.88e-02 | 6.57e-01 |
NCAM SIGNALING FOR NEURITE OUT GROWTH | 62 | 5.08e-01 | -4.87e-02 | 7.10e-01 |
PI3K AKT SIGNALING IN CANCER | 91 | 4.23e-01 | 4.87e-02 | 6.42e-01 |
EUKARYOTIC TRANSLATION INITIATION | 115 | 3.68e-01 | -4.86e-02 | 6.06e-01 |
IRF3 MEDIATED INDUCTION OF TYPE I IFN | 11 | 7.82e-01 | 4.82e-02 | 8.98e-01 |
INCRETIN SYNTHESIS SECRETION AND INACTIVATION | 14 | 7.56e-01 | 4.80e-02 | 8.77e-01 |
RHOC GTPASE CYCLE | 73 | 4.80e-01 | 4.78e-02 | 6.84e-01 |
REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | 29 | 6.58e-01 | -4.75e-02 | 8.21e-01 |
CYTOPROTECTION BY HMOX1 | 119 | 3.72e-01 | 4.74e-02 | 6.07e-01 |
SURFACTANT METABOLISM | 16 | 7.43e-01 | 4.74e-02 | 8.70e-01 |
TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | 83 | 4.59e-01 | 4.70e-02 | 6.73e-01 |
VISUAL PHOTOTRANSDUCTION | 62 | 5.23e-01 | 4.69e-02 | 7.20e-01 |
FORMATION OF THE BETA CATENIN TCF TRANSACTIVATING COMPLEX | 50 | 5.74e-01 | -4.60e-02 | 7.63e-01 |
DOWNSTREAM SIGNALING OF ACTIVATED FGFR4 | 20 | 7.22e-01 | 4.60e-02 | 8.67e-01 |
REGULATION OF LIPID METABOLISM BY PPARALPHA | 108 | 4.11e-01 | -4.58e-02 | 6.28e-01 |
BASIGIN INTERACTIONS | 22 | 7.12e-01 | 4.55e-02 | 8.61e-01 |
ANCHORING OF THE BASAL BODY TO THE PLASMA MEMBRANE | 96 | 4.43e-01 | 4.53e-02 | 6.57e-01 |
SUMOYLATION OF UBIQUITINYLATION PROTEINS | 37 | 6.34e-01 | -4.52e-02 | 8.03e-01 |
RHO GTPASES ACTIVATE ROCKS | 19 | 7.33e-01 | -4.52e-02 | 8.68e-01 |
ERBB2 REGULATES CELL MOTILITY | 14 | 7.71e-01 | 4.49e-02 | 8.90e-01 |
SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 107 | 4.23e-01 | -4.48e-02 | 6.42e-01 |
REGULATION OF TP53 ACTIVITY | 152 | 3.41e-01 | 4.48e-02 | 5.84e-01 |
SLC TRANSPORTER DISORDERS | 76 | 5.02e-01 | 4.45e-02 | 7.06e-01 |
EXPORT OF VIRAL RIBONUCLEOPROTEINS FROM NUCLEUS | 31 | 6.68e-01 | -4.45e-02 | 8.27e-01 |
NICOTINATE METABOLISM | 23 | 7.13e-01 | 4.44e-02 | 8.61e-01 |
STIMULI SENSING CHANNELS | 76 | 5.10e-01 | -4.38e-02 | 7.11e-01 |
RND1 GTPASE CYCLE | 38 | 6.42e-01 | 4.35e-02 | 8.09e-01 |
ERK MAPK TARGETS | 22 | 7.26e-01 | 4.31e-02 | 8.67e-01 |
TNFS BIND THEIR PHYSIOLOGICAL RECEPTORS | 12 | 7.96e-01 | 4.30e-02 | 9.06e-01 |
RHO GTPASES ACTIVATE PAKS | 21 | 7.34e-01 | 4.29e-02 | 8.68e-01 |
SIGNALING BY CYTOSOLIC FGFR1 FUSION MUTANTS | 18 | 7.53e-01 | -4.29e-02 | 8.76e-01 |
STING MEDIATED INDUCTION OF HOST IMMUNE RESPONSES | 14 | 7.82e-01 | 4.27e-02 | 8.98e-01 |
SIGNALING BY ACTIVIN | 11 | 8.10e-01 | 4.19e-02 | 9.13e-01 |
CELLULAR RESPONSE TO CHEMICAL STRESS | 150 | 3.77e-01 | 4.19e-02 | 6.07e-01 |
SYNTHESIS OF IP2 IP AND INS IN THE CYTOSOL | 13 | 7.94e-01 | -4.17e-02 | 9.06e-01 |
EARLY PHASE OF HIV LIFE CYCLE | 13 | 7.95e-01 | 4.16e-02 | 9.06e-01 |
SIGNALING BY ERBB2 | 48 | 6.19e-01 | 4.16e-02 | 7.96e-01 |
RHO GTPASE CYCLE | 423 | 1.44e-01 | 4.15e-02 | 3.58e-01 |
EXTRACELLULAR MATRIX ORGANIZATION | 250 | 2.60e-01 | -4.14e-02 | 5.02e-01 |
CASPASE ACTIVATION VIA EXTRINSIC APOPTOTIC SIGNALLING PATHWAY | 23 | 7.34e-01 | -4.09e-02 | 8.68e-01 |
BIOSYNTHESIS OF SPECIALIZED PRORESOLVING MEDIATORS SPMS | 11 | 8.15e-01 | -4.08e-02 | 9.16e-01 |
TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | 30 | 7.00e-01 | 4.06e-02 | 8.50e-01 |
RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | 25 | 7.25e-01 | -4.06e-02 | 8.67e-01 |
SIGNALING BY NOTCH1 | 75 | 5.47e-01 | 4.02e-02 | 7.40e-01 |
MOLECULES ASSOCIATED WITH ELASTIC FIBRES | 33 | 6.91e-01 | -4.00e-02 | 8.44e-01 |
ELASTIC FIBRE FORMATION | 38 | 6.72e-01 | -3.96e-02 | 8.31e-01 |
RNA POLYMERASE II TRANSCRIBES SNRNA GENES | 74 | 5.61e-01 | 3.91e-02 | 7.55e-01 |
DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | 26 | 7.32e-01 | 3.89e-02 | 8.68e-01 |
NEGATIVE REGULATORS OF DDX58 IFIH1 SIGNALING | 33 | 6.99e-01 | 3.89e-02 | 8.50e-01 |
REGULATION OF BETA CELL DEVELOPMENT | 30 | 7.14e-01 | -3.87e-02 | 8.62e-01 |
TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | 74 | 5.66e-01 | -3.86e-02 | 7.56e-01 |
LGI ADAM INTERACTIONS | 14 | 8.04e-01 | 3.84e-02 | 9.11e-01 |
DISEASES ASSOCIATED WITH O GLYCOSYLATION OF PROTEINS | 50 | 6.40e-01 | -3.82e-02 | 8.07e-01 |
GLUCAGON TYPE LIGAND RECEPTORS | 26 | 7.39e-01 | 3.77e-02 | 8.68e-01 |
SMOOTH MUSCLE CONTRACTION | 33 | 7.08e-01 | -3.77e-02 | 8.58e-01 |
VOLTAGE GATED POTASSIUM CHANNELS | 38 | 6.88e-01 | 3.77e-02 | 8.42e-01 |
CHROMOSOME MAINTENANCE | 106 | 5.04e-01 | -3.75e-02 | 7.08e-01 |
MRNA CAPPING | 29 | 7.27e-01 | 3.74e-02 | 8.67e-01 |
SIGNALING BY ERYTHROPOIETIN | 24 | 7.54e-01 | -3.70e-02 | 8.76e-01 |
RIPK1 MEDIATED REGULATED NECROSIS | 25 | 7.49e-01 | 3.70e-02 | 8.72e-01 |
SIGNALING BY NOTCH1 PEST DOMAIN MUTANTS IN CANCER | 59 | 6.26e-01 | 3.67e-02 | 8.00e-01 |
DEADENYLATION DEPENDENT MRNA DECAY | 55 | 6.40e-01 | -3.65e-02 | 8.07e-01 |
ERBB2 ACTIVATES PTK6 SIGNALING | 11 | 8.34e-01 | -3.64e-02 | 9.22e-01 |
DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | 13 | 8.20e-01 | -3.64e-02 | 9.17e-01 |
SIGNALING BY MET | 74 | 5.90e-01 | 3.63e-02 | 7.77e-01 |
POLYMERASE SWITCHING | 14 | 8.15e-01 | -3.62e-02 | 9.16e-01 |
CROSSLINKING OF COLLAGEN FIBRILS | 15 | 8.09e-01 | -3.61e-02 | 9.13e-01 |
NRAGE SIGNALS DEATH THROUGH JNK | 54 | 6.48e-01 | -3.60e-02 | 8.15e-01 |
ROLE OF SECOND MESSENGERS IN NETRIN 1 SIGNALING | 10 | 8.45e-01 | -3.57e-02 | 9.24e-01 |
SIGNALING BY LEPTIN | 10 | 8.45e-01 | -3.57e-02 | 9.24e-01 |
REGULATION OF TLR BY ENDOGENOUS LIGAND | 13 | 8.24e-01 | 3.56e-02 | 9.20e-01 |
DOWNSTREAM SIGNALING OF ACTIVATED FGFR1 | 26 | 7.55e-01 | -3.54e-02 | 8.77e-01 |
AMYLOID FIBER FORMATION | 62 | 6.31e-01 | -3.52e-02 | 8.02e-01 |
GENERATION OF SECOND MESSENGER MOLECULES | 19 | 7.91e-01 | -3.51e-02 | 9.04e-01 |
TICAM1 TRAF6 DEPENDENT INDUCTION OF TAK1 COMPLEX | 11 | 8.41e-01 | 3.49e-02 | 9.24e-01 |
DNA STRAND ELONGATION | 32 | 7.34e-01 | 3.47e-02 | 8.68e-01 |
SIGNALING BY PDGF | 56 | 6.54e-01 | -3.47e-02 | 8.18e-01 |
SIGNALING BY ERBB2 ECD MUTANTS | 16 | 8.11e-01 | -3.46e-02 | 9.13e-01 |
FLT3 SIGNALING | 36 | 7.20e-01 | -3.46e-02 | 8.67e-01 |
CELLULAR HEXOSE TRANSPORT | 12 | 8.36e-01 | 3.45e-02 | 9.22e-01 |
PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | 237 | 3.63e-01 | 3.44e-02 | 6.02e-01 |
SIGNALING BY FGFR2 IIIA TM | 19 | 7.95e-01 | -3.44e-02 | 9.06e-01 |
INTERACTIONS OF REV WITH HOST CELLULAR PROTEINS | 35 | 7.29e-01 | 3.39e-02 | 8.67e-01 |
METABOLISM OF AMINE DERIVED HORMONES | 10 | 8.53e-01 | 3.39e-02 | 9.29e-01 |
RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN DIFFERENTIATION OF HSCS | 87 | 5.85e-01 | 3.39e-02 | 7.75e-01 |
RNA POLYMERASE I TRANSCRIPTION INITIATION | 47 | 6.90e-01 | -3.36e-02 | 8.43e-01 |
ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | 73 | 6.20e-01 | -3.36e-02 | 7.97e-01 |
MRNA SPLICING MINOR PATHWAY | 52 | 6.78e-01 | 3.33e-02 | 8.33e-01 |
HCMV EARLY EVENTS | 84 | 6.01e-01 | 3.30e-02 | 7.83e-01 |
SIGNALING BY NOTCH | 193 | 4.37e-01 | 3.25e-02 | 6.54e-01 |
TELOMERE MAINTENANCE | 82 | 6.14e-01 | -3.22e-02 | 7.95e-01 |
REGULATION OF TP53 ACTIVITY THROUGH ACETYLATION | 30 | 7.61e-01 | 3.21e-02 | 8.81e-01 |
NUCLEOTIDE EXCISION REPAIR | 110 | 5.63e-01 | 3.19e-02 | 7.56e-01 |
DEGRADATION OF THE EXTRACELLULAR MATRIX | 110 | 5.64e-01 | -3.18e-02 | 7.56e-01 |
HCMV LATE EVENTS | 69 | 6.50e-01 | -3.16e-02 | 8.15e-01 |
RND2 GTPASE CYCLE | 39 | 7.39e-01 | 3.09e-02 | 8.68e-01 |
CYTOSOLIC SENSORS OF PATHOGEN ASSOCIATED DNA | 59 | 6.84e-01 | -3.06e-02 | 8.40e-01 |
TP53 REGULATES TRANSCRIPTION OF CELL DEATH GENES | 37 | 7.48e-01 | -3.05e-02 | 8.72e-01 |
HIV TRANSCRIPTION INITIATION | 45 | 7.25e-01 | -3.04e-02 | 8.67e-01 |
MITOCHONDRIAL BIOGENESIS | 92 | 6.15e-01 | -3.03e-02 | 7.95e-01 |
FCERI MEDIATED CA 2 MOBILIZATION | 26 | 7.91e-01 | 3.00e-02 | 9.04e-01 |
RECEPTOR TYPE TYROSINE PROTEIN PHOSPHATASES | 20 | 8.18e-01 | 2.98e-02 | 9.16e-01 |
CA2 PATHWAY | 59 | 6.93e-01 | 2.97e-02 | 8.45e-01 |
INSULIN RECEPTOR SIGNALLING CASCADE | 46 | 7.28e-01 | -2.97e-02 | 8.67e-01 |
SIGNALING BY NUCLEAR RECEPTORS | 229 | 4.44e-01 | 2.94e-02 | 6.57e-01 |
FORMATION OF FIBRIN CLOT CLOTTING CASCADE | 23 | 8.07e-01 | -2.94e-02 | 9.13e-01 |
EXTENSION OF TELOMERES | 49 | 7.22e-01 | 2.94e-02 | 8.67e-01 |
TRANSCRIPTIONAL REGULATION OF GRANULOPOIESIS | 48 | 7.26e-01 | -2.93e-02 | 8.67e-01 |
APOPTOTIC FACTOR MEDIATED RESPONSE | 18 | 8.30e-01 | 2.92e-02 | 9.21e-01 |
NONHOMOLOGOUS END JOINING NHEJ | 46 | 7.32e-01 | -2.92e-02 | 8.68e-01 |
REGULATED NECROSIS | 46 | 7.35e-01 | 2.88e-02 | 8.68e-01 |
ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | 24 | 8.08e-01 | 2.87e-02 | 9.13e-01 |
OXIDATIVE STRESS INDUCED SENESCENCE | 82 | 6.57e-01 | -2.84e-02 | 8.20e-01 |
SIGNALING BY KIT IN DISEASE | 20 | 8.27e-01 | 2.82e-02 | 9.21e-01 |
G ALPHA 12 13 SIGNALLING EVENTS | 75 | 6.77e-01 | 2.79e-02 | 8.33e-01 |
PREGNENOLONE BIOSYNTHESIS | 12 | 8.69e-01 | -2.75e-02 | 9.38e-01 |
LAGGING STRAND SYNTHESIS | 20 | 8.34e-01 | -2.70e-02 | 9.22e-01 |
SUMOYLATION OF TRANSCRIPTION FACTORS | 18 | 8.45e-01 | 2.66e-02 | 9.24e-01 |
TRANSLESION SYNTHESIS BY POLH | 19 | 8.43e-01 | -2.63e-02 | 9.24e-01 |
GRB2 EVENTS IN ERBB2 SIGNALING | 15 | 8.60e-01 | 2.62e-02 | 9.34e-01 |
INTERLEUKIN 3 INTERLEUKIN 5 AND GM CSF SIGNALING | 41 | 7.76e-01 | 2.57e-02 | 8.94e-01 |
TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN CYTOCHROME C RELEASE | 19 | 8.46e-01 | 2.57e-02 | 9.25e-01 |
NEUREXINS AND NEUROLIGINS | 54 | 7.44e-01 | 2.57e-02 | 8.71e-01 |
PROCESSING OF CAPPED INTRONLESS PRE MRNA | 28 | 8.17e-01 | -2.53e-02 | 9.16e-01 |
RNA POLYMERASE III CHAIN ELONGATION | 18 | 8.53e-01 | -2.52e-02 | 9.29e-01 |
DETOXIFICATION OF REACTIVE OXYGEN SPECIES | 32 | 8.09e-01 | 2.47e-02 | 9.13e-01 |
CIRCADIAN CLOCK | 68 | 7.28e-01 | -2.44e-02 | 8.67e-01 |
FRS MEDIATED FGFR1 SIGNALING | 18 | 8.58e-01 | 2.43e-02 | 9.33e-01 |
REGULATION OF GENE EXPRESSION BY HYPOXIA INDUCIBLE FACTOR | 10 | 8.95e-01 | -2.41e-02 | 9.46e-01 |
SIGNALING BY FGFR1 IN DISEASE | 33 | 8.11e-01 | 2.41e-02 | 9.13e-01 |
RUNX2 REGULATES OSTEOBLAST DIFFERENTIATION | 23 | 8.42e-01 | 2.41e-02 | 9.24e-01 |
RECOGNITION AND ASSOCIATION OF DNA GLYCOSYLASE WITH SITE CONTAINING AN AFFECTED PURINE | 26 | 8.32e-01 | -2.41e-02 | 9.22e-01 |
SIGNALING BY FGFR3 FUSIONS IN CANCER | 10 | 8.95e-01 | 2.40e-02 | 9.46e-01 |
METABOLISM OF RNA | 645 | 3.02e-01 | 2.39e-02 | 5.49e-01 |
ION CHANNEL TRANSPORT | 143 | 6.23e-01 | 2.38e-02 | 7.98e-01 |
CELLULAR RESPONSE TO STARVATION | 147 | 6.22e-01 | -2.36e-02 | 7.98e-01 |
SIGNALING BY FGFR4 IN DISEASE | 11 | 8.94e-01 | 2.32e-02 | 9.46e-01 |
P75NTR RECRUITS SIGNALLING COMPLEXES | 12 | 8.92e-01 | 2.26e-02 | 9.46e-01 |
ACYL CHAIN REMODELLING OF PS | 14 | 8.84e-01 | 2.26e-02 | 9.45e-01 |
ANTIMICROBIAL PEPTIDES | 15 | 8.82e-01 | 2.22e-02 | 9.45e-01 |
TRANSCRIPTIONAL REGULATION BY VENTX | 35 | 8.21e-01 | -2.21e-02 | 9.17e-01 |
DDX58 IFIH1 MEDIATED INDUCTION OF INTERFERON ALPHA BETA | 63 | 7.62e-01 | -2.21e-02 | 8.81e-01 |
TELOMERE C STRAND LAGGING STRAND SYNTHESIS | 33 | 8.27e-01 | 2.20e-02 | 9.21e-01 |
METABOLIC DISORDERS OF BIOLOGICAL OXIDATION ENZYMES | 20 | 8.65e-01 | 2.19e-02 | 9.38e-01 |
NERVOUS SYSTEM DEVELOPMENT | 554 | 3.80e-01 | 2.19e-02 | 6.08e-01 |
ROLE OF LAT2 NTAL LAB ON CALCIUM MOBILIZATION | 14 | 8.88e-01 | 2.18e-02 | 9.46e-01 |
FRS MEDIATED FGFR2 SIGNALING | 19 | 8.70e-01 | -2.16e-02 | 9.39e-01 |
ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | 33 | 8.30e-01 | -2.16e-02 | 9.21e-01 |
SIGNALING BY NTRK3 TRKC | 17 | 8.78e-01 | -2.16e-02 | 9.43e-01 |
ACETYLCHOLINE REGULATES INSULIN SECRETION | 10 | 9.09e-01 | -2.09e-02 | 9.52e-01 |
RHOQ GTPASE CYCLE | 58 | 7.85e-01 | 2.07e-02 | 8.99e-01 |
FORMATION OF THE EARLY ELONGATION COMPLEX | 33 | 8.37e-01 | 2.07e-02 | 9.22e-01 |
RNA POLYMERASE II TRANSCRIPTION | 1098 | 2.55e-01 | -2.05e-02 | 4.99e-01 |
CDC42 GTPASE CYCLE | 153 | 6.63e-01 | -2.04e-02 | 8.23e-01 |
P75 NTR RECEPTOR MEDIATED SIGNALLING | 93 | 7.36e-01 | 2.02e-02 | 8.68e-01 |
PLATELET HOMEOSTASIS | 78 | 7.58e-01 | 2.02e-02 | 8.78e-01 |
IRAK1 RECRUITS IKK COMPLEX | 14 | 8.97e-01 | 2.00e-02 | 9.47e-01 |
PROCESSIVE SYNTHESIS ON THE C STRAND OF THE TELOMERE | 19 | 8.81e-01 | -1.98e-02 | 9.45e-01 |
RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | 78 | 7.63e-01 | 1.98e-02 | 8.82e-01 |
THE CITRIC ACID TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | 172 | 6.56e-01 | 1.97e-02 | 8.20e-01 |
RNA POLYMERASE II TRANSCRIPTION TERMINATION | 65 | 7.86e-01 | -1.95e-02 | 9.00e-01 |
SUMOYLATION OF SUMOYLATION PROTEINS | 33 | 8.48e-01 | -1.93e-02 | 9.25e-01 |
ABERRANT REGULATION OF MITOTIC G1 S TRANSITION IN CANCER DUE TO RB1 DEFECTS | 17 | 8.92e-01 | 1.91e-02 | 9.46e-01 |
PYROPTOSIS | 21 | 8.80e-01 | 1.90e-02 | 9.45e-01 |
NETRIN 1 SIGNALING | 50 | 8.16e-01 | 1.90e-02 | 9.16e-01 |
DNA DAMAGE TELOMERE STRESS INDUCED SENESCENCE | 48 | 8.28e-01 | -1.81e-02 | 9.21e-01 |
SNRNP ASSEMBLY | 51 | 8.25e-01 | 1.79e-02 | 9.20e-01 |
CARNITINE METABOLISM | 14 | 9.08e-01 | -1.79e-02 | 9.52e-01 |
NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 48 | 8.33e-01 | -1.76e-02 | 9.22e-01 |
CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | 72 | 7.98e-01 | -1.75e-02 | 9.06e-01 |
SIGNALING BY EGFR IN CANCER | 22 | 8.88e-01 | 1.74e-02 | 9.46e-01 |
TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | 79 | 7.96e-01 | 1.69e-02 | 9.06e-01 |
TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX WITHIN TLR4 COMPLEX | 15 | 9.10e-01 | -1.68e-02 | 9.52e-01 |
NOD1 2 SIGNALING PATHWAY | 35 | 8.65e-01 | 1.66e-02 | 9.38e-01 |
SIGNALING BY ERBB2 IN CANCER | 25 | 8.87e-01 | 1.65e-02 | 9.46e-01 |
DAP12 SIGNALING | 24 | 8.90e-01 | -1.63e-02 | 9.46e-01 |
ABORTIVE ELONGATION OF HIV 1 TRANSCRIPT IN THE ABSENCE OF TAT | 23 | 8.93e-01 | -1.62e-02 | 9.46e-01 |
RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 1 PROMOTER | 28 | 8.83e-01 | -1.60e-02 | 9.45e-01 |
CAMK IV MEDIATED PHOSPHORYLATION OF CREB | 10 | 9.32e-01 | -1.57e-02 | 9.64e-01 |
NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | 53 | 8.48e-01 | -1.52e-02 | 9.25e-01 |
CONSTITUTIVE SIGNALING BY LIGAND RESPONSIVE EGFR CANCER VARIANTS | 19 | 9.09e-01 | -1.52e-02 | 9.52e-01 |
HIV TRANSCRIPTION ELONGATION | 42 | 8.67e-01 | -1.50e-02 | 9.38e-01 |
SENESCENCE ASSOCIATED SECRETORY PHENOTYPE SASP | 67 | 8.35e-01 | -1.47e-02 | 9.22e-01 |
SENSORY PROCESSING OF SOUND BY OUTER HAIR CELLS OF THE COCHLEA | 41 | 8.73e-01 | -1.45e-02 | 9.41e-01 |
MECP2 REGULATES NEURONAL RECEPTORS AND CHANNELS | 18 | 9.16e-01 | -1.44e-02 | 9.56e-01 |
SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | 16 | 9.23e-01 | 1.40e-02 | 9.60e-01 |
IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX | 10 | 9.40e-01 | -1.37e-02 | 9.70e-01 |
FGFR2 ALTERNATIVE SPLICING | 25 | 9.06e-01 | 1.36e-02 | 9.52e-01 |
SEMA4D IN SEMAPHORIN SIGNALING | 24 | 9.09e-01 | -1.36e-02 | 9.52e-01 |
TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR TC NER | 78 | 8.37e-01 | 1.35e-02 | 9.22e-01 |
ZBP1 DAI MEDIATED INDUCTION OF TYPE I IFNS | 18 | 9.21e-01 | 1.35e-02 | 9.59e-01 |
NUCLEAR PORE COMPLEX NPC DISASSEMBLY | 32 | 8.95e-01 | -1.35e-02 | 9.46e-01 |
SYNDECAN INTERACTIONS | 27 | 9.07e-01 | 1.30e-02 | 9.52e-01 |
SIGNAL REGULATORY PROTEIN FAMILY INTERACTIONS | 11 | 9.41e-01 | 1.29e-02 | 9.70e-01 |
SIGNALING BY FGFR IN DISEASE | 57 | 8.67e-01 | -1.28e-02 | 9.38e-01 |
DCC MEDIATED ATTRACTIVE SIGNALING | 14 | 9.34e-01 | 1.27e-02 | 9.65e-01 |
SHC MEDIATED CASCADE FGFR1 | 16 | 9.31e-01 | -1.25e-02 | 9.64e-01 |
DOWNREGULATION OF ERBB2 SIGNALING | 28 | 9.09e-01 | -1.25e-02 | 9.52e-01 |
AKT PHOSPHORYLATES TARGETS IN THE NUCLEUS | 10 | 9.48e-01 | 1.20e-02 | 9.74e-01 |
FGFR1 MUTANT RECEPTOR ACTIVATION | 26 | 9.19e-01 | 1.15e-02 | 9.59e-01 |
TP53 REGULATES METABOLIC GENES | 85 | 8.55e-01 | -1.14e-02 | 9.30e-01 |
NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | 13 | 9.43e-01 | -1.14e-02 | 9.71e-01 |
ION HOMEOSTASIS | 50 | 8.91e-01 | -1.12e-02 | 9.46e-01 |
SIGNALING BY ROBO RECEPTORS | 208 | 7.84e-01 | 1.10e-02 | 8.99e-01 |
PERK REGULATES GENE EXPRESSION | 28 | 9.20e-01 | 1.09e-02 | 9.59e-01 |
YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | 12 | 9.49e-01 | -1.06e-02 | 9.75e-01 |
METALLOPROTEASE DUBS | 27 | 9.25e-01 | 1.05e-02 | 9.61e-01 |
RHOB GTPASE CYCLE | 67 | 8.83e-01 | 1.04e-02 | 9.45e-01 |
RAC1 GTPASE CYCLE | 177 | 8.17e-01 | 1.01e-02 | 9.16e-01 |
TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | 32 | 9.21e-01 | 1.01e-02 | 9.59e-01 |
CONSTITUTIVE SIGNALING BY EGFRVIII | 15 | 9.46e-01 | -1.00e-02 | 9.74e-01 |
DNA DOUBLE STRAND BREAK RESPONSE | 55 | 8.98e-01 | 1.00e-02 | 9.47e-01 |
TRANSCRIPTION OF THE HIV GENOME | 67 | 8.91e-01 | 9.73e-03 | 9.46e-01 |
SENSORY PROCESSING OF SOUND | 62 | 9.03e-01 | -8.92e-03 | 9.52e-01 |
SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | 31 | 9.33e-01 | -8.77e-03 | 9.65e-01 |
ESR MEDIATED SIGNALING | 172 | 8.44e-01 | 8.72e-03 | 9.24e-01 |
TRNA PROCESSING | 105 | 8.78e-01 | 8.70e-03 | 9.43e-01 |
ARACHIDONIC ACID METABOLISM | 38 | 9.26e-01 | 8.67e-03 | 9.61e-01 |
SUMOYLATION OF RNA BINDING PROTEINS | 45 | 9.28e-01 | -7.76e-03 | 9.63e-01 |
REGULATION OF EXPRESSION OF SLITS AND ROBOS | 163 | 8.68e-01 | -7.58e-03 | 9.38e-01 |
SIGNALING BY TGF BETA RECEPTOR COMPLEX | 72 | 9.15e-01 | 7.23e-03 | 9.56e-01 |
CYTOKINE SIGNALING IN IMMUNE SYSTEM | 542 | 7.98e-01 | -6.43e-03 | 9.06e-01 |
SYNTHESIS SECRETION AND INACTIVATION OF GLUCAGON LIKE PEPTIDE 1 GLP 1 | 13 | 9.70e-01 | 5.99e-03 | 9.90e-01 |
RECOGNITION OF DNA DAMAGE BY PCNA CONTAINING REPLICATION COMPLEX | 29 | 9.57e-01 | -5.72e-03 | 9.81e-01 |
DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | 23 | 9.63e-01 | 5.59e-03 | 9.85e-01 |
P75NTR SIGNALS VIA NF KB | 15 | 9.72e-01 | -5.17e-03 | 9.91e-01 |
REGULATION OF PLK1 ACTIVITY AT G2 M TRANSITION | 85 | 9.38e-01 | 4.91e-03 | 9.68e-01 |
TRANSCRIPTIONAL REGULATION BY TP53 | 343 | 8.77e-01 | 4.85e-03 | 9.43e-01 |
SIGNALING BY PDGFR IN DISEASE | 20 | 9.70e-01 | -4.78e-03 | 9.90e-01 |
FORMATION OF RNA POL II ELONGATION COMPLEX | 57 | 9.51e-01 | -4.74e-03 | 9.76e-01 |
RHO GTPASES ACTIVATE PKNS | 51 | 9.56e-01 | 4.49e-03 | 9.80e-01 |
DEVELOPMENTAL BIOLOGY | 833 | 8.29e-01 | 4.43e-03 | 9.21e-01 |
SIGNALLING TO RAS | 19 | 9.76e-01 | 4.00e-03 | 9.93e-01 |
ELEVATION OF CYTOSOLIC CA2 LEVELS | 14 | 9.81e-01 | 3.69e-03 | 9.94e-01 |
INTERLEUKIN RECEPTOR SHC SIGNALING | 20 | 9.78e-01 | 3.52e-03 | 9.94e-01 |
PROCESSING OF INTRONLESS PRE MRNAS | 19 | 9.79e-01 | -3.41e-03 | 9.94e-01 |
DISEASES OF PROGRAMMED CELL DEATH | 58 | 9.66e-01 | -3.28e-03 | 9.87e-01 |
ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | 17 | 9.81e-01 | 3.27e-03 | 9.94e-01 |
AURKA ACTIVATION BY TPX2 | 71 | 9.63e-01 | -3.16e-03 | 9.85e-01 |
INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | 34 | 9.76e-01 | 3.00e-03 | 9.93e-01 |
MISMATCH REPAIR | 15 | 9.85e-01 | -2.80e-03 | 9.95e-01 |
RIP MEDIATED NFKB ACTIVATION VIA ZBP1 | 15 | 9.87e-01 | -2.43e-03 | 9.95e-01 |
NUCLEAR IMPORT OF REV PROTEIN | 32 | 9.81e-01 | 2.37e-03 | 9.94e-01 |
UNBLOCKING OF NMDA RECEPTORS GLUTAMATE BINDING AND ACTIVATION | 21 | 9.86e-01 | 2.28e-03 | 9.95e-01 |
RUNX2 REGULATES BONE DEVELOPMENT | 29 | 9.87e-01 | -1.70e-03 | 9.95e-01 |
RRNA MODIFICATION IN THE NUCLEUS AND CYTOSOL | 59 | 9.82e-01 | 1.69e-03 | 9.94e-01 |
PECAM1 INTERACTIONS | 12 | 9.92e-01 | 1.61e-03 | 9.99e-01 |
ION TRANSPORT BY P TYPE ATPASES | 50 | 9.88e-01 | -1.27e-03 | 9.95e-01 |
REPRESSION OF WNT TARGET GENES | 14 | 9.94e-01 | -1.11e-03 | 1.00e+00 |
PYRIMIDINE CATABOLISM | 10 | 9.95e-01 | 1.09e-03 | 1.00e+00 |
CONSTITUTIVE SIGNALING BY ABERRANT PI3K IN CANCER | 64 | 9.96e-01 | -3.96e-04 | 1.00e+00 |
PLASMA LIPOPROTEIN REMODELING | 14 | 9.99e-01 | -2.36e-04 | 1.00e+00 |
ANTIGEN ACTIVATES B CELL RECEPTOR BCR LEADING TO GENERATION OF SECOND MESSENGERS | 26 | 9.98e-01 | -2.15e-04 | 1.00e+00 |
SIGNALING BY NOTCH3 | 48 | 9.98e-01 | -1.97e-04 | 1.00e+00 |
CELLULAR SENESCENCE | 146 | 9.99e-01 | 8.71e-05 | 1.00e+00 |
SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | 14 | 1.00e+00 | 1.63e-05 | 1.00e+00 |
FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC
340 | |
---|---|
set | FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC |
setSize | 19 |
pANOVA | 9.33e-08 |
s.dist | 0.707 |
p.adjustANOVA | 5.5e-06 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Cct6a | 8139 |
Tubb2a | 8130 |
Tuba1b | 7873 |
Tubb4b | 7622 |
Tubb4a | 7517 |
Tubb2b | 7504 |
Cct5 | 7328 |
Tuba4a | 7208 |
Cct3 | 7150 |
Tuba1a | 7067 |
Tcp1 | 6639 |
Cct8 | 6486 |
Cct4 | 6252 |
Tubb3 | 5842 |
Cct7 | 4843 |
Tuba1c | 4485 |
Cct2 | 3832 |
Tubb6 | 1806 |
Tuba8 | -5577 |
GeneID | Gene Rank |
---|---|
Cct6a | 8139 |
Tubb2a | 8130 |
Tuba1b | 7873 |
Tubb4b | 7622 |
Tubb4a | 7517 |
Tubb2b | 7504 |
Cct5 | 7328 |
Tuba4a | 7208 |
Cct3 | 7150 |
Tuba1a | 7067 |
Tcp1 | 6639 |
Cct8 | 6486 |
Cct4 | 6252 |
Tubb3 | 5842 |
Cct7 | 4843 |
Tuba1c | 4485 |
Cct2 | 3832 |
Tubb6 | 1806 |
Tuba8 | -5577 |
ALPHA LINOLENIC OMEGA3 AND LINOLEIC OMEGA6 ACID METABOLISM
47 | |
---|---|
set | ALPHA LINOLENIC OMEGA3 AND LINOLEIC OMEGA6 ACID METABOLISM |
setSize | 12 |
pANOVA | 0.000265 |
s.dist | 0.608 |
p.adjustANOVA | 0.004 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Fads2 | 8315 |
Fads1 | 8229 |
Elovl1 | 7473 |
Hsd17b4 | 6568 |
Acox1 | 6066 |
Acaa1a | 5291 |
Scp2 | 3811 |
Acot8 | 3545 |
Acsl1 | 2715 |
Elovl5 | 2632 |
Elovl2 | 2613 |
Abcd1 | 1865 |
GeneID | Gene Rank |
---|---|
Fads2 | 8315 |
Fads1 | 8229 |
Elovl1 | 7473 |
Hsd17b4 | 6568 |
Acox1 | 6066 |
Acaa1a | 5291 |
Scp2 | 3811 |
Acot8 | 3545 |
Acsl1 | 2715 |
Elovl5 | 2632 |
Elovl2 | 2613 |
Abcd1 | 1865 |
GOLGI CISTERNAE PERICENTRIOLAR STACK REORGANIZATION
398 | |
---|---|
set | GOLGI CISTERNAE PERICENTRIOLAR STACK REORGANIZATION |
setSize | 12 |
pANOVA | 0.000567 |
s.dist | 0.575 |
p.adjustANOVA | 0.00704 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Mapk3 | 7701 |
Gorasp2 | 7540 |
Mapk1 | 7097 |
Uso1 | 6853 |
Rab2a | 6470 |
Rab1b | 6316 |
Rab1a | 6145 |
Ccnb2 | 5891 |
Blzf1 | 4985 |
Gorasp1 | 4112 |
Golga2 | -3175 |
Plk1 | -4344 |
GeneID | Gene Rank |
---|---|
Mapk3 | 7701 |
Gorasp2 | 7540 |
Mapk1 | 7097 |
Uso1 | 6853 |
Rab2a | 6470 |
Rab1b | 6316 |
Rab1a | 6145 |
Ccnb2 | 5891 |
Blzf1 | 4985 |
Gorasp1 | 4112 |
Golga2 | -3175 |
Plk1 | -4344 |
PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS
757 | |
---|---|
set | PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS |
setSize | 12 |
pANOVA | 0.000789 |
s.dist | 0.56 |
p.adjustANOVA | 0.00911 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Impdh2 | 7591 |
Gart | 7383 |
Paics | 7071 |
Adss | 6927 |
Gmps | 6784 |
Atic | 6715 |
Adsl | 5423 |
Adssl1 | 5346 |
Impdh1 | 3125 |
Ppat | 1917 |
Lhpp | 1163 |
Pfas | -5437 |
GeneID | Gene Rank |
---|---|
Impdh2 | 7591 |
Gart | 7383 |
Paics | 7071 |
Adss | 6927 |
Gmps | 6784 |
Atic | 6715 |
Adsl | 5423 |
Adssl1 | 5346 |
Impdh1 | 3125 |
Ppat | 1917 |
Lhpp | 1163 |
Pfas | -5437 |
RHOBTB3 ATPASE CYCLE
860 | |
---|---|
set | RHOBTB3 ATPASE CYCLE |
setSize | 10 |
pANOVA | 0.00245 |
s.dist | 0.553 |
p.adjustANOVA | 0.021 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Htr7 | 7894 |
Ccne1 | 7431 |
Rab9b | 5924 |
Cul3 | 5822 |
Hgs | 5340 |
Plin3 | 5265 |
Lrrc41 | 4586 |
Vhl | 2253 |
Rhobtb3 | 402 |
Rab9 | -457 |
GeneID | Gene Rank |
---|---|
Htr7 | 7894 |
Ccne1 | 7431 |
Rab9b | 5924 |
Cul3 | 5822 |
Hgs | 5340 |
Plin3 | 5265 |
Lrrc41 | 4586 |
Vhl | 2253 |
Rhobtb3 | 402 |
Rab9 | -457 |
TRANSPORT OF CONNEXONS TO THE PLASMA MEMBRANE
1138 | |
---|---|
set | TRANSPORT OF CONNEXONS TO THE PLASMA MEMBRANE |
setSize | 13 |
pANOVA | 0.000836 |
s.dist | 0.535 |
p.adjustANOVA | 0.00938 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Tubb2a | 8130 |
Tuba1b | 7873 |
Tubb4b | 7622 |
Tubb4a | 7517 |
Tubb2b | 7504 |
Tuba4a | 7208 |
Tuba1a | 7067 |
Tubb3 | 5842 |
Gja1 | 5105 |
Tuba1c | 4485 |
Tubb6 | 1806 |
Tuba8 | -5577 |
Gjb2 | -8878 |
GeneID | Gene Rank |
---|---|
Tubb2a | 8130 |
Tuba1b | 7873 |
Tubb4b | 7622 |
Tubb4a | 7517 |
Tubb2b | 7504 |
Tuba4a | 7208 |
Tuba1a | 7067 |
Tubb3 | 5842 |
Gja1 | 5105 |
Tuba1c | 4485 |
Tubb6 | 1806 |
Tuba8 | -5577 |
Gjb2 | -8878 |
BBSOME MEDIATED CARGO TARGETING TO CILIUM
92 | |
---|---|
set | BBSOME MEDIATED CARGO TARGETING TO CILIUM |
setSize | 23 |
pANOVA | 9.28e-06 |
s.dist | 0.534 |
p.adjustANOVA | 0.00028 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Mkks | 8028 |
Bbs10 | 7881 |
Cct5 | 7328 |
Mchr1 | 7255 |
Bbs9 | 7234 |
Cct3 | 7150 |
Arl6 | 6976 |
Tcp1 | 6639 |
Lztfl1 | 6504 |
Cct8 | 6486 |
Cct4 | 6252 |
Rab3ip | 6224 |
Ttc8 | 6172 |
Bbs1 | 5926 |
Smo | 5053 |
Bbs7 | 4516 |
Cct2 | 3832 |
Bbs2 | 2160 |
Bbip1 | 1835 |
Bbs4 | 1657 |
GeneID | Gene Rank |
---|---|
Mkks | 8028 |
Bbs10 | 7881 |
Cct5 | 7328 |
Mchr1 | 7255 |
Bbs9 | 7234 |
Cct3 | 7150 |
Arl6 | 6976 |
Tcp1 | 6639 |
Lztfl1 | 6504 |
Cct8 | 6486 |
Cct4 | 6252 |
Rab3ip | 6224 |
Ttc8 | 6172 |
Bbs1 | 5926 |
Smo | 5053 |
Bbs7 | 4516 |
Cct2 | 3832 |
Bbs2 | 2160 |
Bbip1 | 1835 |
Bbs4 | 1657 |
Sstr3 | -5368 |
Bbs5 | -5698 |
Bbs12 | -5783 |
CITRIC ACID CYCLE TCA CYCLE
154 | |
---|---|
set | CITRIC ACID CYCLE TCA CYCLE |
setSize | 22 |
pANOVA | 2.49e-05 |
s.dist | 0.519 |
p.adjustANOVA | 0.000636 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Idh2 | 8249 |
Idh3a | 7988 |
Fh1 | 7915 |
Sucla2 | 6928 |
Dld | 6906 |
Idh3b | 6659 |
Dlst | 6472 |
Suclg2 | 5337 |
Mdh2 | 5325 |
Sdhd | 5079 |
Aco2 | 4730 |
Idh3g | 4298 |
Sdha | 4003 |
Cs | 3839 |
Ogdh | 3656 |
Suclg1 | 3555 |
Nnt | 3360 |
Sdhb | 2165 |
Fahd1 | 1729 |
Sdhc | 1198 |
GeneID | Gene Rank |
---|---|
Idh2 | 8249 |
Idh3a | 7988 |
Fh1 | 7915 |
Sucla2 | 6928 |
Dld | 6906 |
Idh3b | 6659 |
Dlst | 6472 |
Suclg2 | 5337 |
Mdh2 | 5325 |
Sdhd | 5079 |
Aco2 | 4730 |
Idh3g | 4298 |
Sdha | 4003 |
Cs | 3839 |
Ogdh | 3656 |
Suclg1 | 3555 |
Nnt | 3360 |
Sdhb | 2165 |
Fahd1 | 1729 |
Sdhc | 1198 |
Me2 | -3407 |
Me3 | -4847 |
NUCLEOBASE BIOSYNTHESIS
655 | |
---|---|
set | NUCLEOBASE BIOSYNTHESIS |
setSize | 15 |
pANOVA | 0.000668 |
s.dist | 0.507 |
p.adjustANOVA | 0.00803 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Umps | 7689 |
Impdh2 | 7591 |
Gart | 7383 |
Paics | 7071 |
Adss | 6927 |
Gmps | 6784 |
Atic | 6715 |
Adsl | 5423 |
Adssl1 | 5346 |
Impdh1 | 3125 |
Ppat | 1917 |
Lhpp | 1163 |
Dhodh | 1010 |
Cad | -2095 |
Pfas | -5437 |
GeneID | Gene Rank |
---|---|
Umps | 7689 |
Impdh2 | 7591 |
Gart | 7383 |
Paics | 7071 |
Adss | 6927 |
Gmps | 6784 |
Atic | 6715 |
Adsl | 5423 |
Adssl1 | 5346 |
Impdh1 | 3125 |
Ppat | 1917 |
Lhpp | 1163 |
Dhodh | 1010 |
Cad | -2095 |
Pfas | -5437 |
KERATAN SULFATE BIOSYNTHESIS
505 | |
---|---|
set | KERATAN SULFATE BIOSYNTHESIS |
setSize | 24 |
pANOVA | 2.54e-05 |
s.dist | 0.497 |
p.adjustANOVA | 0.000636 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Prelp | 8307 |
B4galt4 | 8133 |
B4gat1 | 7867 |
B4galt1 | 7206 |
B4galt2 | 7053 |
Chst2 | 6910 |
B3gnt2 | 6456 |
Chst1 | 5732 |
St3gal4 | 5412 |
Acan | 5261 |
St3gal2 | 4804 |
B4galt6 | 4181 |
B3gnt4 | 4171 |
Fmod | 4018 |
Lum | 3386 |
Slc35d2 | 3267 |
B3gnt7 | 2820 |
St3gal1 | 2423 |
B4galt3 | 2030 |
St3gal3 | 1871 |
GeneID | Gene Rank |
---|---|
Prelp | 8307 |
B4galt4 | 8133 |
B4gat1 | 7867 |
B4galt1 | 7206 |
B4galt2 | 7053 |
Chst2 | 6910 |
B3gnt2 | 6456 |
Chst1 | 5732 |
St3gal4 | 5412 |
Acan | 5261 |
St3gal2 | 4804 |
B4galt6 | 4181 |
B3gnt4 | 4171 |
Fmod | 4018 |
Lum | 3386 |
Slc35d2 | 3267 |
B3gnt7 | 2820 |
St3gal1 | 2423 |
B4galt3 | 2030 |
St3gal3 | 1871 |
B4galt5 | 1637 |
Chst5 | 1487 |
Ogn | -1934 |
St3gal6 | -7863 |
COPI INDEPENDENT GOLGI TO ER RETROGRADE TRAFFIC
182 | |
---|---|
set | COPI INDEPENDENT GOLGI TO ER RETROGRADE TRAFFIC |
setSize | 44 |
pANOVA | 1.48e-08 |
s.dist | 0.493 |
p.adjustANOVA | 1.16e-06 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Tubb2a | 8130 |
Tuba1b | 7873 |
Capza2 | 7704 |
Tubb4b | 7622 |
Tubb4a | 7517 |
Tubb2b | 7504 |
Actr1a | 7389 |
Capza1 | 7253 |
Tuba4a | 7208 |
Dctn4 | 7177 |
Tuba1a | 7067 |
Rab6a | 6581 |
Rab18 | 6537 |
Dctn6 | 6465 |
Dctn1 | 6188 |
Rab3gap1 | 6072 |
Tubb3 | 5842 |
Dync1i1 | 5759 |
Pla2g6 | 5480 |
Dctn5 | 5433 |
GeneID | Gene Rank |
---|---|
Tubb2a | 8130 |
Tuba1b | 7873 |
Capza2 | 7704 |
Tubb4b | 7622 |
Tubb4a | 7517 |
Tubb2b | 7504 |
Actr1a | 7389 |
Capza1 | 7253 |
Tuba4a | 7208 |
Dctn4 | 7177 |
Tuba1a | 7067 |
Rab6a | 6581 |
Rab18 | 6537 |
Dctn6 | 6465 |
Dctn1 | 6188 |
Rab3gap1 | 6072 |
Tubb3 | 5842 |
Dync1i1 | 5759 |
Pla2g6 | 5480 |
Dctn5 | 5433 |
Rab6b | 5302 |
Capzb | 5208 |
Pla2g4a | 4647 |
Tuba1c | 4485 |
Galnt1 | 4231 |
Dynll1 | 3613 |
Dctn2 | 3314 |
Actr10 | 2962 |
Pafah1b3 | 2884 |
Galnt2 | 2757 |
Dync1li1 | 2623 |
Pafah1b1 | 2584 |
Pafah1b2 | 2292 |
Rab3gap2 | 2191 |
Agpat3 | 1986 |
Tubb6 | 1806 |
Dync1h1 | 1341 |
Dctn3 | 329 |
Bicd2 | -362 |
Dynll2 | -1891 |
Dync1li2 | -3541 |
Dync1i2 | -3902 |
Bicd1 | -3999 |
Tuba8 | -5577 |
COOPERATION OF PREFOLDIN AND TRIC CCT IN ACTIN AND TUBULIN FOLDING
180 | |
---|---|
set | COOPERATION OF PREFOLDIN AND TRIC CCT IN ACTIN AND TUBULIN FOLDING |
setSize | 26 |
pANOVA | 2.52e-05 |
s.dist | 0.477 |
p.adjustANOVA | 0.000636 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Cct6a | 8139 |
Tubb2a | 8130 |
Tuba1b | 7873 |
Tubb4b | 7622 |
Tubb4a | 7517 |
Tubb2b | 7504 |
Cct5 | 7328 |
Tuba4a | 7208 |
Cct3 | 7150 |
Tuba1a | 7067 |
Tcp1 | 6639 |
Cct8 | 6486 |
Cct4 | 6252 |
Tubb3 | 5842 |
Cct7 | 4843 |
Pfdn4 | 4529 |
Tuba1c | 4485 |
Cct2 | 3832 |
Vbp1 | 3176 |
Tubb6 | 1806 |
GeneID | Gene Rank |
---|---|
Cct6a | 8139 |
Tubb2a | 8130 |
Tuba1b | 7873 |
Tubb4b | 7622 |
Tubb4a | 7517 |
Tubb2b | 7504 |
Cct5 | 7328 |
Tuba4a | 7208 |
Cct3 | 7150 |
Tuba1a | 7067 |
Tcp1 | 6639 |
Cct8 | 6486 |
Cct4 | 6252 |
Tubb3 | 5842 |
Cct7 | 4843 |
Pfdn4 | 4529 |
Tuba1c | 4485 |
Cct2 | 3832 |
Vbp1 | 3176 |
Tubb6 | 1806 |
Pfdn1 | 574 |
Pfdn5 | -3196 |
Pfdn6 | -3809 |
Pfdn2 | -4915 |
Tuba8 | -5577 |
Actb | -8390 |
HSP90 CHAPERONE CYCLE FOR STEROID HORMONE RECEPTORS SHR
435 | |
---|---|
set | HSP90 CHAPERONE CYCLE FOR STEROID HORMONE RECEPTORS SHR |
setSize | 48 |
pANOVA | 2.46e-08 |
s.dist | 0.465 |
p.adjustANOVA | 1.7e-06 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Hspa2 | 8280 |
Hspa1b | 8162 |
Tubb2a | 8130 |
Dnaja2 | 7983 |
Tuba1b | 7873 |
Capza2 | 7704 |
Tubb4b | 7622 |
Dnaja4 | 7556 |
Tubb4a | 7517 |
Tubb2b | 7504 |
Actr1a | 7389 |
Dnaja1 | 7327 |
Capza1 | 7253 |
Tuba4a | 7208 |
Dctn4 | 7177 |
Tuba1a | 7067 |
Stip1 | 6832 |
Dctn6 | 6465 |
Dctn1 | 6188 |
Fkbp5 | 5985 |
GeneID | Gene Rank |
---|---|
Hspa2 | 8280 |
Hspa1b | 8162 |
Tubb2a | 8130 |
Dnaja2 | 7983 |
Tuba1b | 7873 |
Capza2 | 7704 |
Tubb4b | 7622 |
Dnaja4 | 7556 |
Tubb4a | 7517 |
Tubb2b | 7504 |
Actr1a | 7389 |
Dnaja1 | 7327 |
Capza1 | 7253 |
Tuba4a | 7208 |
Dctn4 | 7177 |
Tuba1a | 7067 |
Stip1 | 6832 |
Dctn6 | 6465 |
Dctn1 | 6188 |
Fkbp5 | 5985 |
Tubb3 | 5842 |
Dync1i1 | 5759 |
Fkbp4 | 5611 |
Dctn5 | 5433 |
Capzb | 5208 |
Hspa8 | 5004 |
Tuba1c | 4485 |
Dynll1 | 3613 |
Ptges3 | 3550 |
Dctn2 | 3314 |
Actr10 | 2962 |
Dync1li1 | 2623 |
Nr3c2 | 2400 |
Tubb6 | 1806 |
Dnajb1 | 1793 |
Dync1h1 | 1341 |
Dctn3 | 329 |
Ar | 266 |
Nr3c1 | -1009 |
Dynll2 | -1891 |
Hsp90ab1 | -2348 |
Hspa1l | -2920 |
Hsp90aa1 | -2970 |
Pgr | -3538 |
Dync1li2 | -3541 |
Dync1i2 | -3902 |
Hspa1a | -5092 |
Tuba8 | -5577 |
KERATAN SULFATE KERATIN METABOLISM
507 | |
---|---|
set | KERATAN SULFATE KERATIN METABOLISM |
setSize | 30 |
pANOVA | 1.46e-05 |
s.dist | 0.457 |
p.adjustANOVA | 0.000409 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Prelp | 8307 |
B4galt4 | 8133 |
B4gat1 | 7867 |
B4galt1 | 7206 |
B4galt2 | 7053 |
Chst2 | 6910 |
B3gnt2 | 6456 |
Chst1 | 5732 |
Hexa | 5632 |
St3gal4 | 5412 |
Acan | 5261 |
St3gal2 | 4804 |
Gns | 4656 |
Hexb | 4301 |
B4galt6 | 4181 |
B3gnt4 | 4171 |
Fmod | 4018 |
Lum | 3386 |
Slc35d2 | 3267 |
B3gnt7 | 2820 |
GeneID | Gene Rank |
---|---|
Prelp | 8307 |
B4galt4 | 8133 |
B4gat1 | 7867 |
B4galt1 | 7206 |
B4galt2 | 7053 |
Chst2 | 6910 |
B3gnt2 | 6456 |
Chst1 | 5732 |
Hexa | 5632 |
St3gal4 | 5412 |
Acan | 5261 |
St3gal2 | 4804 |
Gns | 4656 |
Hexb | 4301 |
B4galt6 | 4181 |
B3gnt4 | 4171 |
Fmod | 4018 |
Lum | 3386 |
Slc35d2 | 3267 |
B3gnt7 | 2820 |
St3gal1 | 2423 |
Glb1 | 2200 |
B4galt3 | 2030 |
St3gal3 | 1871 |
B4galt5 | 1637 |
Chst5 | 1487 |
Glb1l | 552 |
Ogn | -1934 |
Galns | -4080 |
St3gal6 | -7863 |
CALNEXIN CALRETICULIN CYCLE
110 | |
---|---|
set | CALNEXIN CALRETICULIN CYCLE |
setSize | 26 |
pANOVA | 5.9e-05 |
s.dist | 0.455 |
p.adjustANOVA | 0.0012 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Calr | 8220 |
Derl2 | 8209 |
Pdia3 | 7888 |
Prkcsh | 7715 |
Ganab | 7291 |
Rnf185 | 6706 |
Os9 | 6588 |
Canx | 6365 |
Man1b1 | 6134 |
Marchf6 | 5839 |
Rnf5 | 5661 |
Edem2 | 5636 |
Amfr | 5428 |
Rnf139 | 5303 |
Uggt1 | 5299 |
Syvn1 | 5168 |
Ubc | 4500 |
Edem3 | 2269 |
Ubb | 1303 |
Rps27a | -478 |
GeneID | Gene Rank |
---|---|
Calr | 8220 |
Derl2 | 8209 |
Pdia3 | 7888 |
Prkcsh | 7715 |
Ganab | 7291 |
Rnf185 | 6706 |
Os9 | 6588 |
Canx | 6365 |
Man1b1 | 6134 |
Marchf6 | 5839 |
Rnf5 | 5661 |
Edem2 | 5636 |
Amfr | 5428 |
Rnf139 | 5303 |
Uggt1 | 5299 |
Syvn1 | 5168 |
Ubc | 4500 |
Edem3 | 2269 |
Ubb | 1303 |
Rps27a | -478 |
Rnf103 | -721 |
Edem1 | -1059 |
Sel1l | -2256 |
Uggt2 | -2738 |
Trim13 | -3011 |
Uba52 | -8214 |
GLYCOGEN STORAGE DISEASES
391 | |
---|---|
set | GLYCOGEN STORAGE DISEASES |
setSize | 12 |
pANOVA | 0.00644 |
s.dist | 0.454 |
p.adjustANOVA | 0.0424 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Gyg | 7709 |
Gaa | 7535 |
Gbe1 | 7309 |
Nhlrc1 | 6939 |
G6pc3 | 6444 |
Epm2a | 5095 |
Ubc | 4500 |
Ppp1r3c | 2878 |
Gys1 | 1875 |
Ubb | 1303 |
Rps27a | -478 |
Uba52 | -8214 |
GeneID | Gene Rank |
---|---|
Gyg | 7709 |
Gaa | 7535 |
Gbe1 | 7309 |
Nhlrc1 | 6939 |
G6pc3 | 6444 |
Epm2a | 5095 |
Ubc | 4500 |
Ppp1r3c | 2878 |
Gys1 | 1875 |
Ubb | 1303 |
Rps27a | -478 |
Uba52 | -8214 |
GAP JUNCTION ASSEMBLY
371 | |
---|---|
set | GAP JUNCTION ASSEMBLY |
setSize | 21 |
pANOVA | 0.000314 |
s.dist | 0.454 |
p.adjustANOVA | 0.00462 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Tubb2a | 8130 |
Tuba1b | 7873 |
Tubb4b | 7622 |
Gjb6 | 7577 |
Tubb4a | 7517 |
Tubb2b | 7504 |
Tuba4a | 7208 |
Tuba1a | 7067 |
Gjd2 | 6953 |
Gjd3 | 5958 |
Tubb3 | 5842 |
Gja1 | 5105 |
Tuba1c | 4485 |
Gjb1 | 3853 |
Gjc1 | 2485 |
Tubb6 | 1806 |
Gjc2 | 1414 |
Gja4 | -1332 |
Tuba8 | -5577 |
Gja5 | -7589 |
GeneID | Gene Rank |
---|---|
Tubb2a | 8130 |
Tuba1b | 7873 |
Tubb4b | 7622 |
Gjb6 | 7577 |
Tubb4a | 7517 |
Tubb2b | 7504 |
Tuba4a | 7208 |
Tuba1a | 7067 |
Gjd2 | 6953 |
Gjd3 | 5958 |
Tubb3 | 5842 |
Gja1 | 5105 |
Tuba1c | 4485 |
Gjb1 | 3853 |
Gjc1 | 2485 |
Tubb6 | 1806 |
Gjc2 | 1414 |
Gja4 | -1332 |
Tuba8 | -5577 |
Gja5 | -7589 |
Gjb2 | -8878 |
ENDOSOMAL VACUOLAR PATHWAY
284 | |
---|---|
set | ENDOSOMAL VACUOLAR PATHWAY |
setSize | 10 |
pANOVA | 0.0131 |
s.dist | -0.453 |
p.adjustANOVA | 0.0681 |
Top enriched genes
GeneID | Gene Rank |
---|---|
H2-T23 | -9188 |
H2-M3 | -8824 |
H2-Q7 | -7765 |
B2m | -7131 |
H2-Q10 | -6983 |
H2-D1 | -5043 |
Lnpep | -4287 |
H2-Q2 | -2917 |
Ctss | 2781 |
Ctsl | 5335 |
GeneID | Gene Rank |
---|---|
H2-T23 | -9188 |
H2-M3 | -8824 |
H2-Q7 | -7765 |
B2m | -7131 |
H2-Q10 | -6983 |
H2-D1 | -5043 |
Lnpep | -4287 |
H2-Q2 | -2917 |
Ctss | 2781 |
Ctsl | 5335 |
RETROGRADE NEUROTROPHIN SIGNALLING
842 | |
---|---|
set | RETROGRADE NEUROTROPHIN SIGNALLING |
setSize | 13 |
pANOVA | 0.00477 |
s.dist | 0.452 |
p.adjustANOVA | 0.0339 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ap2m1 | 7792 |
Dnm2 | 7614 |
Ap2b1 | 7522 |
Dnal4 | 7381 |
Ap2a2 | 6984 |
Ap2a1 | 6110 |
Cltc | 4483 |
Clta | 3556 |
Sh3gl2 | 2855 |
Dnm3 | 2297 |
Dnm1 | 814 |
Ap2s1 | -3475 |
Ntrk1 | -7720 |
GeneID | Gene Rank |
---|---|
Ap2m1 | 7792 |
Dnm2 | 7614 |
Ap2b1 | 7522 |
Dnal4 | 7381 |
Ap2a2 | 6984 |
Ap2a1 | 6110 |
Cltc | 4483 |
Clta | 3556 |
Sh3gl2 | 2855 |
Dnm3 | 2297 |
Dnm1 | 814 |
Ap2s1 | -3475 |
Ntrk1 | -7720 |
GLYCOGEN SYNTHESIS
392 | |
---|---|
set | GLYCOGEN SYNTHESIS |
setSize | 14 |
pANOVA | 0.00363 |
s.dist | 0.449 |
p.adjustANOVA | 0.0274 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Pgm1 | 8318 |
Ugp2 | 8093 |
Gyg | 7709 |
Gbe1 | 7309 |
Nhlrc1 | 6939 |
Pgm2 | 6644 |
Epm2a | 5095 |
Ubc | 4500 |
Ppp1r3c | 2878 |
Gys1 | 1875 |
Ubb | 1303 |
Rps27a | -478 |
Pgm2l1 | -2578 |
Uba52 | -8214 |
GeneID | Gene Rank |
---|---|
Pgm1 | 8318 |
Ugp2 | 8093 |
Gyg | 7709 |
Gbe1 | 7309 |
Nhlrc1 | 6939 |
Pgm2 | 6644 |
Epm2a | 5095 |
Ubc | 4500 |
Ppp1r3c | 2878 |
Gys1 | 1875 |
Ubb | 1303 |
Rps27a | -478 |
Pgm2l1 | -2578 |
Uba52 | -8214 |
SEALING OF THE NUCLEAR ENVELOPE NE BY ESCRT III
909 | |
---|---|
set | SEALING OF THE NUCLEAR ENVELOPE NE BY ESCRT III |
setSize | 23 |
pANOVA | 0.000265 |
s.dist | 0.439 |
p.adjustANOVA | 0.004 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Tubb2a | 8130 |
Tuba1b | 7873 |
Tubb4b | 7622 |
Tubb4a | 7517 |
Tubb2b | 7504 |
Vps4a | 7252 |
Tuba4a | 7208 |
Chmp7 | 7151 |
Chmp3 | 7107 |
Tuba1a | 7067 |
Chmp2b | 6346 |
Chmp4b | 6041 |
Spast | 5925 |
Tubb3 | 5842 |
Tuba1c | 4485 |
Tubb6 | 1806 |
Chmp6 | 1720 |
Lemd2 | -1060 |
Chmp2a | -2646 |
Ist1 | -4378 |
GeneID | Gene Rank |
---|---|
Tubb2a | 8130 |
Tuba1b | 7873 |
Tubb4b | 7622 |
Tubb4a | 7517 |
Tubb2b | 7504 |
Vps4a | 7252 |
Tuba4a | 7208 |
Chmp7 | 7151 |
Chmp3 | 7107 |
Tuba1a | 7067 |
Chmp2b | 6346 |
Chmp4b | 6041 |
Spast | 5925 |
Tubb3 | 5842 |
Tuba1c | 4485 |
Tubb6 | 1806 |
Chmp6 | 1720 |
Lemd2 | -1060 |
Chmp2a | -2646 |
Ist1 | -4378 |
Cc2d1b | -5268 |
Tuba8 | -5577 |
Chmp4c | -8521 |
LDL CLEARANCE
516 | |
---|---|
set | LDL CLEARANCE |
setSize | 16 |
pANOVA | 0.00246 |
s.dist | 0.437 |
p.adjustANOVA | 0.021 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Lipa | 8232 |
Ap2m1 | 7792 |
Ap2b1 | 7522 |
Npc1 | 7221 |
Ap2a2 | 6984 |
Soat1 | 6714 |
Ap2a1 | 6110 |
Nceh1 | 5557 |
Cltc | 4483 |
Clta | 3556 |
Ldlr | 1991 |
Npc2 | 1627 |
Lsr | 745 |
Ap2s1 | -3475 |
Pcsk9 | -4163 |
Ldlrap1 | -6117 |
GeneID | Gene Rank |
---|---|
Lipa | 8232 |
Ap2m1 | 7792 |
Ap2b1 | 7522 |
Npc1 | 7221 |
Ap2a2 | 6984 |
Soat1 | 6714 |
Ap2a1 | 6110 |
Nceh1 | 5557 |
Cltc | 4483 |
Clta | 3556 |
Ldlr | 1991 |
Npc2 | 1627 |
Lsr | 745 |
Ap2s1 | -3475 |
Pcsk9 | -4163 |
Ldlrap1 | -6117 |
CHK1 CHK2 CDS1 MEDIATED INACTIVATION OF CYCLIN B CDK1 COMPLEX
146 | |
---|---|
set | CHK1 CHK2 CDS1 MEDIATED INACTIVATION OF CYCLIN B CDK1 COMPLEX |
setSize | 10 |
pANOVA | 0.0169 |
s.dist | 0.436 |
p.adjustANOVA | 0.08 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Sfn | 6246 |
Chek1 | 6044 |
Ywhaq | 5968 |
Ywhab | 4891 |
Ywhah | 3722 |
Wee1 | 3716 |
Ywhae | 2826 |
Ywhaz | 1182 |
Ywhag | 961 |
Chek2 | -1400 |
GeneID | Gene Rank |
---|---|
Sfn | 6246 |
Chek1 | 6044 |
Ywhaq | 5968 |
Ywhab | 4891 |
Ywhah | 3722 |
Wee1 | 3716 |
Ywhae | 2826 |
Ywhaz | 1182 |
Ywhag | 961 |
Chek2 | -1400 |
OLFACTORY SIGNALING PATHWAY
664 | |
---|---|
set | OLFACTORY SIGNALING PATHWAY |
setSize | 40 |
pANOVA | 2.56e-06 |
s.dist | -0.43 |
p.adjustANOVA | 0.000112 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Rtp4 | -9185 |
Olfr981 | -9130 |
Olfr354 | -9066 |
Olfr635 | -8967 |
Olfr1310 | -8891 |
Olfr1192-ps1 | -8827 |
Olfr796 | -8547 |
Olfr1564 | -8513 |
Olfr2 | -8472 |
Olfr735 | -8412 |
Olfr63 | -8335 |
Olfr1309 | -8324 |
Olfr986 | -8079 |
Olfr287 | -7681 |
Olfr90 | -7344 |
Olfr78 | -7306 |
Olfr31 | -6758 |
Olfr804 | -6712 |
Gng13 | -6622 |
Olfr1385 | -6534 |
GeneID | Gene Rank |
---|---|
Rtp4 | -9185 |
Olfr981 | -9130 |
Olfr354 | -9066 |
Olfr635 | -8967 |
Olfr1310 | -8891 |
Olfr1192-ps1 | -8827 |
Olfr796 | -8547 |
Olfr1564 | -8513 |
Olfr2 | -8472 |
Olfr735 | -8412 |
Olfr63 | -8335 |
Olfr1309 | -8324 |
Olfr986 | -8079 |
Olfr287 | -7681 |
Olfr90 | -7344 |
Olfr78 | -7306 |
Olfr31 | -6758 |
Olfr804 | -6712 |
Gng13 | -6622 |
Olfr1385 | -6534 |
Olfr161 | -5851 |
Olfr365 | -5455 |
Olfr137 | -5449 |
Olfr713 | -5014 |
Reep4 | -4431 |
Olfr648 | -4383 |
Olfr147 | -3210 |
Olfr558 | -2465 |
Olfr1507 | -587 |
Reep6 | -581 |
Reep3 | -347 |
Olfr446 | 176 |
Olfr95 | 313 |
Olfr552 | 353 |
Reep1 | 2405 |
Gnal | 4239 |
Reep2 | 5124 |
Olfr464 | 6000 |
Gnb1 | 6352 |
Reep5 | 6884 |
RHO GTPASES ACTIVATE IQGAPS
848 | |
---|---|
set | RHO GTPASES ACTIVATE IQGAPS |
setSize | 23 |
pANOVA | 0.000381 |
s.dist | 0.428 |
p.adjustANOVA | 0.00521 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Tubb2a | 8130 |
Tuba1b | 7873 |
Tubb4b | 7622 |
Tubb4a | 7517 |
Tubb2b | 7504 |
Ctnna1 | 7489 |
Tuba4a | 7208 |
Tuba1a | 7067 |
Ctnnb1 | 6810 |
Men1 | 6234 |
Rac1 | 6022 |
Tubb3 | 5842 |
Tuba1c | 4485 |
Cdc42 | 3640 |
Iqgap2 | 2145 |
Actg1 | 1983 |
Tubb6 | 1806 |
Calm1 | 451 |
Iqgap1 | -602 |
Cdh1 | -3096 |
GeneID | Gene Rank |
---|---|
Tubb2a | 8130 |
Tuba1b | 7873 |
Tubb4b | 7622 |
Tubb4a | 7517 |
Tubb2b | 7504 |
Ctnna1 | 7489 |
Tuba4a | 7208 |
Tuba1a | 7067 |
Ctnnb1 | 6810 |
Men1 | 6234 |
Rac1 | 6022 |
Tubb3 | 5842 |
Tuba1c | 4485 |
Cdc42 | 3640 |
Iqgap2 | 2145 |
Actg1 | 1983 |
Tubb6 | 1806 |
Calm1 | 451 |
Iqgap1 | -602 |
Cdh1 | -3096 |
Clip1 | -5312 |
Tuba8 | -5577 |
Actb | -8390 |
RECEPTOR MEDIATED MITOPHAGY
777 | |
---|---|
set | RECEPTOR MEDIATED MITOPHAGY |
setSize | 11 |
pANOVA | 0.0149 |
s.dist | 0.424 |
p.adjustANOVA | 0.0749 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Fundc1 | 6709 |
Atg12 | 6464 |
Csnk2a2 | 5876 |
Csnk2b | 5064 |
Ulk1 | 4360 |
Map1lc3b | 3536 |
Src | 2551 |
Pgam5 | 2243 |
Atg5 | 1480 |
Map1lc3a | 861 |
Csnk2a1 | -2742 |
GeneID | Gene Rank |
---|---|
Fundc1 | 6709 |
Atg12 | 6464 |
Csnk2a2 | 5876 |
Csnk2b | 5064 |
Ulk1 | 4360 |
Map1lc3b | 3536 |
Src | 2551 |
Pgam5 | 2243 |
Atg5 | 1480 |
Map1lc3a | 861 |
Csnk2a1 | -2742 |
PURINE SALVAGE
758 | |
---|---|
set | PURINE SALVAGE |
setSize | 12 |
pANOVA | 0.0114 |
s.dist | 0.422 |
p.adjustANOVA | 0.0622 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Adk | 6834 |
Pnp2 | 6409 |
Gmpr2 | 6404 |
Dck | 6351 |
Dguok | 5001 |
Hprt | 4960 |
Gmpr | 3868 |
Adal | 3166 |
Ampd3 | 2029 |
Ampd2 | 746 |
Ada | -2926 |
Aprt | -3368 |
GeneID | Gene Rank |
---|---|
Adk | 6834 |
Pnp2 | 6409 |
Gmpr2 | 6404 |
Dck | 6351 |
Dguok | 5001 |
Hprt | 4960 |
Gmpr | 3868 |
Adal | 3166 |
Ampd3 | 2029 |
Ampd2 | 746 |
Ada | -2926 |
Aprt | -3368 |
N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE
595 | |
---|---|
set | N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE |
setSize | 35 |
pANOVA | 1.74e-05 |
s.dist | 0.42 |
p.adjustANOVA | 0.000475 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Calr | 8220 |
Derl2 | 8209 |
Pdia3 | 7888 |
Ngly1 | 7717 |
Prkcsh | 7715 |
Mlec | 7562 |
Vcp | 7408 |
Ganab | 7291 |
Rnf185 | 6706 |
Os9 | 6588 |
Derl1 | 6478 |
Canx | 6365 |
Man1b1 | 6134 |
Marchf6 | 5839 |
Rnf5 | 5661 |
Edem2 | 5636 |
Amfr | 5428 |
Rnf139 | 5303 |
Uggt1 | 5299 |
Syvn1 | 5168 |
GeneID | Gene Rank |
---|---|
Calr | 8220 |
Derl2 | 8209 |
Pdia3 | 7888 |
Ngly1 | 7717 |
Prkcsh | 7715 |
Mlec | 7562 |
Vcp | 7408 |
Ganab | 7291 |
Rnf185 | 6706 |
Os9 | 6588 |
Derl1 | 6478 |
Canx | 6365 |
Man1b1 | 6134 |
Marchf6 | 5839 |
Rnf5 | 5661 |
Edem2 | 5636 |
Amfr | 5428 |
Rnf139 | 5303 |
Uggt1 | 5299 |
Syvn1 | 5168 |
Ubc | 4500 |
Rad23b | 3835 |
Edem3 | 2269 |
Ubb | 1303 |
Psmc1 | 753 |
Rps27a | -478 |
Rnf103 | -721 |
Edem1 | -1059 |
Ubxn1 | -2035 |
Sel1l | -2256 |
Uggt2 | -2738 |
Trim13 | -3011 |
Mogs | -3451 |
Engase | -7024 |
Uba52 | -8214 |
CD28 DEPENDENT VAV1 PATHWAY
125 | |
---|---|
set | CD28 DEPENDENT VAV1 PATHWAY |
setSize | 11 |
pANOVA | 0.0164 |
s.dist | 0.418 |
p.adjustANOVA | 0.0789 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Cd86 | 6435 |
Pak1 | 6372 |
Rac1 | 6022 |
Pak2 | 5893 |
Fyn | 4408 |
Cdc42 | 3640 |
Pak3 | 3584 |
Lck | 3286 |
Vav1 | 1300 |
Grb2 | -450 |
Cd80 | -4688 |
GeneID | Gene Rank |
---|---|
Cd86 | 6435 |
Pak1 | 6372 |
Rac1 | 6022 |
Pak2 | 5893 |
Fyn | 4408 |
Cdc42 | 3640 |
Pak3 | 3584 |
Lck | 3286 |
Vav1 | 1300 |
Grb2 | -450 |
Cd80 | -4688 |
ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING
43 | |
---|---|
set | ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING |
setSize | 11 |
pANOVA | 0.0165 |
s.dist | 0.417 |
p.adjustANOVA | 0.0789 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Prkcsh | 7715 |
Capza2 | 7704 |
Mapk3 | 7701 |
Capza1 | 7253 |
Mapk1 | 7097 |
Ddost | 5927 |
App | 5597 |
Hmgb1 | -1491 |
Ager | -2689 |
Lgals3 | -3826 |
S100b | -5232 |
GeneID | Gene Rank |
---|---|
Prkcsh | 7715 |
Capza2 | 7704 |
Mapk3 | 7701 |
Capza1 | 7253 |
Mapk1 | 7097 |
Ddost | 5927 |
App | 5597 |
Hmgb1 | -1491 |
Ager | -2689 |
Lgals3 | -3826 |
S100b | -5232 |
N GLYCAN ANTENNAE ELONGATION
593 | |
---|---|
set | N GLYCAN ANTENNAE ELONGATION |
setSize | 15 |
pANOVA | 0.00519 |
s.dist | 0.417 |
p.adjustANOVA | 0.0356 |
Top enriched genes
GeneID | Gene Rank |
---|---|
B4galt4 | 8133 |
B4galt1 | 7206 |
B4galt2 | 7053 |
St8sia3 | 5894 |
St3gal4 | 5412 |
B4galt6 | 4181 |
St8sia2 | 3411 |
Mgat4b | 3296 |
B4galt3 | 2030 |
B4galt5 | 1637 |
St8sia6 | 1391 |
Mgat4c | 919 |
Mgat4a | 5 |
St6gal1 | -307 |
Mgat5 | -1593 |
GeneID | Gene Rank |
---|---|
B4galt4 | 8133 |
B4galt1 | 7206 |
B4galt2 | 7053 |
St8sia3 | 5894 |
St3gal4 | 5412 |
B4galt6 | 4181 |
St8sia2 | 3411 |
Mgat4b | 3296 |
B4galt3 | 2030 |
B4galt5 | 1637 |
St8sia6 | 1391 |
Mgat4c | 919 |
Mgat4a | 5 |
St6gal1 | -307 |
Mgat5 | -1593 |
TRANSLATION OF REPLICASE AND ASSEMBLY OF THE REPLICATION TRANSCRIPTION COMPLEX
1129 | |
---|---|
set | TRANSLATION OF REPLICASE AND ASSEMBLY OF THE REPLICATION TRANSCRIPTION COMPLEX |
setSize | 12 |
pANOVA | 0.0124 |
s.dist | 0.417 |
p.adjustANOVA | 0.0654 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Chmp7 | 7151 |
Chmp3 | 7107 |
Chmp2b | 6346 |
Becn1 | 6136 |
Chmp4b | 6041 |
Uvrag | 5912 |
Pik3c3 | 3997 |
Map1lc3b | 3536 |
Pik3r4 | 2154 |
Chmp6 | 1720 |
Chmp2a | -2646 |
Chmp4c | -8521 |
GeneID | Gene Rank |
---|---|
Chmp7 | 7151 |
Chmp3 | 7107 |
Chmp2b | 6346 |
Becn1 | 6136 |
Chmp4b | 6041 |
Uvrag | 5912 |
Pik3c3 | 3997 |
Map1lc3b | 3536 |
Pik3r4 | 2154 |
Chmp6 | 1720 |
Chmp2a | -2646 |
Chmp4c | -8521 |
WNT5A DEPENDENT INTERNALIZATION OF FZD2 FZD5 AND ROR2
1173 | |
---|---|
set | WNT5A DEPENDENT INTERNALIZATION OF FZD2 FZD5 AND ROR2 |
setSize | 13 |
pANOVA | 0.00963 |
s.dist | 0.415 |
p.adjustANOVA | 0.0544 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Fzd2 | 8203 |
Ap2m1 | 7792 |
Ap2b1 | 7522 |
Ap2a2 | 6984 |
Fzd5 | 6688 |
Ap2a1 | 6110 |
Cltc | 4483 |
Clta | 3556 |
Ror2 | 3167 |
Cltb | 3123 |
Ap2s1 | -3475 |
Wnt5a | -5644 |
Ror1 | -6564 |
GeneID | Gene Rank |
---|---|
Fzd2 | 8203 |
Ap2m1 | 7792 |
Ap2b1 | 7522 |
Ap2a2 | 6984 |
Fzd5 | 6688 |
Ap2a1 | 6110 |
Cltc | 4483 |
Clta | 3556 |
Ror2 | 3167 |
Cltb | 3123 |
Ap2s1 | -3475 |
Wnt5a | -5644 |
Ror1 | -6564 |
SYNTHESIS OF PYROPHOSPHATES IN THE CYTOSOL
1049 | |
---|---|
set | SYNTHESIS OF PYROPHOSPHATES IN THE CYTOSOL |
setSize | 10 |
pANOVA | 0.0235 |
s.dist | 0.414 |
p.adjustANOVA | 0.1 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Itpk1 | 7922 |
Nudt11 | 7798 |
Ip6k3 | 7087 |
Nudt10 | 5333 |
Nudt4 | 3963 |
Ip6k1 | 2822 |
Nudt3 | 2741 |
Ippk | 610 |
Ppip5k1 | -2554 |
Ppip5k2 | -3534 |
GeneID | Gene Rank |
---|---|
Itpk1 | 7922 |
Nudt11 | 7798 |
Ip6k3 | 7087 |
Nudt10 | 5333 |
Nudt4 | 3963 |
Ip6k1 | 2822 |
Nudt3 | 2741 |
Ippk | 610 |
Ppip5k1 | -2554 |
Ppip5k2 | -3534 |
GLYCOGEN METABOLISM
390 | |
---|---|
set | GLYCOGEN METABOLISM |
setSize | 25 |
pANOVA | 0.000353 |
s.dist | 0.413 |
p.adjustANOVA | 0.00501 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Pgm1 | 8318 |
Ugp2 | 8093 |
Gyg | 7709 |
Gaa | 7535 |
Pygb | 7372 |
Gbe1 | 7309 |
Nhlrc1 | 6939 |
Pygm | 6866 |
Pgm2 | 6644 |
Phkb | 5292 |
Epm2a | 5095 |
Ubc | 4500 |
Phka1 | 3669 |
Ppp1r3c | 2878 |
Gys1 | 1875 |
Phkg1 | 1377 |
Phkg2 | 1354 |
Ubb | 1303 |
Agl | 1034 |
Calm1 | 451 |
GeneID | Gene Rank |
---|---|
Pgm1 | 8318 |
Ugp2 | 8093 |
Gyg | 7709 |
Gaa | 7535 |
Pygb | 7372 |
Gbe1 | 7309 |
Nhlrc1 | 6939 |
Pygm | 6866 |
Pgm2 | 6644 |
Phkb | 5292 |
Epm2a | 5095 |
Ubc | 4500 |
Phka1 | 3669 |
Ppp1r3c | 2878 |
Gys1 | 1875 |
Phkg1 | 1377 |
Phkg2 | 1354 |
Ubb | 1303 |
Agl | 1034 |
Calm1 | 451 |
Rps27a | -478 |
Phka2 | -1545 |
Pgm2l1 | -2578 |
Pygl | -2603 |
Uba52 | -8214 |
REGULATION OF TP53 ACTIVITY THROUGH ASSOCIATION WITH CO FACTORS
824 | |
---|---|
set | REGULATION OF TP53 ACTIVITY THROUGH ASSOCIATION WITH CO FACTORS |
setSize | 14 |
pANOVA | 0.00818 |
s.dist | 0.408 |
p.adjustANOVA | 0.0492 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Pou4f1 | 7924 |
Banp | 7905 |
Trp73 | 7773 |
Ppp1r13b | 7716 |
Pou4f2 | 5931 |
Ppp1r13l | 4079 |
Trp53 | 3770 |
Akt1 | 2876 |
Zfp385a | 2516 |
Phf20 | 1127 |
Akt3 | -553 |
Akt2 | -867 |
Trp53bp2 | -1465 |
Trp63 | -4363 |
GeneID | Gene Rank |
---|---|
Pou4f1 | 7924 |
Banp | 7905 |
Trp73 | 7773 |
Ppp1r13b | 7716 |
Pou4f2 | 5931 |
Ppp1r13l | 4079 |
Trp53 | 3770 |
Akt1 | 2876 |
Zfp385a | 2516 |
Phf20 | 1127 |
Akt3 | -553 |
Akt2 | -867 |
Trp53bp2 | -1465 |
Trp63 | -4363 |
CYTOSOLIC TRNA AMINOACYLATION
204 | |
---|---|
set | CYTOSOLIC TRNA AMINOACYLATION |
setSize | 24 |
pANOVA | 0.000542 |
s.dist | 0.408 |
p.adjustANOVA | 0.00694 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Hars | 8296 |
Rars | 7470 |
Aimp2 | 7422 |
Farsb | 7200 |
Ppa1 | 7100 |
Eef1e1 | 6693 |
Yars | 6613 |
Mars1 | 6307 |
Wars | 6255 |
Aars | 5085 |
Iars | 5037 |
Qars | 4241 |
Gars | 3840 |
Dars | 3101 |
Kars | 2794 |
Nars | 1886 |
Lars | 954 |
Aimp1 | -438 |
Tars | -1336 |
Cars | -1854 |
GeneID | Gene Rank |
---|---|
Hars | 8296 |
Rars | 7470 |
Aimp2 | 7422 |
Farsb | 7200 |
Ppa1 | 7100 |
Eef1e1 | 6693 |
Yars | 6613 |
Mars1 | 6307 |
Wars | 6255 |
Aars | 5085 |
Iars | 5037 |
Qars | 4241 |
Gars | 3840 |
Dars | 3101 |
Kars | 2794 |
Nars | 1886 |
Lars | 954 |
Aimp1 | -438 |
Tars | -1336 |
Cars | -1854 |
Sars | -2074 |
Eprs | -2545 |
Vars | -2868 |
Farsa | -3226 |
INSERTION OF TAIL ANCHORED PROTEINS INTO THE ENDOPLASMIC RETICULUM MEMBRANE
455 | |
---|---|
set | INSERTION OF TAIL ANCHORED PROTEINS INTO THE ENDOPLASMIC RETICULUM MEMBRANE |
setSize | 22 |
pANOVA | 0.000958 |
s.dist | 0.407 |
p.adjustANOVA | 0.0105 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Get1 | 8075 |
Stx1a | 7268 |
Prnp | 7171 |
Get3 | 7133 |
Bag6 | 5899 |
App | 5597 |
Ubl4a | 5381 |
Sgta | 5139 |
Cyb5a | 5083 |
Vamp2 | 4705 |
Emd | 4453 |
Serp1 | 4344 |
Vapa | 3068 |
Sec61g | 2203 |
Hmox1 | 1080 |
Stx5a | 589 |
Caml | 501 |
Otof | -913 |
Get4 | -945 |
Sec61b | -1209 |
GeneID | Gene Rank |
---|---|
Get1 | 8075 |
Stx1a | 7268 |
Prnp | 7171 |
Get3 | 7133 |
Bag6 | 5899 |
App | 5597 |
Ubl4a | 5381 |
Sgta | 5139 |
Cyb5a | 5083 |
Vamp2 | 4705 |
Emd | 4453 |
Serp1 | 4344 |
Vapa | 3068 |
Sec61g | 2203 |
Hmox1 | 1080 |
Stx5a | 589 |
Caml | 501 |
Otof | -913 |
Get4 | -945 |
Sec61b | -1209 |
Aldh3a2 | -2412 |
Ube2j2 | -2804 |
GLYCOSPHINGOLIPID METABOLISM
395 | |
---|---|
set | GLYCOSPHINGOLIPID METABOLISM |
setSize | 38 |
pANOVA | 1.44e-05 |
s.dist | 0.407 |
p.adjustANOVA | 0.000409 |
Top enriched genes
GeneID | Gene Rank |
---|---|
B3galnt1 | 8049 |
B4galnt1 | 7752 |
Ugt8a | 7448 |
Galc | 7210 |
Neu2 | 7012 |
Smpd1 | 6878 |
Gba2 | 6789 |
Arsa | 6740 |
Arsb | 6727 |
Neu1 | 6712 |
Asah1 | 6628 |
Esyt1 | 6584 |
Gltp | 6313 |
Gm2a | 6086 |
Neu4 | 5752 |
Psap | 5640 |
Hexa | 5632 |
Gba | 5555 |
Gla | 4912 |
Hexb | 4301 |
GeneID | Gene Rank |
---|---|
B3galnt1 | 8049 |
B4galnt1 | 7752 |
Ugt8a | 7448 |
Galc | 7210 |
Neu2 | 7012 |
Smpd1 | 6878 |
Gba2 | 6789 |
Arsa | 6740 |
Arsb | 6727 |
Neu1 | 6712 |
Asah1 | 6628 |
Esyt1 | 6584 |
Gltp | 6313 |
Gm2a | 6086 |
Neu4 | 5752 |
Psap | 5640 |
Hexa | 5632 |
Gba | 5555 |
Gla | 4912 |
Hexb | 4301 |
Smpd3 | 4201 |
Ugcg | 2966 |
Neu3 | 2480 |
Sumf1 | 2210 |
Glb1 | 2200 |
Sumf2 | 2175 |
Arsk | 1769 |
Glb1l | 552 |
Esyt3 | -116 |
Cptp | -917 |
Smpd4 | -2131 |
Ctsa | -2132 |
Arsj | -2309 |
Asah2 | -2426 |
Smpd2 | -2819 |
Arsg | -3310 |
Cerk | -4543 |
Esyt2 | -6870 |
WNT LIGAND BIOGENESIS AND TRAFFICKING
1172 | |
---|---|
set | WNT LIGAND BIOGENESIS AND TRAFFICKING |
setSize | 21 |
pANOVA | 0.00161 |
s.dist | 0.398 |
p.adjustANOVA | 0.0157 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Wnt11 | 8332 |
Wls | 8074 |
Wnt9b | 7248 |
Snx3 | 7021 |
Vps35 | 6713 |
Vps26a | 4676 |
Wnt7b | 4599 |
Vps29 | 4572 |
Wnt9a | 3777 |
Wnt3 | 3484 |
Wnt10a | 2478 |
Wnt2b | 2458 |
Wnt2 | 2439 |
Wnt7a | 2245 |
Wnt4 | 1511 |
Wnt16 | 1064 |
Porcn | 771 |
Tmed5 | 170 |
Wnt5b | 161 |
Wnt6 | -1598 |
GeneID | Gene Rank |
---|---|
Wnt11 | 8332 |
Wls | 8074 |
Wnt9b | 7248 |
Snx3 | 7021 |
Vps35 | 6713 |
Vps26a | 4676 |
Wnt7b | 4599 |
Vps29 | 4572 |
Wnt9a | 3777 |
Wnt3 | 3484 |
Wnt10a | 2478 |
Wnt2b | 2458 |
Wnt2 | 2439 |
Wnt7a | 2245 |
Wnt4 | 1511 |
Wnt16 | 1064 |
Porcn | 771 |
Tmed5 | 170 |
Wnt5b | 161 |
Wnt6 | -1598 |
Wnt5a | -5644 |
SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS
1051 | |
---|---|
set | SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS |
setSize | 20 |
pANOVA | 0.00211 |
s.dist | 0.397 |
p.adjustANOVA | 0.0191 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Acsl4 | 7747 |
Acsbg1 | 7636 |
Hsd17b12 | 7631 |
Elovl1 | 7473 |
Tecr | 7018 |
Hacd2 | 6515 |
Acsl6 | 6049 |
Hacd3 | 5881 |
Elovl4 | 5850 |
Acsl5 | 4917 |
Acsl3 | 4277 |
Elovl6 | 2861 |
Acsl1 | 2715 |
Elovl5 | 2632 |
Elovl2 | 2613 |
Slc27a3 | 2119 |
Acsf3 | -1821 |
Hacd4 | -3874 |
Elovl7 | -8098 |
Hacd1 | -8737 |
GeneID | Gene Rank |
---|---|
Acsl4 | 7747 |
Acsbg1 | 7636 |
Hsd17b12 | 7631 |
Elovl1 | 7473 |
Tecr | 7018 |
Hacd2 | 6515 |
Acsl6 | 6049 |
Hacd3 | 5881 |
Elovl4 | 5850 |
Acsl5 | 4917 |
Acsl3 | 4277 |
Elovl6 | 2861 |
Acsl1 | 2715 |
Elovl5 | 2632 |
Elovl2 | 2613 |
Slc27a3 | 2119 |
Acsf3 | -1821 |
Hacd4 | -3874 |
Elovl7 | -8098 |
Hacd1 | -8737 |
GLYCOGEN BREAKDOWN GLYCOGENOLYSIS
389 | |
---|---|
set | GLYCOGEN BREAKDOWN GLYCOGENOLYSIS |
setSize | 14 |
pANOVA | 0.0108 |
s.dist | 0.394 |
p.adjustANOVA | 0.0596 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Gyg | 7709 |
Gaa | 7535 |
Pygb | 7372 |
Pygm | 6866 |
Pgm2 | 6644 |
Phkb | 5292 |
Phka1 | 3669 |
Phkg1 | 1377 |
Phkg2 | 1354 |
Agl | 1034 |
Calm1 | 451 |
Phka2 | -1545 |
Pgm2l1 | -2578 |
Pygl | -2603 |
GeneID | Gene Rank |
---|---|
Gyg | 7709 |
Gaa | 7535 |
Pygb | 7372 |
Pygm | 6866 |
Pgm2 | 6644 |
Phkb | 5292 |
Phka1 | 3669 |
Phkg1 | 1377 |
Phkg2 | 1354 |
Agl | 1034 |
Calm1 | 451 |
Phka2 | -1545 |
Pgm2l1 | -2578 |
Pygl | -2603 |
SUPPRESSION OF PHAGOSOMAL MATURATION
1029 | |
---|---|
set | SUPPRESSION OF PHAGOSOMAL MATURATION |
setSize | 12 |
pANOVA | 0.0183 |
s.dist | 0.393 |
p.adjustANOVA | 0.0839 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Rab5a | 7203 |
Atp6v1h | 6959 |
Rab7 | 5493 |
Hgs | 5340 |
Kpna1 | 5148 |
Ubc | 4500 |
Coro1a | 3187 |
Kpnb1 | 3095 |
Vps33b | 2935 |
Ubb | 1303 |
Rps27a | -478 |
Uba52 | -8214 |
GeneID | Gene Rank |
---|---|
Rab5a | 7203 |
Atp6v1h | 6959 |
Rab7 | 5493 |
Hgs | 5340 |
Kpna1 | 5148 |
Ubc | 4500 |
Coro1a | 3187 |
Kpnb1 | 3095 |
Vps33b | 2935 |
Ubb | 1303 |
Rps27a | -478 |
Uba52 | -8214 |
CS DS DEGRADATION
192 | |
---|---|
set | CS DS DEGRADATION |
setSize | 14 |
pANOVA | 0.0124 |
s.dist | 0.386 |
p.adjustANOVA | 0.0653 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ids | 7281 |
Arsb | 6727 |
Vcan | 6689 |
Bgn | 6560 |
Hexa | 5632 |
Cspg4 | 4947 |
Bcan | 4794 |
Cspg5 | 4632 |
Hexb | 4301 |
Hyal3 | 1783 |
Hyal1 | -217 |
Dcn | -2326 |
Ncan | -3335 |
Idua | -5808 |
GeneID | Gene Rank |
---|---|
Ids | 7281 |
Arsb | 6727 |
Vcan | 6689 |
Bgn | 6560 |
Hexa | 5632 |
Cspg4 | 4947 |
Bcan | 4794 |
Cspg5 | 4632 |
Hexb | 4301 |
Hyal3 | 1783 |
Hyal1 | -217 |
Dcn | -2326 |
Ncan | -3335 |
Idua | -5808 |
IRE1ALPHA ACTIVATES CHAPERONES
499 | |
---|---|
set | IRE1ALPHA ACTIVATES CHAPERONES |
setSize | 50 |
pANOVA | 2.69e-06 |
s.dist | 0.384 |
p.adjustANOVA | 0.000113 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Tpp1 | 8361 |
Pdia6 | 8350 |
Dnajc3 | 8341 |
Hspa5 | 8305 |
Xbp1 | 8257 |
Srprb | 7690 |
Atp6v0d1 | 7589 |
Dnajb11 | 7552 |
Gfpt1 | 7055 |
Dnajb9 | 7051 |
Srpr | 6286 |
Lmna | 6276 |
Dctn1 | 6188 |
Preb | 6171 |
Hyou1 | 6156 |
Kdelr3 | 6076 |
Ppp2r5b | 5757 |
Yif1a | 5615 |
Ssr1 | 5263 |
Cxxc1 | 5183 |
GeneID | Gene Rank |
---|---|
Tpp1 | 8361 |
Pdia6 | 8350 |
Dnajc3 | 8341 |
Hspa5 | 8305 |
Xbp1 | 8257 |
Srprb | 7690 |
Atp6v0d1 | 7589 |
Dnajb11 | 7552 |
Gfpt1 | 7055 |
Dnajb9 | 7051 |
Srpr | 6286 |
Lmna | 6276 |
Dctn1 | 6188 |
Preb | 6171 |
Hyou1 | 6156 |
Kdelr3 | 6076 |
Ppp2r5b | 5757 |
Yif1a | 5615 |
Ssr1 | 5263 |
Cxxc1 | 5183 |
Syvn1 | 5168 |
Gosr2 | 4982 |
Add1 | 4819 |
Gsk3a | 4754 |
Serp1 | 4344 |
Fkbp14 | 3752 |
Klhdc3 | 3596 |
Sec31a | 2662 |
Hdgf | 2607 |
Extl2 | 1797 |
Zbtb17 | 1437 |
Shc1 | 1324 |
Tln1 | 568 |
Pla2g4b | 350 |
Extl3 | 129 |
Ddx11 | -7 |
Tspyl2 | -19 |
Cul7 | -176 |
Mydgf | -424 |
Sult1a1 | -440 |
Ctdsp2 | -499 |
Arfgap1 | -632 |
Edem1 | -1059 |
Ern1 | -1073 |
Tatdn2 | -2662 |
Wfs1 | -2872 |
Extl1 | -3822 |
Acadvl | -5474 |
Wipi1 | -6579 |
Pdia5 | -6746 |
KERATAN SULFATE DEGRADATION
506 | |
---|---|
set | KERATAN SULFATE DEGRADATION |
setSize | 11 |
pANOVA | 0.0284 |
s.dist | 0.382 |
p.adjustANOVA | 0.114 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Prelp | 8307 |
Hexa | 5632 |
Acan | 5261 |
Gns | 4656 |
Hexb | 4301 |
Fmod | 4018 |
Lum | 3386 |
Glb1 | 2200 |
Glb1l | 552 |
Ogn | -1934 |
Galns | -4080 |
GeneID | Gene Rank |
---|---|
Prelp | 8307 |
Hexa | 5632 |
Acan | 5261 |
Gns | 4656 |
Hexb | 4301 |
Fmod | 4018 |
Lum | 3386 |
Glb1 | 2200 |
Glb1l | 552 |
Ogn | -1934 |
Galns | -4080 |
ACTIVATION OF AMPK DOWNSTREAM OF NMDARS
15 | |
---|---|
set | ACTIVATION OF AMPK DOWNSTREAM OF NMDARS |
setSize | 20 |
pANOVA | 0.00336 |
s.dist | 0.379 |
p.adjustANOVA | 0.0262 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Tubb2a | 8130 |
Tuba1b | 7873 |
Tubb4b | 7622 |
Tubb4a | 7517 |
Tubb2b | 7504 |
Tuba4a | 7208 |
Tuba1a | 7067 |
Prkab1 | 6043 |
Tubb3 | 5842 |
Prkag2 | 5796 |
Tuba1c | 4485 |
Tubb6 | 1806 |
Prkag1 | 1594 |
Prkaa1 | 1545 |
Prkaa2 | 1347 |
Calm1 | 451 |
Mapt | -5193 |
Tuba8 | -5577 |
Prkab2 | -5817 |
Camkk2 | -7039 |
GeneID | Gene Rank |
---|---|
Tubb2a | 8130 |
Tuba1b | 7873 |
Tubb4b | 7622 |
Tubb4a | 7517 |
Tubb2b | 7504 |
Tuba4a | 7208 |
Tuba1a | 7067 |
Prkab1 | 6043 |
Tubb3 | 5842 |
Prkag2 | 5796 |
Tuba1c | 4485 |
Tubb6 | 1806 |
Prkag1 | 1594 |
Prkaa1 | 1545 |
Prkaa2 | 1347 |
Calm1 | 451 |
Mapt | -5193 |
Tuba8 | -5577 |
Prkab2 | -5817 |
Camkk2 | -7039 |
RECYCLING PATHWAY OF L1
783 | |
---|---|
set | RECYCLING PATHWAY OF L1 |
setSize | 40 |
pANOVA | 3.41e-05 |
s.dist | 0.379 |
p.adjustANOVA | 0.00082 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Rps6ka6 | 8267 |
Tubb2a | 8130 |
Tuba1b | 7873 |
Ap2m1 | 7792 |
Tubb4b | 7622 |
Dnm2 | 7614 |
Ap2b1 | 7522 |
Tubb4a | 7517 |
Tubb2b | 7504 |
Rps6ka4 | 7347 |
Tuba4a | 7208 |
Mapk1 | 7097 |
Tuba1a | 7067 |
Ap2a2 | 6984 |
Ezr | 6776 |
Ap2a1 | 6110 |
Tubb3 | 5842 |
Tuba1c | 4485 |
Cltc | 4483 |
Clta | 3556 |
GeneID | Gene Rank |
---|---|
Rps6ka6 | 8267 |
Tubb2a | 8130 |
Tuba1b | 7873 |
Ap2m1 | 7792 |
Tubb4b | 7622 |
Dnm2 | 7614 |
Ap2b1 | 7522 |
Tubb4a | 7517 |
Tubb2b | 7504 |
Rps6ka4 | 7347 |
Tuba4a | 7208 |
Mapk1 | 7097 |
Tuba1a | 7067 |
Ap2a2 | 6984 |
Ezr | 6776 |
Ap2a1 | 6110 |
Tubb3 | 5842 |
Tuba1c | 4485 |
Cltc | 4483 |
Clta | 3556 |
L1cam | 3330 |
Sh3gl2 | 2855 |
Src | 2551 |
Dnm3 | 2297 |
Rps6ka5 | 2127 |
Actg1 | 1983 |
Tubb6 | 1806 |
Numb | 1403 |
Dnm1 | 814 |
Msn | 773 |
Shtn1 | 78 |
Rps6ka2 | -976 |
Rps6ka3 | -1313 |
Rdx | -1895 |
Ap2s1 | -3475 |
Rps6ka1 | -4789 |
Tuba8 | -5577 |
Dpysl2 | -5750 |
Actb | -8390 |
Kif4 | -8456 |
POST CHAPERONIN TUBULIN FOLDING PATHWAY
725 | |
---|---|
set | POST CHAPERONIN TUBULIN FOLDING PATHWAY |
setSize | 17 |
pANOVA | 0.00701 |
s.dist | 0.378 |
p.adjustANOVA | 0.0449 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Tubb2a | 8130 |
Tuba1b | 7873 |
Tubb4b | 7622 |
Tubb4a | 7517 |
Tubb2b | 7504 |
Tuba4a | 7208 |
Tuba1a | 7067 |
Tbcd | 7046 |
Tubb3 | 5842 |
Tuba1c | 4485 |
Tubb6 | 1806 |
Arl2 | -1610 |
Tbcb | -1675 |
Tbcc | -2972 |
Tbca | -5113 |
Tuba8 | -5577 |
Tbce | -5838 |
GeneID | Gene Rank |
---|---|
Tubb2a | 8130 |
Tuba1b | 7873 |
Tubb4b | 7622 |
Tubb4a | 7517 |
Tubb2b | 7504 |
Tuba4a | 7208 |
Tuba1a | 7067 |
Tbcd | 7046 |
Tubb3 | 5842 |
Tuba1c | 4485 |
Tubb6 | 1806 |
Arl2 | -1610 |
Tbcb | -1675 |
Tbcc | -2972 |
Tbca | -5113 |
Tuba8 | -5577 |
Tbce | -5838 |
COPI MEDIATED ANTEROGRADE TRANSPORT
183 | |
---|---|
set | COPI MEDIATED ANTEROGRADE TRANSPORT |
setSize | 91 |
pANOVA | 5.78e-10 |
s.dist | 0.376 |
p.adjustANOVA | 5.23e-08 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Tmed9 | 8187 |
Tubb2a | 8130 |
Arf4 | 8012 |
Tmed2 | 7972 |
Tuba1b | 7873 |
Cog4 | 7856 |
Capza2 | 7704 |
Tmed7 | 7627 |
Tubb4b | 7622 |
Cog1 | 7546 |
Tubb4a | 7517 |
Tubb2b | 7504 |
Copb1 | 7477 |
Actr1a | 7389 |
Capza1 | 7253 |
Tuba4a | 7208 |
Dctn4 | 7177 |
Tuba1a | 7067 |
Cog6 | 6960 |
Arf1 | 6877 |
GeneID | Gene Rank |
---|---|
Tmed9 | 8187 |
Tubb2a | 8130 |
Arf4 | 8012 |
Tmed2 | 7972 |
Tuba1b | 7873 |
Cog4 | 7856 |
Capza2 | 7704 |
Tmed7 | 7627 |
Tubb4b | 7622 |
Cog1 | 7546 |
Tubb4a | 7517 |
Tubb2b | 7504 |
Copb1 | 7477 |
Actr1a | 7389 |
Capza1 | 7253 |
Tuba4a | 7208 |
Dctn4 | 7177 |
Tuba1a | 7067 |
Cog6 | 6960 |
Arf1 | 6877 |
Kdelr1 | 6862 |
Uso1 | 6853 |
Dctn6 | 6465 |
Arcn1 | 6445 |
Cd55 | 6367 |
Rab1b | 6316 |
Dctn1 | 6188 |
Rab1a | 6145 |
Kdelr3 | 6076 |
Tmed10 | 6028 |
Napg | 5982 |
Tubb3 | 5842 |
Dync1i1 | 5759 |
Arfgap3 | 5741 |
Napa | 5703 |
Folr1 | 5697 |
Dctn5 | 5433 |
Arfgap2 | 5268 |
Capzb | 5208 |
Gosr2 | 4982 |
Nsf | 4518 |
Tmed3 | 4493 |
Tuba1c | 4485 |
Tmem115 | 4275 |
Ykt6 | 4251 |
Copa | 4198 |
Gorasp1 | 4112 |
Copb2 | 3644 |
Dynll1 | 3613 |
Copz1 | 3591 |
Gbf1 | 3363 |
Dctn2 | 3314 |
Cope | 3293 |
Cog5 | 3262 |
Copg1 | 3114 |
Actr10 | 2962 |
Dync1li1 | 2623 |
Napb | 2381 |
Tubb6 | 1806 |
Arf3 | 1385 |
Dync1h1 | 1341 |
Sptbn5 | 1069 |
Cog2 | 852 |
Copg2 | 838 |
Sptan1 | 630 |
Stx5a | 589 |
Dctn3 | 329 |
Cog7 | 83 |
Bet1 | -245 |
Gosr1 | -355 |
Arfgap1 | -632 |
Sptbn1 | -845 |
Arf5 | -1490 |
Cog8 | -1844 |
Dynll2 | -1891 |
Cog3 | -2028 |
Sptbn2 | -2336 |
Sptb | -2663 |
Golga2 | -3175 |
Sptbn4 | -3397 |
Copz2 | -3435 |
Dync1li2 | -3541 |
Dync1i2 | -3902 |
Ank1 | -5320 |
Cd59b | -5413 |
Tuba8 | -5577 |
Kdelr2 | -5779 |
Ank2 | -6065 |
Bet1l | -7424 |
Golgb1 | -7435 |
Ank3 | -8754 |
Here is the session info with all the versions of packages used.
sessionInfo()
## R version 4.1.3 (2022-03-10)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 20.04.4 LTS
##
## Matrix products: default
## BLAS: /usr/lib/x86_64-linux-gnu/blas/libblas.so.3.9.0
## LAPACK: /usr/lib/x86_64-linux-gnu/lapack/liblapack.so.3.9.0
##
## locale:
## [1] LC_CTYPE=en_US.UTF-8 LC_NUMERIC=C
## [3] LC_TIME=en_US.UTF-8 LC_COLLATE=en_US.UTF-8
## [5] LC_MONETARY=en_US.UTF-8 LC_MESSAGES=en_US.UTF-8
## [7] LC_PAPER=en_US.UTF-8 LC_NAME=C
## [9] LC_ADDRESS=C LC_TELEPHONE=C
## [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C
##
## attached base packages:
## [1] parallel stats4 stats graphics grDevices utils datasets
## [8] methods base
##
## other attached packages:
## [1] pkgload_1.2.4 GGally_2.1.2
## [3] gtools_3.9.2 echarts4r_0.4.3
## [5] beeswarm_0.4.0 vioplot_0.3.7
## [7] sm_2.2-5.7 kableExtra_1.3.4
## [9] topconfects_1.8.0 limma_3.48.3
## [11] eulerr_6.1.1 mitch_1.4.1
## [13] MASS_7.3-55 fgsea_1.18.0
## [15] gplots_3.1.1 DESeq2_1.32.0
## [17] SummarizedExperiment_1.22.0 Biobase_2.52.0
## [19] MatrixGenerics_1.4.3 matrixStats_0.61.0
## [21] GenomicRanges_1.44.0 GenomeInfoDb_1.28.4
## [23] IRanges_2.26.0 S4Vectors_0.30.2
## [25] BiocGenerics_0.38.0 reshape2_1.4.4
## [27] forcats_0.5.1 stringr_1.4.0
## [29] dplyr_1.0.8 purrr_0.3.4
## [31] readr_2.1.2 tidyr_1.2.0
## [33] tibble_3.1.6 ggplot2_3.3.5
## [35] tidyverse_1.3.1 zoo_1.8-9
##
## loaded via a namespace (and not attached):
## [1] readxl_1.3.1 backports_1.4.1 fastmatch_1.1-3
## [4] systemfonts_1.0.3 plyr_1.8.6 polylabelr_0.2.0
## [7] splines_4.1.3 BiocParallel_1.26.2 digest_0.6.29
## [10] htmltools_0.5.2 fansi_1.0.2 magrittr_2.0.2
## [13] memoise_2.0.1 tzdb_0.2.0 Biostrings_2.60.2
## [16] annotate_1.70.0 modelr_0.1.8 svglite_2.1.0
## [19] prettyunits_1.1.1 colorspace_2.0-2 blob_1.2.2
## [22] rvest_1.0.2 haven_2.4.3 xfun_0.29
## [25] crayon_1.4.2 RCurl_1.98-1.6 jsonlite_1.7.3
## [28] genefilter_1.74.1 survival_3.2-13 glue_1.6.1
## [31] polyclip_1.10-0 gtable_0.3.0 zlibbioc_1.38.0
## [34] XVector_0.32.0 webshot_0.5.2 DelayedArray_0.18.0
## [37] scales_1.1.1 DBI_1.1.2 Rcpp_1.0.8
## [40] progress_1.2.2 viridisLite_0.4.0 xtable_1.8-4
## [43] bit_4.0.4 htmlwidgets_1.5.4 httr_1.4.2
## [46] RColorBrewer_1.1-2 ellipsis_0.3.2 farver_2.1.0
## [49] pkgconfig_2.0.3 reshape_0.8.8 XML_3.99-0.8
## [52] sass_0.4.0 dbplyr_2.1.1 locfit_1.5-9.4
## [55] utf8_1.2.2 labeling_0.4.2 tidyselect_1.1.1
## [58] rlang_1.0.1 later_1.3.0 AnnotationDbi_1.54.1
## [61] munsell_0.5.0 cellranger_1.1.0 tools_4.1.3
## [64] cachem_1.0.6 cli_3.1.1 generics_0.1.2
## [67] RSQLite_2.2.9 broom_0.7.12 evaluate_0.14
## [70] fastmap_1.1.0 yaml_2.2.2 knitr_1.37
## [73] bit64_4.0.5 fs_1.5.2 caTools_1.18.2
## [76] KEGGREST_1.32.0 mime_0.12 xml2_1.3.3
## [79] compiler_4.1.3 rstudioapi_0.13 png_0.1-7
## [82] reprex_2.0.1 geneplotter_1.70.0 bslib_0.3.1
## [85] stringi_1.7.6 highr_0.9 desc_1.4.0
## [88] lattice_0.20-45 Matrix_1.4-0 vctrs_0.3.8
## [91] pillar_1.7.0 lifecycle_1.0.1 jquerylib_0.1.4
## [94] data.table_1.14.2 bitops_1.0-7 httpuv_1.6.5
## [97] R6_2.5.1 promises_1.2.0.1 KernSmooth_2.23-20
## [100] gridExtra_2.3 assertthat_0.2.1 rprojroot_2.0.2
## [103] withr_2.4.3 GenomeInfoDbData_1.2.6 hms_1.1.1
## [106] grid_4.1.3 rmarkdown_2.11 shiny_1.7.1
## [109] lubridate_1.8.0
END of report